{"data":{"filter_options":{"titles":[{"name":"Managing Partner Atlanta Office","value":"Managing Partner Atlanta Office"},{"name":"Partner","value":"Partner"},{"name":"Partner / Head of Pro Bono","value":"Partner / Head of Pro Bono"},{"name":"Partner / Chief Operating Officer","value":"Partner / Chief Operating Officer"},{"name":"Partner / General Counsel","value":"Partner / General Counsel"},{"name":"Partner / Dir. E-Discovery Ops","value":"Partner / Dir. E-Discovery Ops"},{"name":"Partner / Chairman, Saudi Arabia Practice","value":"Partner / Chairman, Saudi Arabia Practice"},{"name":"K\u0026S Talent Partner","value":"K\u0026S Talent Partner"},{"name":"Partner / Chief Human Resources Officer","value":"Partner / Chief Human Resources Officer"},{"name":"Chairman","value":"Chairman"},{"name":"Senior Counsel","value":"Senior Counsel"},{"name":"Associate Director, E-Discovery Operations","value":"Associate Director, E-Discovery Operations"},{"name":"Counsel","value":"Counsel"},{"name":"Senior Associate","value":"Senior Associate"},{"name":"Associate","value":"Associate"},{"name":"Senior Attorney","value":"Senior Attorney"},{"name":"Senior Lawyer","value":"Senior Lawyer"},{"name":"Attorney","value":"Attorney"},{"name":"Senior Counsel and Policy Advisor","value":"Senior Counsel and Policy Advisor"},{"name":"Managing Director - Capital Solutions","value":"Managing Director - Capital Solutions"},{"name":"Senior Government Relations Advisor","value":"Senior Government Relations Advisor"},{"name":"Associate General Counsel","value":"Associate General Counsel"},{"name":"Senior Advisor","value":"Senior Advisor"},{"name":"Patent Agent","value":"Patent Agent"},{"name":"Consultant","value":"Consultant"},{"name":"Government Relations Advisor","value":"Government Relations Advisor"},{"name":"Chief of Lateral Partner Recruiting \u0026 Integration","value":"Chief of Lateral Partner Recruiting \u0026 Integration"},{"name":"Chief Financial Officer","value":"Chief Financial Officer"},{"name":"Chief Information Officer","value":"Chief Information Officer"},{"name":"Chief Revenue Officer","value":"Chief Revenue Officer"},{"name":"Chief Recruiting Officer","value":"Chief Recruiting Officer"},{"name":"Chief Lawyer Talent Development Officer","value":"Chief Lawyer Talent Development Officer"},{"name":"Chief Marketing Officer","value":"Chief Marketing Officer"},{"name":"Tax Consultant","value":"Tax Consultant"},{"name":"Director of Community Affairs","value":"Director of Community Affairs"},{"name":"Director of Facilities \u0026 Admin Operations","value":"Director of Facilities \u0026 Admin Operations"},{"name":"Senior Office Manager","value":"Senior Office Manager"},{"name":"Director of Operations","value":"Director of Operations"},{"name":"Pro Bono Deputy","value":"Pro Bono Deputy"},{"name":"Director of Office Operations","value":"Director of Office Operations"},{"name":"Director of Operations Europe","value":"Director of Operations Europe"},{"name":"Law Clerk","value":"Law Clerk"},{"name":"Deputy General Counsel","value":"Deputy General Counsel"}],"schools":[{"name":"(Commercial Law), in front of Monash University, Australia","value":3045},{"name":"Aberystwyth University","value":3004},{"name":"Albany Law School","value":2118},{"name":"American University Washington College of Law","value":3042},{"name":"American University, Washington College of Law","value":3024},{"name":"Appalachian School of Law","value":2891},{"name":"Ateneo de Manila University","value":2914},{"name":"Ave Maria School of Law","value":2892},{"name":"Baylor University School of Law","value":181},{"name":"Benjamin N. Cardozo School of Law","value":2619},{"name":"Binghamton University","value":3002},{"name":"Boston College Law School","value":245},{"name":"Boston University School of Law","value":247},{"name":"BPP Law School Leeds","value":2642},{"name":"BPP Law School London","value":2782},{"name":"BPP University","value":2984},{"name":"Brooklyn Law School","value":2705},{"name":"Cairo University, Law School","value":2962},{"name":"California Western School of Law","value":315},{"name":"Capital University Law School","value":327},{"name":"Case Western Reserve University School of Law","value":345},{"name":"Cecil C. Humphreys School of Law","value":2235},{"name":"Chapman University School of Law","value":377},{"name":"Charleston School of Law","value":2910},{"name":"City Law School, London","value":2998},{"name":"City Law School","value":2857},{"name":"Clark University","value":3006},{"name":"Cleveland-Marshall College of Law","value":426},{"name":"Columbia University School of International and Public Affairs","value":3008},{"name":"Columbia University School of Law","value":485},{"name":"Columbia University","value":3126},{"name":"Columbus School of Law, Catholic University of America","value":3010},{"name":"Columbus School of Law","value":350},{"name":"Concord Law School of Kaplan University","value":1026},{"name":"Cornell Law School","value":512},{"name":"Creighton University School of Law","value":518},{"name":"Creighton University","value":3025},{"name":"Cumberland School of Law","value":1759},{"name":"CUNY School of Law","value":2893},{"name":"David A. Clarke School of Law","value":2399},{"name":"Deakin University School of Law","value":2907},{"name":"DePaul University College of Law","value":565},{"name":"DePaul University College of Law","value":3060},{"name":"Dickinson School of Law","value":2719},{"name":"Drake University Law School","value":609},{"name":"Duke University School of Law","value":613},{"name":"Duquesne University School of Law","value":614},{"name":"Dwayne O. Andreas School of Law","value":173},{"name":"Edinburgh Law School","value":3160},{"name":"Emory University School of Law","value":659},{"name":"ESADE Business and Law School – Universidad Ramon Llull","value":3215},{"name":"Fachseminare von Fürstenberg","value":2918},{"name":"Faculté Libre de Droit, Université Catholique de Lille","value":3055},{"name":"Faculty of Law, University of Zagreb","value":2983},{"name":"Faculty of Law","value":2944},{"name":"Faculty of Law","value":3039},{"name":"Federal University of Rio de Janeiro","value":3022},{"name":"Federal University of Rio Grande do Sul School of Law (Brazil)","value":3062},{"name":"Florida A\u0026M University College of Law","value":699},{"name":"Florida Coastal School of Law","value":2894},{"name":"Florida International College of Law","value":707},{"name":"Florida State University College of Law","value":720},{"name":"Fordham University School of Law","value":722},{"name":"Franklin Pierce Law Center","value":734},{"name":"Friedrich-Schiller-Universität Jena","value":3015},{"name":"George Mason University School of Law","value":752},{"name":"George Washington University Law School","value":753},{"name":"Georgetown University Law Center","value":755},{"name":"Georgia State University College of Law","value":761},{"name":"Ghent Law School","value":2793},{"name":"Golden Gate University School of Law","value":770},{"name":"Gonzaga University School of Law","value":772},{"name":"Graduate Institute of International and Development Studies, Geneva","value":2997},{"name":"Hamline University School of Law","value":811},{"name":"Harvard Law School","value":824},{"name":"Hebrew University of Jerusalem Faculty of Law","value":2994},{"name":"Hofstra University School of Law","value":858},{"name":"Howard University School of Law","value":872},{"name":"Huazhong University of Science and Technology","value":3016},{"name":"Humboldt University of Berlin","value":3012},{"name":"Indiana University School of Law","value":2711},{"name":"Indiana University School of Law","value":890},{"name":"International Association of Privacy Professionals","value":3009},{"name":"J. Reuben Clark Law School","value":262},{"name":"Jacob D. Fuchsberg Law Center","value":2084},{"name":"James Cook University of North Queensland","value":3034},{"name":"Jean Moulin University Lyon 3, France","value":2938},{"name":"Johns Hopkins Bloomberg School of Public Health","value":2992},{"name":"Justus-Liebig-Universität Gießen Rechtswissenschaft (Germany)","value":3063},{"name":"Kansas City School of Law","value":2247},{"name":"Keio University","value":2968},{"name":"Kent College of Law","value":883},{"name":"Kline School of Law","value":611},{"name":"KU Leuven","value":3007},{"name":"Levin College of Law","value":2189},{"name":"Lewis and Clark Law School","value":1089},{"name":"Liberty University School of Law","value":1094},{"name":"Lincoln College of Law","value":2253},{"name":"LL.M. in International Crime and Justice UNICRI","value":2937},{"name":"Loyola Law School","value":2895},{"name":"Loyola University Chicago School of Law","value":1135},{"name":"Loyola University New Orleans College of Law","value":1136},{"name":"Marquette University Law School","value":1176},{"name":"McGeorge School of Law","value":2402},{"name":"McGill University","value":2659},{"name":"Melbourne Law School","value":2899},{"name":"Mercer University Walter F. George School of Law","value":1221},{"name":"Mexico Autonomous Institute of Technology","value":2996},{"name":"Michael E. Moritz College of Law","value":2728},{"name":"Michigan State University College of Law","value":1245},{"name":"Mississippi College School of Law","value":1285},{"name":"Moscow State University","value":2815},{"name":"National and Kapodistrian University of Athens","value":3032},{"name":"National Law University Jodhpur","value":3020},{"name":"National University of Singapore, Faculty of Law","value":2662},{"name":"New England School of Law","value":2886},{"name":"New York Law School","value":1403},{"name":"New York University School of Law","value":1406},{"name":"Norman Adrian Wiggins School of Law","value":323},{"name":"North Carolina Central University School of Law","value":1417},{"name":"Northeastern University School of Law","value":1430},{"name":"Northern Illinois University College of Law","value":1432},{"name":"Northwestern Pritzker School of Law","value":1451},{"name":"Notre Dame Law School","value":2278},{"name":"Ohio Northern University Law School","value":3036},{"name":"Oklahoma City University School of Law","value":1487},{"name":"Osgoode Hall Law School","value":3124},{"name":"Pace University School of Law","value":1516},{"name":"Panteion University","value":3033},{"name":"Paul M. Hebert Law Center","value":2713},{"name":"Pennsylvania State University, Dickinson School of Law","value":1562},{"name":"Pepperdine University School of Law","value":1570},{"name":"Pettit College of Law","value":1473},{"name":"Pontificia Universidad Catolica de Chile","value":3203},{"name":"Pontificia Universidad Catolica del Peru","value":3011},{"name":"Pontificia Universidad Javeriana","value":3013},{"name":"Pontificia Universidade Catolica de Sao Paulo","value":3095},{"name":"Prince Sultan University College of Law","value":3167},{"name":"Queens College, Cambridge","value":3003},{"name":"Quinnipiac University School of Law","value":1626},{"name":"Ralph R. Papitto School of Law","value":1686},{"name":"Regent University School of Law","value":1649},{"name":"Rice University","value":3043},{"name":"Ruprecht-Karls-Universität Heidelberg","value":3049},{"name":"Rutgers University School of Law-Newark","value":1699},{"name":"Rutgers University School of Law","value":1697},{"name":"S.J. Quinney College of Law","value":2408},{"name":"Saint Louis University School of Law","value":1732},{"name":"Salmon P. Chase College of Law","value":1433},{"name":"Sandra Day O'Connor College of Law","value":103},{"name":"Santa Clara University School of Law","value":1771},{"name":"Seattle University School of Law","value":1787},{"name":"Seton Hall University School of Law","value":1790},{"name":"Shepard Broad Law Center","value":1460},{"name":"South Texas College of Law","value":2721},{"name":"Southern Illinois University School of Law","value":1849},{"name":"Southern Methodist University Dedman School of Law","value":1852},{"name":"Southern University Law Center","value":1857},{"name":"Southwestern Law School","value":1876},{"name":"St. John's University School of Law","value":2724},{"name":"St. Mary's University School of Law","value":1896},{"name":"St. Thomas University School of Law","value":1746},{"name":"Stanford Law School","value":1904},{"name":"Stetson University College of Law","value":1910},{"name":"Sturm College of Law","value":2184},{"name":"Suffolk University Law School","value":1921},{"name":"Syracuse University College of Law","value":1956},{"name":"Temple University Beasley School of Law","value":1974},{"name":"Texas A\u0026M School of Law","value":1980},{"name":"Texas Tech University School of Law","value":1994},{"name":"Texas Wesleyan University School of Law","value":1996},{"name":"The College of Law Australia","value":3091},{"name":"The College of Law, London","value":2935},{"name":"The John Marshall Law School","value":2034},{"name":"The Judge Advocate General's Legal Center and School","value":2896},{"name":"The Ohio State University Moritz College of Law","value":2990},{"name":"The University of Akron School of Law","value":2143},{"name":"The University of Alabama School of Law","value":2045},{"name":"The University of Birmingham, U.K.","value":2796},{"name":"The University of Iowa College of Law","value":2206},{"name":"The University of Texas School of Law","value":2055},{"name":"The University of Tulsa College of Law","value":2407},{"name":"Thomas Jefferson School of Law","value":685},{"name":"Thomas M. Cooley Law School","value":2729},{"name":"Thurgood Marshall School of Law","value":1992},{"name":"Tianjin University of Commerce","value":2995},{"name":"Tulane University Law School","value":2113},{"name":"UC Davis School of Law","value":2160},{"name":"UCLA School of Law","value":2162},{"name":"Universidad Católica de Honduras","value":2916},{"name":"Universidad Francisco Marroquin","value":3090},{"name":"Universidad Panamericana","value":2904},{"name":"Universidad Torcuato di Tella","value":3035},{"name":"Universidade de São Paulo, Faculdade de Direito","value":3028},{"name":"Universidade Presbiteriana Mackenzie","value":2977},{"name":"Università Commerciale Luigi Bocconi","value":3135},{"name":"University at Buffalo Law School","value":1928},{"name":"University College Dublin Law School","value":2900},{"name":"University of Alberta Faculty of Law","value":3088},{"name":"University of Amsterdam","value":2980},{"name":"University of Arizona, James E. Rogers College of Law","value":2149},{"name":"University of Arkansas School of Law","value":2154},{"name":"University of Baltimore School of Law","value":2156},{"name":"University of California College of the Law","value":3196},{"name":"University of California Hastings College of Law","value":2158},{"name":"University of California Irvine School of Law","value":2161},{"name":"University of California, Berkeley, School of Law","value":2159},{"name":"University of California, Davis","value":3019},{"name":"University of Cambridge, U.K","value":2991},{"name":"University of Canterbury","value":2981},{"name":"University of Central Florida","value":3027},{"name":"University of Chester Law School","value":3005},{"name":"University of Chicago Law School","value":2174},{"name":"University of Chicago","value":3038},{"name":"University of Cincinnati College of Law","value":2175},{"name":"University of Colorado School of Law","value":2177},{"name":"University of Connecticut School of Law","value":2180},{"name":"University of Dayton School of Law","value":2182},{"name":"University of Detroit Mercy School of Law","value":2185},{"name":"University of East Anglia","value":3000},{"name":"University of Florida, Levin College of Law","value":3188},{"name":"University of Georgia School of Law","value":2190},{"name":"University of Houston Law Center","value":2197},{"name":"University of Hull","value":3040},{"name":"University of Idaho College of Law","value":2201},{"name":"University of Illinois College of Law","value":2204},{"name":"University of Kansas School of Law","value":2208},{"name":"University of Kentucky College of Law","value":2210},{"name":"University of La Verne College of Law","value":2211},{"name":"University of Law, London","value":2999},{"name":"University of Lethbridge","value":3030},{"name":"University of Louisville Brandeis School of Law","value":2214},{"name":"University of Maine School of Law","value":2391},{"name":"University of Maryland School of Law","value":2224},{"name":"University of Miami School of Law","value":2236},{"name":"University of Michigan Law School","value":2237},{"name":"University of Minnesota Law School","value":2243},{"name":"University of Mississippi School of Law","value":2244},{"name":"University of Missouri School of Law","value":2246},{"name":"University of Montana School of Law","value":2048},{"name":"University of Nebraska College of Law","value":2744},{"name":"University of New Mexico School of Law","value":2262},{"name":"University of North Carolina School of Law","value":2266},{"name":"University of North Dakota School of Law","value":2271},{"name":"University of Oklahoma Law Center","value":2747},{"name":"University of Oregon School of Law","value":2281},{"name":"University of Pennsylvania Law School","value":2282},{"name":"University of Pittsburgh School of Law","value":2354},{"name":"University of Richmond School of Law","value":2370},{"name":"University of San Diego School of Law","value":2377},{"name":"University of San Francisco School of Law","value":2378},{"name":"University of South Carolina School of Law","value":2750},{"name":"University of South Dakota School of Law","value":2387},{"name":"University of Southern California Gould School of Law","value":3051},{"name":"University of St. Thomas School of Law","value":2751},{"name":"University of Sydney Law School","value":3031},{"name":"University of Tennessee College of Law","value":2051},{"name":"University of the West of England, Bristol","value":3001},{"name":"University of Toledo College of Law","value":2406},{"name":"University of Toronto","value":2912},{"name":"University of Utah","value":3026},{"name":"University of Virginia School of Law","value":2410},{"name":"University of Washington School of Law","value":2412},{"name":"University of Wisconsin Law School","value":2419},{"name":"University of Wyoming College of Law","value":2429},{"name":"University of Zürich","value":3037},{"name":"University Paris Dauphine","value":2976},{"name":"University Paris II Assas","value":2975},{"name":"University Paris II Assas","value":3052},{"name":"USC Gould School of Law","value":2389},{"name":"Utrecht University","value":3085},{"name":"Valparaiso University School of Law","value":2441},{"name":"Vanderbilt University School of Law","value":2442},{"name":"Vermont Law School","value":2451},{"name":"Villanova University School of Law","value":2454},{"name":"Wake Forest University School of Law","value":2471},{"name":"Washburn University School of Law","value":2482},{"name":"Washington and Lee University School of Law","value":2484},{"name":"Washington College of Law","value":61},{"name":"Washington University in St. Louis School of Law","value":2489},{"name":"Wayne State University Law School","value":2493},{"name":"West Virginia University College of Law","value":2517},{"name":"Western New England College School of Law","value":2528},{"name":"Western State College of Law","value":2897},{"name":"Wharton School of Business","value":3044},{"name":"Whittier Law School","value":2564},{"name":"Widener University Delaware Law School","value":2569},{"name":"Willamette University College of Law","value":2573},{"name":"William \u0026 Mary Law School","value":462},{"name":"William H. Bowen School of Law","value":2150},{"name":"William Mitchell College of Law","value":2758},{"name":"William S. Boyd School of Law","value":2256},{"name":"William S. Richardson School of Law","value":2195},{"name":"Wilmington University","value":2993},{"name":"Yale Law School","value":2605}],"offices":[{"name":"Abu Dhabi","value":13},{"name":"Atlanta","value":1},{"name":"Austin","value":12},{"name":"Brussels","value":23},{"name":"Charlotte","value":8},{"name":"Chicago","value":21},{"name":"Dallas","value":28},{"name":"Denver","value":22},{"name":"Dubai","value":6},{"name":"Frankfurt","value":9},{"name":"Geneva","value":15},{"name":"Houston","value":4},{"name":"London","value":5},{"name":"Los Angeles","value":19},{"name":"Miami","value":25},{"name":"New York","value":3},{"name":"Northern Virginia","value":24},{"name":"Paris","value":14},{"name":"Riyadh","value":27},{"name":"Sacramento","value":20},{"name":"San Francisco","value":10},{"name":"Silicon Valley","value":11},{"name":"Singapore","value":16},{"name":"Sydney","value":26},{"name":"Tokyo","value":18},{"name":"Washington, D.C.","value":2}],"capabilities":[{"name":"Corporate, Finance and Investments","value":"cg-1"},{"name":"Activist Defense","value":72},{"name":"Capital Markets","value":26},{"name":"Construction and Procurement","value":40},{"name":"Corporate Governance","value":27},{"name":"Emerging Companies and Venture Capital","value":80},{"name":"Employee Benefits and Executive Compensation","value":28},{"name":"Energy and Infrastructure Projects","value":35},{"name":"Financial Restructuring","value":10},{"name":"Fund Finance","value":134},{"name":"Global Human Capital and Compliance ","value":121},{"name":"Investment Funds and Asset Management","value":78},{"name":"Leveraged Finance","value":29},{"name":"Mergers and Acquisitions (M\u0026A)","value":32},{"name":"Middle East and Islamic Finance and Investment","value":31},{"name":"Private Equity","value":33},{"name":"Public Companies","value":126},{"name":"Real Estate","value":36},{"name":"Structured Finance and Securitization","value":82},{"name":"Tax","value":37},{"name":"Technology Transactions","value":115},{"name":"Government Matters","value":"cg-2"},{"name":"Antitrust","value":1},{"name":"Data, Privacy and Security","value":6},{"name":"Environmental, Health and Safety","value":71},{"name":"FDA and Life Sciences","value":21},{"name":"Government Advocacy and Public Policy","value":23},{"name":"Government Contracts","value":116},{"name":"Healthcare","value":24},{"name":"Innovation Protection","value":135},{"name":"International Trade","value":25},{"name":"National Security and Corporate Espionage","value":110},{"name":"Securities Enforcement and Regulation","value":20},{"name":"Special Matters and Government Investigations","value":11},{"name":"Trial and Global Disputes","value":"cg-3"},{"name":"Antitrust ","value":129},{"name":"Appellate, Constitutional and Administrative Law","value":2},{"name":"Bankruptcy and Insolvency Litigation","value":38},{"name":"Class Action Defense","value":3},{"name":"Commercial Litigation","value":5},{"name":"Corporate and Securities Litigation","value":19},{"name":"E-Discovery","value":7},{"name":"Global Construction and Infrastructure Disputes","value":4},{"name":"Innovation Protection","value":136},{"name":"Intellectual Property","value":13},{"name":"International Arbitration and Litigation","value":14},{"name":"Labor and Employment","value":15},{"name":"Product Liability","value":17},{"name":"Professional Liability","value":18},{"name":"Toxic \u0026 Environmental Torts","value":16},{"name":"Industries / Issues","value":"cg-4"},{"name":"Artificial Intelligence (AI) and Machine Learning","value":133},{"name":"Automotive, Transportation and Mobility","value":106},{"name":"Buy American","value":124},{"name":"Crisis Management","value":111},{"name":"Doing Business in Latin America","value":132},{"name":"Energy Transition","value":131},{"name":"Energy","value":102},{"name":"Environmental Agenda","value":125},{"name":"Environmental, Social and Governance (ESG)","value":127},{"name":"Financial Services","value":107},{"name":"Focus on Women's Health","value":112},{"name":"Food and Beverage","value":105},{"name":"Higher Education","value":109},{"name":"Life Sciences and Healthcare","value":103},{"name":"Russia/Ukraine","value":128},{"name":"Special Purpose Acquisition Companies (SPACs)","value":123},{"name":"Technology","value":118}]},"title_id":null,"school_id":null,"office_id":"2","capability_id":null,"extra_filter_id":null,"extra_filter_type":null,"q":null,"starts_with":"S","per_page":12,"people":[{"id":426410,"version":1,"owner_type":"Person","owner_id":3373,"payload":{"bio":"\u003cp\u003eDan Sale defends clients in high-stakes government and Congressional investigations, enforcement proceedings, and parallel civil litigation.\u0026nbsp; Concentrating in complex criminal and civil litigation, Dan regularly represents life sciences companies, financial institutions, other highly-regulated companies, and their boards and senior executives in high-profile and sensitive investigations and litigation.\u0026nbsp; Dan has special experience in matters involving: life sciences criminal and civil investigations; Congressional investigations;\u0026nbsp;the False Claims Act; financial crimes, the Foreign Corrupt Practices Act (FCPA);\u0026nbsp; antitrust and market manipulation matters; the securities laws; whistleblower cases; and transnational tax investigations.\u0026nbsp;[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eDan has special experience in cases involving allegations of off-label promotion and kickbacks in the life sciences industry and represented clients in the three largest Anti-Kickback Statute investigations ever resolved with DOJ.\u0026nbsp; Dan also has special experience in state attorney general investigations, and has personally negotiated quiet resolutions with all 50 state AG offices and the District of Columbia.\u0026nbsp; In addition, Dan has considerable experience defending clients in multi-jurisdictional investigations and litigation conducted cooperatively by United States, European, Middle Eastern, Asian and African authorities\u003c/p\u003e\n\u003cp\u003eThe Special Matters \u0026amp; Government Investigations group has been twice recognized by\u0026nbsp;\u003cem\u003eLaw 360\u003c/em\u003e\u0026nbsp;as the \u0026ldquo;White-Collar Group of the Year\u0026rdquo; and described as \u0026ldquo;the premier firm in this practice area\u0026rdquo; by the\u0026nbsp;\u003cem\u003eU.S. News \u0026amp; World Report/Best Lawyers\u0026rsquo;\u003c/em\u003e\u0026nbsp;\u0026ldquo;Best Law Firms\u0026rdquo; survey.\u003c/p\u003e\n\u003cp\u003eDan began his legal career as a law clerk to the Honorable Richard D. Bennett of the United States District Court for the District of Maryland. \u0026nbsp;He received his J.D. from Georgetown University Law Center, where he was an Editorial Board Member of the Tax Lawyer law journal, and his B.A. in economics from Yale University, where he was a Division I All New England Scholar Athlete lacrosse player.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eDan holds Top Secret/SCI security clearances until their expiration.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003ePublications\u003c/strong\u003e\u003c/p\u003e\n\u003cul\u003e\n\u003cli\u003eDan is a regular contributor to the American Bar Association's Criminal Litigation Section's Practice Points publication\u003c/li\u003e\n\u003cli\u003e\u003cem\u003eThe US v. Vascular Solutions Acquittal: Three Lessons for Targets of Off-Label Promotion Enforcement\u003c/em\u003e, Washington Legal Foundation Legal Backgrounder (2016)\u003c/li\u003e\n\u003cli\u003e\u003cem\u003eRecent Trends in Health Care Enforcement and Compliance\u003c/em\u003e, Inside the Minds: Health Care Law Enforcement and Compliance (Apastore 2013)\u003c/li\u003e\n\u003cli\u003e\u003cem\u003eThe Future of Off-Label Promotion Enforcement in the Wake of Caronia \u0026mdash; Toward a First Amendment Safe Harbor\u003c/em\u003e, The Sedona Conference Journal, Volume 14 (2013)\u003c/li\u003e\n\u003cli\u003e\u003cem\u003eOff-Label Promotion: The Criminalization of Scientific Exchange\u003c/em\u003e, Pharma Magazine (UK) (2013)\u003c/li\u003e\n\u003cli\u003e\u003cem\u003eFDA as Arbiter of Truth? The First Amendment, Caronia, and the Future of Off-Label Promotion Enforcement\u003c/em\u003e, ABA White Collar Crime (2013)\u003c/li\u003e\n\u003cli\u003e\u003cem\u003eTenure Trap: Third Circuit Joins Sixth in Holding Tenure Buy-out Payments Subject to FICA Taxation in University of Pittsburgh v. United States\u003c/em\u003e, The Tax Lawyer, Volume 63 (2010)\u003c/li\u003e\n\u003c/ul\u003e","slug":"daniel-sale","email":"dsale@kslaw.com","phone":null,"matters":["\u003cp\u003eRepresenting\u0026nbsp;\u003cem\u003epro bono\u003c/em\u003e\u0026nbsp;a former Army Ranger convicted by court martial of murder in Iraq, resulting in a full Presidential pardon.\u003c/p\u003e","\u003cp\u003eRepresenting an individual in connection with the Special Counsel investigation conducted by Robert Mueller.\u003c/p\u003e","\u003cp\u003eRepresenting a global pharmaceutical company in an industry-wide investigation regarding donations to charitable patient assistance foundations.\u003c/p\u003e","\u003cp\u003eSecured a declination of all criminal and civil liability for a global medical device manufacturer in an investigation involving off-label promotion and fraud issues\u003c/p\u003e","\u003cp\u003eRepresented Vascular Solutions, Inc., a publicly traded medical device manufacturer that was indicted on federal criminal charges relating to off-label promotion and acquitted by a jury of all charges after a four week trial in February 2016.\u003c/p\u003e","\u003cp\u003eRepresenting several individual witnesses and targets in connection with domestic and international investigations of foreign exchange (FX) trading, resulting in no charges.\u003c/p\u003e","\u003cp\u003eRepresented leading pharmaceutical manufacturers into off-label promotion issues by the Department of Justice and multiple U.S. Attorneys\u0026rsquo; Offices, the FDA, the Department of Health and Human Services Office of Inspector General, and various state Attorneys General, as well as parallel federal False Claims Act\u0026nbsp;\u003cem\u003equi tam\u003c/em\u003e\u0026nbsp;litigation.\u003c/p\u003e","\u003cp\u003eRepresented current and former CEOs, high-level executives, and other individuals in FCPA investigations related to events throughout Latin America, the Middle East, China, Mexico, and Eastern Europe.\u003c/p\u003e"],"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":81,"guid":"81.capabilities","index":0,"source":"capabilities"},{"id":687,"guid":"687.smart_tags","index":1,"source":"smartTags"},{"id":2,"guid":"2.capabilities","index":2,"source":"capabilities"},{"id":103,"guid":"103.capabilities","index":3,"source":"capabilities"},{"id":21,"guid":"21.capabilities","index":4,"source":"capabilities"},{"id":102,"guid":"102.capabilities","index":5,"source":"capabilities"},{"id":107,"guid":"107.capabilities","index":6,"source":"capabilities"},{"id":780,"guid":"780.smart_tags","index":7,"source":"smartTags"},{"id":750,"guid":"750.smart_tags","index":8,"source":"smartTags"},{"id":20,"guid":"20.capabilities","index":9,"source":"capabilities"},{"id":952,"guid":"952.smart_tags","index":10,"source":"smartTags"},{"id":5,"guid":"5.capabilities","index":11,"source":"capabilities"},{"id":11,"guid":"11.capabilities","index":12,"source":"capabilities"},{"id":6,"guid":"6.capabilities","index":13,"source":"capabilities"},{"id":7,"guid":"7.capabilities","index":14,"source":"capabilities"},{"id":1248,"guid":"1248.smart_tags","index":15,"source":"smartTags"}],"is_active":true,"last_name":"Sale","nick_name":"Daniel","clerkships":[{"name":"Law Clerk, Richard D. Bennett, U.S. District Court for the District of Maryland","years_held":"2010-2012"}],"first_name":"Daniel","title_rank":9999,"updated_by":202,"law_schools":[{"id":755,"meta":{"degree":"J.D.","honors":null,"is_law_school":1,"graduation_date":"2010-01-01 00:00:00 UTC"},"order":1,"pin_order":null,"pin_expiration":null}],"middle_name":"C.","name_suffix":"","recognitions":null,"linked_in_url":"https://www.linkedin.com/in/daniel-sale-27063baa/","seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eDan Sale defends clients in high-stakes government and Congressional investigations, enforcement proceedings, and parallel civil litigation.\u0026nbsp; Concentrating in complex criminal and civil litigation, Dan regularly represents life sciences companies, financial institutions, other highly-regulated companies, and their boards and senior executives in high-profile and sensitive investigations and litigation.\u0026nbsp; Dan has special experience in matters involving: life sciences criminal and civil investigations; Congressional investigations;\u0026nbsp;the False Claims Act; financial crimes, the Foreign Corrupt Practices Act (FCPA);\u0026nbsp; antitrust and market manipulation matters; the securities laws; whistleblower cases; and transnational tax investigations.\u0026nbsp;[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eDan has special experience in cases involving allegations of off-label promotion and kickbacks in the life sciences industry and represented clients in the three largest Anti-Kickback Statute investigations ever resolved with DOJ.\u0026nbsp; Dan also has special experience in state attorney general investigations, and has personally negotiated quiet resolutions with all 50 state AG offices and the District of Columbia.\u0026nbsp; In addition, Dan has considerable experience defending clients in multi-jurisdictional investigations and litigation conducted cooperatively by United States, European, Middle Eastern, Asian and African authorities\u003c/p\u003e\n\u003cp\u003eThe Special Matters \u0026amp; Government Investigations group has been twice recognized by\u0026nbsp;\u003cem\u003eLaw 360\u003c/em\u003e\u0026nbsp;as the \u0026ldquo;White-Collar Group of the Year\u0026rdquo; and described as \u0026ldquo;the premier firm in this practice area\u0026rdquo; by the\u0026nbsp;\u003cem\u003eU.S. News \u0026amp; World Report/Best Lawyers\u0026rsquo;\u003c/em\u003e\u0026nbsp;\u0026ldquo;Best Law Firms\u0026rdquo; survey.\u003c/p\u003e\n\u003cp\u003eDan began his legal career as a law clerk to the Honorable Richard D. Bennett of the United States District Court for the District of Maryland. \u0026nbsp;He received his J.D. from Georgetown University Law Center, where he was an Editorial Board Member of the Tax Lawyer law journal, and his B.A. in economics from Yale University, where he was a Division I All New England Scholar Athlete lacrosse player.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eDan holds Top Secret/SCI security clearances until their expiration.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003ePublications\u003c/strong\u003e\u003c/p\u003e\n\u003cul\u003e\n\u003cli\u003eDan is a regular contributor to the American Bar Association's Criminal Litigation Section's Practice Points publication\u003c/li\u003e\n\u003cli\u003e\u003cem\u003eThe US v. Vascular Solutions Acquittal: Three Lessons for Targets of Off-Label Promotion Enforcement\u003c/em\u003e, Washington Legal Foundation Legal Backgrounder (2016)\u003c/li\u003e\n\u003cli\u003e\u003cem\u003eRecent Trends in Health Care Enforcement and Compliance\u003c/em\u003e, Inside the Minds: Health Care Law Enforcement and Compliance (Apastore 2013)\u003c/li\u003e\n\u003cli\u003e\u003cem\u003eThe Future of Off-Label Promotion Enforcement in the Wake of Caronia \u0026mdash; Toward a First Amendment Safe Harbor\u003c/em\u003e, The Sedona Conference Journal, Volume 14 (2013)\u003c/li\u003e\n\u003cli\u003e\u003cem\u003eOff-Label Promotion: The Criminalization of Scientific Exchange\u003c/em\u003e, Pharma Magazine (UK) (2013)\u003c/li\u003e\n\u003cli\u003e\u003cem\u003eFDA as Arbiter of Truth? The First Amendment, Caronia, and the Future of Off-Label Promotion Enforcement\u003c/em\u003e, ABA White Collar Crime (2013)\u003c/li\u003e\n\u003cli\u003e\u003cem\u003eTenure Trap: Third Circuit Joins Sixth in Holding Tenure Buy-out Payments Subject to FICA Taxation in University of Pittsburgh v. United States\u003c/em\u003e, The Tax Lawyer, Volume 63 (2010)\u003c/li\u003e\n\u003c/ul\u003e","matters":["\u003cp\u003eRepresenting\u0026nbsp;\u003cem\u003epro bono\u003c/em\u003e\u0026nbsp;a former Army Ranger convicted by court martial of murder in Iraq, resulting in a full Presidential pardon.\u003c/p\u003e","\u003cp\u003eRepresenting an individual in connection with the Special Counsel investigation conducted by Robert Mueller.\u003c/p\u003e","\u003cp\u003eRepresenting a global pharmaceutical company in an industry-wide investigation regarding donations to charitable patient assistance foundations.\u003c/p\u003e","\u003cp\u003eSecured a declination of all criminal and civil liability for a global medical device manufacturer in an investigation involving off-label promotion and fraud issues\u003c/p\u003e","\u003cp\u003eRepresented Vascular Solutions, Inc., a publicly traded medical device manufacturer that was indicted on federal criminal charges relating to off-label promotion and acquitted by a jury of all charges after a four week trial in February 2016.\u003c/p\u003e","\u003cp\u003eRepresenting several individual witnesses and targets in connection with domestic and international investigations of foreign exchange (FX) trading, resulting in no charges.\u003c/p\u003e","\u003cp\u003eRepresented leading pharmaceutical manufacturers into off-label promotion issues by the Department of Justice and multiple U.S. Attorneys\u0026rsquo; Offices, the FDA, the Department of Health and Human Services Office of Inspector General, and various state Attorneys General, as well as parallel federal False Claims Act\u0026nbsp;\u003cem\u003equi tam\u003c/em\u003e\u0026nbsp;litigation.\u003c/p\u003e","\u003cp\u003eRepresented current and former CEOs, high-level executives, and other individuals in FCPA investigations related to events throughout Latin America, the Middle East, China, Mexico, and Eastern Europe.\u003c/p\u003e"]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":12360}]},"capability_group_id":2},"created_at":"2025-05-26T04:52:35.000Z","updated_at":"2025-05-26T04:52:35.000Z","searchable_text":"Sale{{ FIELD }}Representing pro bono a former Army Ranger convicted by court martial of murder in Iraq, resulting in a full Presidential pardon.{{ FIELD }}Representing an individual in connection with the Special Counsel investigation conducted by Robert Mueller.{{ FIELD }}Representing a global pharmaceutical company in an industry-wide investigation regarding donations to charitable patient assistance foundations.{{ FIELD }}Secured a declination of all criminal and civil liability for a global medical device manufacturer in an investigation involving off-label promotion and fraud issues{{ FIELD }}Represented Vascular Solutions, Inc., a publicly traded medical device manufacturer that was indicted on federal criminal charges relating to off-label promotion and acquitted by a jury of all charges after a four week trial in February 2016.{{ FIELD }}Representing several individual witnesses and targets in connection with domestic and international investigations of foreign exchange (FX) trading, resulting in no charges.{{ FIELD }}Represented leading pharmaceutical manufacturers into off-label promotion issues by the Department of Justice and multiple U.S. Attorneys’ Offices, the FDA, the Department of Health and Human Services Office of Inspector General, and various state Attorneys General, as well as parallel federal False Claims Act qui tam litigation.{{ FIELD }}Represented current and former CEOs, high-level executives, and other individuals in FCPA investigations related to events throughout Latin America, the Middle East, China, Mexico, and Eastern Europe.{{ FIELD }}Dan Sale defends clients in high-stakes government and Congressional investigations, enforcement proceedings, and parallel civil litigation.  Concentrating in complex criminal and civil litigation, Dan regularly represents life sciences companies, financial institutions, other highly-regulated companies, and their boards and senior executives in high-profile and sensitive investigations and litigation.  Dan has special experience in matters involving: life sciences criminal and civil investigations; Congressional investigations; the False Claims Act; financial crimes, the Foreign Corrupt Practices Act (FCPA);  antitrust and market manipulation matters; the securities laws; whistleblower cases; and transnational tax investigations. \nDan has special experience in cases involving allegations of off-label promotion and kickbacks in the life sciences industry and represented clients in the three largest Anti-Kickback Statute investigations ever resolved with DOJ.  Dan also has special experience in state attorney general investigations, and has personally negotiated quiet resolutions with all 50 state AG offices and the District of Columbia.  In addition, Dan has considerable experience defending clients in multi-jurisdictional investigations and litigation conducted cooperatively by United States, European, Middle Eastern, Asian and African authorities\nThe Special Matters \u0026amp; Government Investigations group has been twice recognized by Law 360 as the “White-Collar Group of the Year” and described as “the premier firm in this practice area” by the U.S. News \u0026amp; World Report/Best Lawyers’ “Best Law Firms” survey.\nDan began his legal career as a law clerk to the Honorable Richard D. Bennett of the United States District Court for the District of Maryland.  He received his J.D. from Georgetown University Law Center, where he was an Editorial Board Member of the Tax Lawyer law journal, and his B.A. in economics from Yale University, where he was a Division I All New England Scholar Athlete lacrosse player. \nDan holds Top Secret/SCI security clearances until their expiration.\nPublications\n\nDan is a regular contributor to the American Bar Association's Criminal Litigation Section's Practice Points publication\nThe US v. Vascular Solutions Acquittal: Three Lessons for Targets of Off-Label Promotion Enforcement, Washington Legal Foundation Legal Backgrounder (2016)\nRecent Trends in Health Care Enforcement and Compliance, Inside the Minds: Health Care Law Enforcement and Compliance (Apastore 2013)\nThe Future of Off-Label Promotion Enforcement in the Wake of Caronia — Toward a First Amendment Safe Harbor, The Sedona Conference Journal, Volume 14 (2013)\nOff-Label Promotion: The Criminalization of Scientific Exchange, Pharma Magazine (UK) (2013)\nFDA as Arbiter of Truth? The First Amendment, Caronia, and the Future of Off-Label Promotion Enforcement, ABA White Collar Crime (2013)\nTenure Trap: Third Circuit Joins Sixth in Holding Tenure Buy-out Payments Subject to FICA Taxation in University of Pittsburgh v. United States, The Tax Lawyer, Volume 63 (2010)\n Partner Yale University Yale Law School Georgetown University Georgetown University Law Center U.S. Court of Appeals for the Fourth Circuit U.S. District Court for the District of Maryland District of Columbia Maryland Law Clerk, Richard D. Bennett, U.S. District Court for the District of Maryland Representing pro bono a former Army Ranger convicted by court martial of murder in Iraq, resulting in a full Presidential pardon. Representing an individual in connection with the Special Counsel investigation conducted by Robert Mueller. Representing a global pharmaceutical company in an industry-wide investigation regarding donations to charitable patient assistance foundations. Secured a declination of all criminal and civil liability for a global medical device manufacturer in an investigation involving off-label promotion and fraud issues Represented Vascular Solutions, Inc., a publicly traded medical device manufacturer that was indicted on federal criminal charges relating to off-label promotion and acquitted by a jury of all charges after a four week trial in February 2016. Representing several individual witnesses and targets in connection with domestic and international investigations of foreign exchange (FX) trading, resulting in no charges. Represented leading pharmaceutical manufacturers into off-label promotion issues by the Department of Justice and multiple U.S. Attorneys’ Offices, the FDA, the Department of Health and Human Services Office of Inspector General, and various state Attorneys General, as well as parallel federal False Claims Act qui tam litigation. Represented current and former CEOs, high-level executives, and other individuals in FCPA investigations related to events throughout Latin America, the Middle East, China, Mexico, and Eastern Europe.","searchable_name":"Daniel C. Sale","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":202,"capability_group_featured":null,"home_page_featured":null},{"id":426475,"version":1,"owner_type":"Person","owner_id":3801,"payload":{"bio":"\u003cp\u003eIlana Saltzbart focuses on environmental law and litigation. As a partner in our Environmental practice, Ilana defends companies in governmental investigations or enforcement actions regarding environmental issues.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eIlana represents clients in investigations and enforcement actions initiated by the Environmental Protection Agency, the Department of Justice, and state environmental agencies such as the California Air Resources Board. She also counsels clients on environmental regulatory matters.\u003c/p\u003e\n\u003cp\u003eBefore entering private practice in 2011, Ilana spent a decade as an attorney at EPA\u0026rsquo;s headquarters in Washington, D.C. In her tenure at EPA, Ilana was involved in the enforcement of several environmental laws, including the Clean Air Act, the Resource Conservation and Recovery Act, and the Toxic Substances Control Act, among others.\u003c/p\u003e\n\u003cp\u003eIlana litigated and settled some of the most high-profile matters at EPA, including a Toxic Substances Control Act enforcement action under Section 8(e) against a major chemical manufacturer. From 2006 to 2011, Ilana managed EPA\u0026rsquo;s Clean Air Act national enforcement initiative for the electric power generation sector. This initiative addresses New Source Review compliance, among other Clean Air Act requirements, and facilitated Ilana\u0026rsquo;s extensive understanding and knowledge of the Clean Air Act. In this role, Ilana settled several landmark cases, most notably with the Tennessee Valley Authority and American Electric Power.\u003c/p\u003e\n\u003cp\u003eAs part of her specialization in environmental law, Ilana received a Certificate in Environmental and Natural Resources Law from Lewis \u0026amp; Clark Law School in 2001.\u003c/p\u003e\n\u003cp\u003eIn 2015 and 2016, Ilana received recognition for environmental law in the \u003cem data-redactor-tag=\"em\"\u003eLegal 500 U.S.\u003c/em\u003e guide.\u003c/p\u003e","slug":"ilana-saltzbart","email":"isaltzbart@kslaw.com","phone":null,"matters":null,"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":16,"guid":"16.capabilities","index":0,"source":"capabilities"},{"id":102,"guid":"102.capabilities","index":1,"source":"capabilities"},{"id":107,"guid":"107.capabilities","index":2,"source":"capabilities"},{"id":105,"guid":"105.capabilities","index":3,"source":"capabilities"},{"id":81,"guid":"81.capabilities","index":4,"source":"capabilities"},{"id":71,"guid":"71.capabilities","index":5,"source":"capabilities"},{"id":106,"guid":"106.capabilities","index":6,"source":"capabilities"},{"id":1015,"guid":"1015.smart_tags","index":7,"source":"smartTags"},{"id":984,"guid":"984.smart_tags","index":8,"source":"smartTags"},{"id":1143,"guid":"1143.smart_tags","index":9,"source":"smartTags"},{"id":1168,"guid":"1168.smart_tags","index":10,"source":"smartTags"},{"id":1199,"guid":"1199.smart_tags","index":11,"source":"smartTags"},{"id":125,"guid":"125.capabilities","index":12,"source":"capabilities"},{"id":1206,"guid":"1206.smart_tags","index":13,"source":"smartTags"},{"id":1269,"guid":"1269.smart_tags","index":14,"source":"smartTags"},{"id":1270,"guid":"1270.smart_tags","index":15,"source":"smartTags"}],"is_active":true,"last_name":"Saltzbart","nick_name":"Ilana","clerkships":[],"first_name":"Ilana","title_rank":9999,"updated_by":176,"law_schools":[],"middle_name":" ","name_suffix":"","recognitions":[{"title":"\"Top Ranked Lawyer\", Environment ","detail":"Chambers USA, District of Columbia (2021-2022)"},{"title":"Ilana is a phenomenal lawyer with an amazing work ethic and amazing insights ","detail":"Chambers USA (2022)"},{"title":"Environmental Law ","detail":"Legal 500 U.S., 2015 and 2016"}],"linked_in_url":null,"seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eIlana Saltzbart focuses on environmental law and litigation. As a partner in our Environmental practice, Ilana defends companies in governmental investigations or enforcement actions regarding environmental issues.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eIlana represents clients in investigations and enforcement actions initiated by the Environmental Protection Agency, the Department of Justice, and state environmental agencies such as the California Air Resources Board. She also counsels clients on environmental regulatory matters.\u003c/p\u003e\n\u003cp\u003eBefore entering private practice in 2011, Ilana spent a decade as an attorney at EPA\u0026rsquo;s headquarters in Washington, D.C. In her tenure at EPA, Ilana was involved in the enforcement of several environmental laws, including the Clean Air Act, the Resource Conservation and Recovery Act, and the Toxic Substances Control Act, among others.\u003c/p\u003e\n\u003cp\u003eIlana litigated and settled some of the most high-profile matters at EPA, including a Toxic Substances Control Act enforcement action under Section 8(e) against a major chemical manufacturer. From 2006 to 2011, Ilana managed EPA\u0026rsquo;s Clean Air Act national enforcement initiative for the electric power generation sector. This initiative addresses New Source Review compliance, among other Clean Air Act requirements, and facilitated Ilana\u0026rsquo;s extensive understanding and knowledge of the Clean Air Act. In this role, Ilana settled several landmark cases, most notably with the Tennessee Valley Authority and American Electric Power.\u003c/p\u003e\n\u003cp\u003eAs part of her specialization in environmental law, Ilana received a Certificate in Environmental and Natural Resources Law from Lewis \u0026amp; Clark Law School in 2001.\u003c/p\u003e\n\u003cp\u003eIn 2015 and 2016, Ilana received recognition for environmental law in the \u003cem data-redactor-tag=\"em\"\u003eLegal 500 U.S.\u003c/em\u003e guide.\u003c/p\u003e","recognitions":[{"title":"\"Top Ranked Lawyer\", Environment ","detail":"Chambers USA, District of Columbia (2021-2022)"},{"title":"Ilana is a phenomenal lawyer with an amazing work ethic and amazing insights ","detail":"Chambers USA (2022)"},{"title":"Environmental Law ","detail":"Legal 500 U.S., 2015 and 2016"}]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":1162}]},"capability_group_id":2},"created_at":"2025-05-26T04:53:37.000Z","updated_at":"2025-05-26T04:53:37.000Z","searchable_text":"Saltzbart{{ FIELD }}{:title=\u0026gt;\"\\\"Top Ranked Lawyer\\\", Environment \", :detail=\u0026gt;\"Chambers USA, District of Columbia (2021-2022)\"}{{ FIELD }}{:title=\u0026gt;\"Ilana is a phenomenal lawyer with an amazing work ethic and amazing insights \", :detail=\u0026gt;\"Chambers USA (2022)\"}{{ FIELD }}{:title=\u0026gt;\"Environmental Law \", :detail=\u0026gt;\"Legal 500 U.S., 2015 and 2016\"}{{ FIELD }}Ilana Saltzbart focuses on environmental law and litigation. As a partner in our Environmental practice, Ilana defends companies in governmental investigations or enforcement actions regarding environmental issues.\nIlana represents clients in investigations and enforcement actions initiated by the Environmental Protection Agency, the Department of Justice, and state environmental agencies such as the California Air Resources Board. She also counsels clients on environmental regulatory matters.\nBefore entering private practice in 2011, Ilana spent a decade as an attorney at EPA’s headquarters in Washington, D.C. In her tenure at EPA, Ilana was involved in the enforcement of several environmental laws, including the Clean Air Act, the Resource Conservation and Recovery Act, and the Toxic Substances Control Act, among others.\nIlana litigated and settled some of the most high-profile matters at EPA, including a Toxic Substances Control Act enforcement action under Section 8(e) against a major chemical manufacturer. From 2006 to 2011, Ilana managed EPA’s Clean Air Act national enforcement initiative for the electric power generation sector. This initiative addresses New Source Review compliance, among other Clean Air Act requirements, and facilitated Ilana’s extensive understanding and knowledge of the Clean Air Act. In this role, Ilana settled several landmark cases, most notably with the Tennessee Valley Authority and American Electric Power.\nAs part of her specialization in environmental law, Ilana received a Certificate in Environmental and Natural Resources Law from Lewis \u0026amp; Clark Law School in 2001.\nIn 2015 and 2016, Ilana received recognition for environmental law in the Legal 500 U.S. guide. Partner \"Top Ranked Lawyer\", Environment  Chambers USA, District of Columbia (2021-2022) Ilana is a phenomenal lawyer with an amazing work ethic and amazing insights  Chambers USA (2022) Environmental Law  Legal 500 U.S., 2015 and 2016 District of Columbia Maryland","searchable_name":"Ilana Saltzbart","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":176,"capability_group_featured":null,"home_page_featured":null},{"id":426539,"version":1,"owner_type":"Person","owner_id":4092,"payload":{"bio":"\u003cp\u003eKyle Sampson focuses on Food and Drug Administration regulatory, compliance and enforcement issues. As a partner in our FDA and Life Sciences practice, Kyle represents companies in the full range of regulatory and enforcement issues.\u003c/p\u003e\n\u003cp\u003e[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eKyle advises food, drug, biologics, medical device, cosmetics and dietary supplement companies on FDA compliance, regulatory and enforcement matters. His practice also includes strategic advice and compliance counseling, enforcement, litigation and transactional matters.\u003c/p\u003e\n\u003cp\u003eKyle has engaged in extensive public service in every branch of the federal government. He served in the White House as Associate Counsel to the President; at the Department of Justice as a Special Assistant U.S. Attorney and as Counselor and Chief of Staff to two attorneys general; and in the U.S. Senate as Counsel to the Senate Judiciary Committee.\u003c/p\u003e\n\u003cp\u003e\u0026nbsp;\u003c/p\u003e\n\u003cp\u003e\u0026nbsp;\u003c/p\u003e","slug":"kyle-sampson","email":"ksampson@kslaw.com","phone":"+1 202 340 8202","matters":["\u003cp\u003eAssist \u003cstrong data-redactor-tag=\"strong\"\u003epharmaceutical and medical device companies\u003c/strong\u003e in developing and implementing comprehensive regulatory and healthcare fraud and abuse compliance programs involving off-label promotion, anti-kickback violations, federal healthcare program reimbursement, and pricing and false claims actions.\u003c/p\u003e","\u003cp\u003eServe as counsel to \u003cstrong data-redactor-tag=\"strong\"\u003epharmaceutical, biotechnology and medical device companies\u003c/strong\u003e in regulatory matters involving product development and commercialization.\u003c/p\u003e","\u003cp\u003eRepresent \u003cstrong data-redactor-tag=\"strong\"\u003epharmaceutical and medical device manufacturers\u003c/strong\u003e in responding to FDA enforcement actions, including Form FDA-483 observations and Warning Letters.\u003c/p\u003e","\u003cp\u003eServe as compliance counsel for \u003cstrong data-redactor-tag=\"strong\"\u003ea\u003c/strong\u003e \u003cstrong data-redactor-tag=\"strong\"\u003epharmaceutical company\u003c/strong\u003e subject to consent decree resulting from allegation that company provided false scientific data to FDA in regulatory submissions.\u003c/p\u003e","\u003cp\u003eRepresent \u003cstrong data-redactor-tag=\"strong\"\u003ea medical device manufacturer\u003c/strong\u003e in consent decree negotiations with FDA and Department of Justice.\u003c/p\u003e","\u003cp\u003eWith Monitor appointed by U.S. Attorney\u0026rsquo;s Office for the District of New Jersey under Deferred Prosecution Agreement (DPA), oversaw \u003cstrong data-redactor-tag=\"strong\"\u003eorthopedic device manufacturer\u003c/strong\u003e's compliance with federal Anti-Kickback Statute and other federal healthcare laws and its implementation of comprehensive compliance program.\u003c/p\u003e","\u003cp\u003eReview advertising and promotional materials and activities for prescription drugs, biologics and devices for \u003cstrong data-redactor-tag=\"strong\"\u003evarious clients.\u003c/strong\u003e\u003c/p\u003e","\u003cp\u003eProvide advice to \u003cstrong data-redactor-tag=\"strong\"\u003emanufacturers\u003c/strong\u003e \u003cstrong data-redactor-tag=\"strong\"\u003eof controlled substances and listed chemicals\u003c/strong\u003e regarding compliance with the Controlled Substances Act and Drug Enforcement Administration regulations.\u003c/p\u003e","\u003cp\u003eRepresent \u003cstrong data-redactor-tag=\"strong\"\u003emanufacturers of drug, medical device, human food, animal feed and consumer products\u003c/strong\u003e in negotiations with the FDA over recalls of manufacturers\u0026rsquo; products, including proper classification of recall, assessment of health hazard, and development and implementation of recall strategy.\u003c/p\u003e","\u003cp\u003eRepresent \u003cstrong data-redactor-tag=\"strong\"\u003eforeign manufacturers and domestic importers\u003c/strong\u003e in responding to the FDA\u0026rsquo;s detention of imports and placement of firms on Import Alert, including negotiating firms\u0026rsquo; removal from Detention Without Physical Examination (DWPE).\u003c/p\u003e","\u003cp\u003eHelp \u003cstrong data-redactor-tag=\"strong\"\u003epharmaceutical and medical device companies\u003c/strong\u003e respond to widespread counterfeiting of products and unlawful importation by Internet pharmacies and others in violation of the Federal Food, Drug, and Cosmetic Act and the Lanham Act.\u003c/p\u003e","\u003cul\u003e\n\u003cli\u003eProvided advice to two \u003cstrong data-redactor-tag=\"strong\"\u003eattorneys general\u003c/strong\u003e on legal and policy issues, coordinated Justice Department positions in criminal prosecutions and civil litigation, and formulated and implemented policy initiatives and legislative proposals.\u003c/li\u003e\n\u003c/ul\u003e","\u003cp\u003eAs Special Assistant U.S. Attorney, conducted \u003cstrong data-redactor-tag=\"strong\"\u003etrial and appellate litigation,\u003c/strong\u003e including arguing three cases in the U.S. Courts of Appeals for the Fourth and Ninth Circuits.\u003c/p\u003e"],"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":103,"guid":"103.capabilities","index":0,"source":"capabilities"},{"id":21,"guid":"21.capabilities","index":1,"source":"capabilities"},{"id":81,"guid":"81.capabilities","index":2,"source":"capabilities"},{"id":24,"guid":"24.capabilities","index":3,"source":"capabilities"},{"id":970,"guid":"970.smart_tags","index":4,"source":"smartTags"},{"id":112,"guid":"112.capabilities","index":5,"source":"capabilities"},{"id":1193,"guid":"1193.smart_tags","index":6,"source":"smartTags"},{"id":1223,"guid":"1223.smart_tags","index":7,"source":"smartTags"},{"id":133,"guid":"133.capabilities","index":8,"source":"capabilities"}],"is_active":true,"last_name":"Sampson","nick_name":"D.","clerkships":[{"name":"Law Clerk, Hon. Karen J. Williams, U.S. Court of Appeals for the Fourth Circuit","years_held":"1996-1997"}],"first_name":"D.","title_rank":9999,"updated_by":202,"law_schools":[{"id":2174,"meta":{"degree":"J.D.","honors":"with honors","is_law_school":1,"graduation_date":"1996-01-01 00:00:00 UTC"},"order":1,"pin_order":null,"pin_expiration":null}],"middle_name":"Kyle","name_suffix":"","recognitions":[{"title":"Attorney General’s Award for Outstanding Service to the Attorney General, the Department of Justice, and to America ","detail":"U.S. Department of Justice, 2005"}],"linked_in_url":"https://www.linkedin.com/in/kyle-sampson-4302348/","seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eKyle Sampson focuses on Food and Drug Administration regulatory, compliance and enforcement issues. As a partner in our FDA and Life Sciences practice, Kyle represents companies in the full range of regulatory and enforcement issues.\u003c/p\u003e\n\u003cp\u003e[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eKyle advises food, drug, biologics, medical device, cosmetics and dietary supplement companies on FDA compliance, regulatory and enforcement matters. His practice also includes strategic advice and compliance counseling, enforcement, litigation and transactional matters.\u003c/p\u003e\n\u003cp\u003eKyle has engaged in extensive public service in every branch of the federal government. He served in the White House as Associate Counsel to the President; at the Department of Justice as a Special Assistant U.S. Attorney and as Counselor and Chief of Staff to two attorneys general; and in the U.S. Senate as Counsel to the Senate Judiciary Committee.\u003c/p\u003e\n\u003cp\u003e\u0026nbsp;\u003c/p\u003e\n\u003cp\u003e\u0026nbsp;\u003c/p\u003e","matters":["\u003cp\u003eAssist \u003cstrong data-redactor-tag=\"strong\"\u003epharmaceutical and medical device companies\u003c/strong\u003e in developing and implementing comprehensive regulatory and healthcare fraud and abuse compliance programs involving off-label promotion, anti-kickback violations, federal healthcare program reimbursement, and pricing and false claims actions.\u003c/p\u003e","\u003cp\u003eServe as counsel to \u003cstrong data-redactor-tag=\"strong\"\u003epharmaceutical, biotechnology and medical device companies\u003c/strong\u003e in regulatory matters involving product development and commercialization.\u003c/p\u003e","\u003cp\u003eRepresent \u003cstrong data-redactor-tag=\"strong\"\u003epharmaceutical and medical device manufacturers\u003c/strong\u003e in responding to FDA enforcement actions, including Form FDA-483 observations and Warning Letters.\u003c/p\u003e","\u003cp\u003eServe as compliance counsel for \u003cstrong data-redactor-tag=\"strong\"\u003ea\u003c/strong\u003e \u003cstrong data-redactor-tag=\"strong\"\u003epharmaceutical company\u003c/strong\u003e subject to consent decree resulting from allegation that company provided false scientific data to FDA in regulatory submissions.\u003c/p\u003e","\u003cp\u003eRepresent \u003cstrong data-redactor-tag=\"strong\"\u003ea medical device manufacturer\u003c/strong\u003e in consent decree negotiations with FDA and Department of Justice.\u003c/p\u003e","\u003cp\u003eWith Monitor appointed by U.S. Attorney\u0026rsquo;s Office for the District of New Jersey under Deferred Prosecution Agreement (DPA), oversaw \u003cstrong data-redactor-tag=\"strong\"\u003eorthopedic device manufacturer\u003c/strong\u003e's compliance with federal Anti-Kickback Statute and other federal healthcare laws and its implementation of comprehensive compliance program.\u003c/p\u003e","\u003cp\u003eReview advertising and promotional materials and activities for prescription drugs, biologics and devices for \u003cstrong data-redactor-tag=\"strong\"\u003evarious clients.\u003c/strong\u003e\u003c/p\u003e","\u003cp\u003eProvide advice to \u003cstrong data-redactor-tag=\"strong\"\u003emanufacturers\u003c/strong\u003e \u003cstrong data-redactor-tag=\"strong\"\u003eof controlled substances and listed chemicals\u003c/strong\u003e regarding compliance with the Controlled Substances Act and Drug Enforcement Administration regulations.\u003c/p\u003e","\u003cp\u003eRepresent \u003cstrong data-redactor-tag=\"strong\"\u003emanufacturers of drug, medical device, human food, animal feed and consumer products\u003c/strong\u003e in negotiations with the FDA over recalls of manufacturers\u0026rsquo; products, including proper classification of recall, assessment of health hazard, and development and implementation of recall strategy.\u003c/p\u003e","\u003cp\u003eRepresent \u003cstrong data-redactor-tag=\"strong\"\u003eforeign manufacturers and domestic importers\u003c/strong\u003e in responding to the FDA\u0026rsquo;s detention of imports and placement of firms on Import Alert, including negotiating firms\u0026rsquo; removal from Detention Without Physical Examination (DWPE).\u003c/p\u003e","\u003cp\u003eHelp \u003cstrong data-redactor-tag=\"strong\"\u003epharmaceutical and medical device companies\u003c/strong\u003e respond to widespread counterfeiting of products and unlawful importation by Internet pharmacies and others in violation of the Federal Food, Drug, and Cosmetic Act and the Lanham Act.\u003c/p\u003e","\u003cul\u003e\n\u003cli\u003eProvided advice to two \u003cstrong data-redactor-tag=\"strong\"\u003eattorneys general\u003c/strong\u003e on legal and policy issues, coordinated Justice Department positions in criminal prosecutions and civil litigation, and formulated and implemented policy initiatives and legislative proposals.\u003c/li\u003e\n\u003c/ul\u003e","\u003cp\u003eAs Special Assistant U.S. Attorney, conducted \u003cstrong data-redactor-tag=\"strong\"\u003etrial and appellate litigation,\u003c/strong\u003e including arguing three cases in the U.S. Courts of Appeals for the Fourth and Ninth Circuits.\u003c/p\u003e"],"recognitions":[{"title":"Attorney General’s Award for Outstanding Service to the Attorney General, the Department of Justice, and to America ","detail":"U.S. Department of Justice, 2005"}]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":12357}]},"capability_group_id":2},"created_at":"2025-05-26T04:54:31.000Z","updated_at":"2025-05-26T04:54:31.000Z","searchable_text":"Sampson{{ FIELD }}{:title=\u0026gt;\"Attorney General’s Award for Outstanding Service to the Attorney General, the Department of Justice, and to America \", :detail=\u0026gt;\"U.S. Department of Justice, 2005\"}{{ FIELD }}Assist pharmaceutical and medical device companies in developing and implementing comprehensive regulatory and healthcare fraud and abuse compliance programs involving off-label promotion, anti-kickback violations, federal healthcare program reimbursement, and pricing and false claims actions.{{ FIELD }}Serve as counsel to pharmaceutical, biotechnology and medical device companies in regulatory matters involving product development and commercialization.{{ FIELD }}Represent pharmaceutical and medical device manufacturers in responding to FDA enforcement actions, including Form FDA-483 observations and Warning Letters.{{ FIELD }}Serve as compliance counsel for a pharmaceutical company subject to consent decree resulting from allegation that company provided false scientific data to FDA in regulatory submissions.{{ FIELD }}Represent a medical device manufacturer in consent decree negotiations with FDA and Department of Justice.{{ FIELD }}With Monitor appointed by U.S. Attorney’s Office for the District of New Jersey under Deferred Prosecution Agreement (DPA), oversaw orthopedic device manufacturer's compliance with federal Anti-Kickback Statute and other federal healthcare laws and its implementation of comprehensive compliance program.{{ FIELD }}Review advertising and promotional materials and activities for prescription drugs, biologics and devices for various clients.{{ FIELD }}Provide advice to manufacturers of controlled substances and listed chemicals regarding compliance with the Controlled Substances Act and Drug Enforcement Administration regulations.{{ FIELD }}Represent manufacturers of drug, medical device, human food, animal feed and consumer products in negotiations with the FDA over recalls of manufacturers’ products, including proper classification of recall, assessment of health hazard, and development and implementation of recall strategy.{{ FIELD }}Represent foreign manufacturers and domestic importers in responding to the FDA’s detention of imports and placement of firms on Import Alert, including negotiating firms’ removal from Detention Without Physical Examination (DWPE).{{ FIELD }}Help pharmaceutical and medical device companies respond to widespread counterfeiting of products and unlawful importation by Internet pharmacies and others in violation of the Federal Food, Drug, and Cosmetic Act and the Lanham Act.{{ FIELD }}\nProvided advice to two attorneys general on legal and policy issues, coordinated Justice Department positions in criminal prosecutions and civil litigation, and formulated and implemented policy initiatives and legislative proposals.\n{{ FIELD }}As Special Assistant U.S. Attorney, conducted trial and appellate litigation, including arguing three cases in the U.S. Courts of Appeals for the Fourth and Ninth Circuits.{{ FIELD }}Kyle Sampson focuses on Food and Drug Administration regulatory, compliance and enforcement issues. As a partner in our FDA and Life Sciences practice, Kyle represents companies in the full range of regulatory and enforcement issues.\n\nKyle advises food, drug, biologics, medical device, cosmetics and dietary supplement companies on FDA compliance, regulatory and enforcement matters. His practice also includes strategic advice and compliance counseling, enforcement, litigation and transactional matters.\nKyle has engaged in extensive public service in every branch of the federal government. He served in the White House as Associate Counsel to the President; at the Department of Justice as a Special Assistant U.S. Attorney and as Counselor and Chief of Staff to two attorneys general; and in the U.S. Senate as Counsel to the Senate Judiciary Committee.\n \n  Partner Attorney General’s Award for Outstanding Service to the Attorney General, the Department of Justice, and to America  U.S. Department of Justice, 2005 Brigham Young University J. Reuben Clark Law School University of Chicago University of Chicago Law School U.S. Court of Appeals for the Fourth Circuit U.S. Court of Appeals for the Eleventh Circuit U.S. Court of Appeals for the D.C. Circuit U.S. District Court for the District of Utah District of Columbia Utah Law Clerk, Hon. Karen J. Williams, U.S. Court of Appeals for the Fourth Circuit Assist pharmaceutical and medical device companies in developing and implementing comprehensive regulatory and healthcare fraud and abuse compliance programs involving off-label promotion, anti-kickback violations, federal healthcare program reimbursement, and pricing and false claims actions. Serve as counsel to pharmaceutical, biotechnology and medical device companies in regulatory matters involving product development and commercialization. Represent pharmaceutical and medical device manufacturers in responding to FDA enforcement actions, including Form FDA-483 observations and Warning Letters. Serve as compliance counsel for a pharmaceutical company subject to consent decree resulting from allegation that company provided false scientific data to FDA in regulatory submissions. Represent a medical device manufacturer in consent decree negotiations with FDA and Department of Justice. With Monitor appointed by U.S. Attorney’s Office for the District of New Jersey under Deferred Prosecution Agreement (DPA), oversaw orthopedic device manufacturer's compliance with federal Anti-Kickback Statute and other federal healthcare laws and its implementation of comprehensive compliance program. Review advertising and promotional materials and activities for prescription drugs, biologics and devices for various clients. Provide advice to manufacturers of controlled substances and listed chemicals regarding compliance with the Controlled Substances Act and Drug Enforcement Administration regulations. Represent manufacturers of drug, medical device, human food, animal feed and consumer products in negotiations with the FDA over recalls of manufacturers’ products, including proper classification of recall, assessment of health hazard, and development and implementation of recall strategy. Represent foreign manufacturers and domestic importers in responding to the FDA’s detention of imports and placement of firms on Import Alert, including negotiating firms’ removal from Detention Without Physical Examination (DWPE). Help pharmaceutical and medical device companies respond to widespread counterfeiting of products and unlawful importation by Internet pharmacies and others in violation of the Federal Food, Drug, and Cosmetic Act and the Lanham Act. \nProvided advice to two attorneys general on legal and policy issues, coordinated Justice Department positions in criminal prosecutions and civil litigation, and formulated and implemented policy initiatives and legislative proposals.\n As Special Assistant U.S. Attorney, conducted trial and appellate litigation, including arguing three cases in the U.S. Courts of Appeals for the Fourth and Ninth Circuits.","searchable_name":"D. Kyle Sampson","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":202,"capability_group_featured":null,"home_page_featured":null},{"id":426468,"version":1,"owner_type":"Person","owner_id":3787,"payload":{"bio":"\u003cp\u003eWilliam (Bill) Sauers represents clients on high-stakes environmental matters, investigations, and technical matters.\u0026nbsp; As a partner in our Environmental, Health and Safety practice, Bill represents clients in a wide range of environmental enforcement, litigation, and compliance matters.\u0026nbsp; He also represents clients in complex litigation and counseling matters regarding trade secret, trademark, patent and copyright matters.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eHis recent environmental matters include representation of several\u0026nbsp;auto manufacturers in enforcement matters related to compliance with the Clean Air Act and related regulations before the Environmental Protection Agency (EPA), the California Air Resources Board (CARB), the Department of Justice (DOJ), and other federal and state agencies.\u003c/p\u003e\n\u003cp\u003eIn addition to extensive IP litigation and trial experience, Bill also advises clients on developing and protecting IP portfolios, including the identification, protection, licensing and enforcement of trademarks, copyrights and trade secrets.\u003c/p\u003e","slug":"william-sauers","email":"wsauers@kslaw.com","phone":null,"matters":null,"taggings":{"tags":[],"meta_tags":[{"id":252}]},"expertise":[{"id":106,"guid":"106.capabilities","index":0,"source":"capabilities"},{"id":103,"guid":"103.capabilities","index":1,"source":"capabilities"},{"id":81,"guid":"81.capabilities","index":2,"source":"capabilities"},{"id":13,"guid":"13.capabilities","index":3,"source":"capabilities"},{"id":763,"guid":"763.smart_tags","index":4,"source":"smartTags"},{"id":16,"guid":"16.capabilities","index":5,"source":"capabilities"},{"id":105,"guid":"105.capabilities","index":6,"source":"capabilities"},{"id":71,"guid":"71.capabilities","index":7,"source":"capabilities"},{"id":102,"guid":"102.capabilities","index":8,"source":"capabilities"},{"id":107,"guid":"107.capabilities","index":9,"source":"capabilities"}],"is_active":true,"last_name":"Sauers","nick_name":"Bill","clerkships":[],"first_name":"William","title_rank":9999,"updated_by":101,"law_schools":[],"middle_name":"J.","name_suffix":"","recognitions":null,"linked_in_url":null,"seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eWilliam (Bill) Sauers represents clients on high-stakes environmental matters, investigations, and technical matters.\u0026nbsp; As a partner in our Environmental, Health and Safety practice, Bill represents clients in a wide range of environmental enforcement, litigation, and compliance matters.\u0026nbsp; He also represents clients in complex litigation and counseling matters regarding trade secret, trademark, patent and copyright matters.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eHis recent environmental matters include representation of several\u0026nbsp;auto manufacturers in enforcement matters related to compliance with the Clean Air Act and related regulations before the Environmental Protection Agency (EPA), the California Air Resources Board (CARB), the Department of Justice (DOJ), and other federal and state agencies.\u003c/p\u003e\n\u003cp\u003eIn addition to extensive IP litigation and trial experience, Bill also advises clients on developing and protecting IP portfolios, including the identification, protection, licensing and enforcement of trademarks, copyrights and trade secrets.\u003c/p\u003e"},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":6104}]},"capability_group_id":2},"created_at":"2025-05-26T04:53:31.000Z","updated_at":"2025-05-26T04:53:31.000Z","searchable_text":"Sauers{{ FIELD }}William (Bill) Sauers represents clients on high-stakes environmental matters, investigations, and technical matters.  As a partner in our Environmental, Health and Safety practice, Bill represents clients in a wide range of environmental enforcement, litigation, and compliance matters.  He also represents clients in complex litigation and counseling matters regarding trade secret, trademark, patent and copyright matters.\nHis recent environmental matters include representation of several auto manufacturers in enforcement matters related to compliance with the Clean Air Act and related regulations before the Environmental Protection Agency (EPA), the California Air Resources Board (CARB), the Department of Justice (DOJ), and other federal and state agencies.\nIn addition to extensive IP litigation and trial experience, Bill also advises clients on developing and protecting IP portfolios, including the identification, protection, licensing and enforcement of trademarks, copyrights and trade secrets. William J. Sauers Partner Supreme Court of the United States District of Columbia Pennsylvania","searchable_name":"William J. Sauers (Bill)","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":101,"capability_group_featured":null,"home_page_featured":null},{"id":442389,"version":1,"owner_type":"Person","owner_id":1036,"payload":{"bio":"\u003cp\u003eChristine Savage leads our firm's practice in sanctions law, export controls, and national security investigations of inbound U.S. investment before the Committee on Foreign Investment in the U.S. (\"CFIUS\").[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eChristine has over 25\u0026nbsp;years of experience helping clients handle their\u0026nbsp;international trade regulatory, compliance, and investigation needs.\u0026nbsp; She advises clients in a broad range of industries, including aerospace and defense, energy, FinTech and financial services, semiconductors and information technology, and biotechnology, on issues involving sanctions and export control laws.\u0026nbsp; She also assists clients in evaluating foreign investment transactions in sensitive U.S. industries and technologies, including helping them navigate proceedings before CFIUS. \u0026nbsp;\u003c/p\u003e\n\u003cp\u003eChristine looks for practical ways to help solve our clients' concerns, including defending clients in enforcement proceedings\u0026nbsp; and inquiries before the Office of Foreign Assets Control, Bureau of Industry and Security, and Directorate of Defense Trade Controls; assisting clients with internal investigations and compliance programs; and analyzing and structuring complex regulatory and licensing solutions.\u0026nbsp; She also represents\u0026nbsp;clients' interests before the Executive Branch and Congress on the impact of trade and national security regulations on their businesses, including advocating for\u0026nbsp;legislative and regulatory solutions to help advance their trade and investment goals.\u003c/p\u003e\n\u003cp\u003ePreviously, Christine served as an advisor in the International Trade Administration at the U.S. Department of Commerce.\u0026nbsp; In that\u0026nbsp;role, she acted as counsel to the government in\u0026nbsp;trade remedy proceedings and litigation involving numerous countries. She also engaged with foreign government officials and industry experts as part of a U.S. government team involved in White House trade initiatives.\u003c/p\u003e\n\u003cp\u003eChristine was recommended by \u003cem\u003eLegal 500 U.S.\u003c/em\u003e in the International Trade category. She is recognized by \u003cem\u003eChambers Global\u003c/em\u003e and \u003cem\u003eChambers U.S.A.\u003c/em\u003e in the International Trade: Export Controls \u0026amp; Economic Sanctions category.\u003c/p\u003e","slug":"christine-savage","email":"csavage@kslaw.com","phone":null,"matters":["\u003cp\u003eAssisted\u0026nbsp;\u003cstrong\u003eenergy, infrastructure, defense, and biotechnology companies\u003c/strong\u003e\u0026nbsp;in evaluating their export controls and compliance procedures for purposes of positioning their investment strategies for clearance by CFIUS.\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003eseveral U.S. and non-U.S. aerospace and defense companies\u003c/strong\u003e\u0026nbsp;in conducting internal investigations of export control and economic sanctions laws and preparing voluntary disclosures before the Bureau of Industry and Security, Directorate of Defense Trade Controls, and the Office of Foreign Assets Control.\u003c/p\u003e","\u003cp\u003eRepresenting\u0026nbsp;\u003cstrong\u003ecompanies in the FinTech industry\u003c/strong\u003e\u0026nbsp;with respect to economic sanctions compliance before OFAC, including responding to government subpoenas, penalty actions, conducting internal investigations, helping to design effective compliance programs, and addressing novel licensing issues.\u003c/p\u003e","\u003cp\u003eAssisted in obtaining clearance by CFIUS for\u0026nbsp;\u003cstrong\u003ecompanies in sensitive sectors, including defense, critical technology, and critical infrastructure industries\u0026nbsp;\u003c/strong\u003eof foreign investment, including addressing issues related to Foreign Ownership, Control and Influence, as well as assisting the companies in negotiating mitigation agreements with the U.S. government.\u003c/p\u003e","\u003cp\u003eAssisted\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003enumerous clients in the pharmaceutical, medical device and agricultural industries\u003c/strong\u003e\u0026nbsp;in obtaining licenses from OFAC for the sale of products in sanctioned countries, including Cuba, Iran and Syria, as well as assisting companies in designing compliance procedures to use existing U.S. government general licenses and license exceptions in a lawful manner.\u003c/p\u003e"],"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":25,"guid":"25.capabilities","index":0,"source":"capabilities"},{"id":81,"guid":"81.capabilities","index":1,"source":"capabilities"},{"id":1327,"guid":"1327.smart_tags","index":2,"source":"smartTags"},{"id":128,"guid":"128.capabilities","index":3,"source":"capabilities"},{"id":1330,"guid":"1330.smart_tags","index":4,"source":"smartTags"},{"id":23,"guid":"23.capabilities","index":5,"source":"capabilities"},{"id":1188,"guid":"1188.smart_tags","index":6,"source":"smartTags"},{"id":1142,"guid":"1142.smart_tags","index":7,"source":"smartTags"},{"id":107,"guid":"107.capabilities","index":8,"source":"capabilities"},{"id":699,"guid":"699.smart_tags","index":9,"source":"smartTags"},{"id":765,"guid":"765.smart_tags","index":10,"source":"smartTags"},{"id":579,"guid":"579.smart_tags","index":11,"source":"smartTags"},{"id":106,"guid":"106.capabilities","index":12,"source":"capabilities"},{"id":133,"guid":"133.capabilities","index":13,"source":"capabilities"},{"id":1233,"guid":"1233.smart_tags","index":14,"source":"smartTags"},{"id":103,"guid":"103.capabilities","index":15,"source":"capabilities"},{"id":102,"guid":"102.capabilities","index":16,"source":"capabilities"}],"is_active":true,"last_name":"Savage","nick_name":"Christine","clerkships":[],"first_name":"Christine","title_rank":9999,"updated_by":202,"law_schools":[],"middle_name":"E.","name_suffix":"","recognitions":[{"title":"Leading Partner, International Trade and National Security: Customs, Export Controls and Economic Sanctions","detail":"Legal 500 USA (2025)"},{"title":"\"Christine has a deep understanding of this area of law and gets all aspects.\"","detail":"Chambers USA, Nationwide (2025)"},{"title":"“She has a phenomenal grasp of the law and her guidance reliably balances the practicalities of our business with...”","detail":"Chambers USA (2023)"},{"title":"“Christine explores legal options with clients to meet business needs and legal obligations.”","detail":"Chambers USA (2023)"},{"title":"“She is able to give practical advice which is solution-orientated.”","detail":"Chambers USA (2023)"},{"title":"“Christine Savage is an expert's expert. She is thorough, business-minded and risk-focused in her advice.”","detail":" Chambers USA (2022)"},{"title":"“She is extremely effective and extraordinarily knowledgeable about export controls issues.”","detail":"Chambers Global (2022)"},{"title":"Top Ranked Lawyer, International Trade: Export Controls \u0026 Economic Sanctions ","detail":"Chambers Global, USA (2012, 2018-2025)"},{"title":"Top Ranked Lawyer, International Trade: Export Controls \u0026 Economic Sanctions","detail":"Chambers USA, Nationwide (2010-2011, 2017-2025)"},{"title":"“Exceptionally well versed in various trade regulations and has provided very insightful counsel...”","detail":"Chambers USA (2018)"},{"title":"Top Rated International Lawyer","detail":"Super Lawyers, Washington, D.C."},{"title":"Recognized Practitioner","detail":"Legal 500 US"}],"linked_in_url":"https://www.linkedin.com/in/christinesavage/","seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eChristine Savage leads our firm's practice in sanctions law, export controls, and national security investigations of inbound U.S. investment before the Committee on Foreign Investment in the U.S. (\"CFIUS\").[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eChristine has over 25\u0026nbsp;years of experience helping clients handle their\u0026nbsp;international trade regulatory, compliance, and investigation needs.\u0026nbsp; She advises clients in a broad range of industries, including aerospace and defense, energy, FinTech and financial services, semiconductors and information technology, and biotechnology, on issues involving sanctions and export control laws.\u0026nbsp; She also assists clients in evaluating foreign investment transactions in sensitive U.S. industries and technologies, including helping them navigate proceedings before CFIUS. \u0026nbsp;\u003c/p\u003e\n\u003cp\u003eChristine looks for practical ways to help solve our clients' concerns, including defending clients in enforcement proceedings\u0026nbsp; and inquiries before the Office of Foreign Assets Control, Bureau of Industry and Security, and Directorate of Defense Trade Controls; assisting clients with internal investigations and compliance programs; and analyzing and structuring complex regulatory and licensing solutions.\u0026nbsp; She also represents\u0026nbsp;clients' interests before the Executive Branch and Congress on the impact of trade and national security regulations on their businesses, including advocating for\u0026nbsp;legislative and regulatory solutions to help advance their trade and investment goals.\u003c/p\u003e\n\u003cp\u003ePreviously, Christine served as an advisor in the International Trade Administration at the U.S. Department of Commerce.\u0026nbsp; In that\u0026nbsp;role, she acted as counsel to the government in\u0026nbsp;trade remedy proceedings and litigation involving numerous countries. She also engaged with foreign government officials and industry experts as part of a U.S. government team involved in White House trade initiatives.\u003c/p\u003e\n\u003cp\u003eChristine was recommended by \u003cem\u003eLegal 500 U.S.\u003c/em\u003e in the International Trade category. She is recognized by \u003cem\u003eChambers Global\u003c/em\u003e and \u003cem\u003eChambers U.S.A.\u003c/em\u003e in the International Trade: Export Controls \u0026amp; Economic Sanctions category.\u003c/p\u003e","matters":["\u003cp\u003eAssisted\u0026nbsp;\u003cstrong\u003eenergy, infrastructure, defense, and biotechnology companies\u003c/strong\u003e\u0026nbsp;in evaluating their export controls and compliance procedures for purposes of positioning their investment strategies for clearance by CFIUS.\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003eseveral U.S. and non-U.S. aerospace and defense companies\u003c/strong\u003e\u0026nbsp;in conducting internal investigations of export control and economic sanctions laws and preparing voluntary disclosures before the Bureau of Industry and Security, Directorate of Defense Trade Controls, and the Office of Foreign Assets Control.\u003c/p\u003e","\u003cp\u003eRepresenting\u0026nbsp;\u003cstrong\u003ecompanies in the FinTech industry\u003c/strong\u003e\u0026nbsp;with respect to economic sanctions compliance before OFAC, including responding to government subpoenas, penalty actions, conducting internal investigations, helping to design effective compliance programs, and addressing novel licensing issues.\u003c/p\u003e","\u003cp\u003eAssisted in obtaining clearance by CFIUS for\u0026nbsp;\u003cstrong\u003ecompanies in sensitive sectors, including defense, critical technology, and critical infrastructure industries\u0026nbsp;\u003c/strong\u003eof foreign investment, including addressing issues related to Foreign Ownership, Control and Influence, as well as assisting the companies in negotiating mitigation agreements with the U.S. government.\u003c/p\u003e","\u003cp\u003eAssisted\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003enumerous clients in the pharmaceutical, medical device and agricultural industries\u003c/strong\u003e\u0026nbsp;in obtaining licenses from OFAC for the sale of products in sanctioned countries, including Cuba, Iran and Syria, as well as assisting companies in designing compliance procedures to use existing U.S. government general licenses and license exceptions in a lawful manner.\u003c/p\u003e"],"recognitions":[{"title":"Leading Partner, International Trade and National Security: Customs, Export Controls and Economic Sanctions","detail":"Legal 500 USA (2025)"},{"title":"\"Christine has a deep understanding of this area of law and gets all aspects.\"","detail":"Chambers USA, Nationwide (2025)"},{"title":"“She has a phenomenal grasp of the law and her guidance reliably balances the practicalities of our business with...”","detail":"Chambers USA (2023)"},{"title":"“Christine explores legal options with clients to meet business needs and legal obligations.”","detail":"Chambers USA (2023)"},{"title":"“She is able to give practical advice which is solution-orientated.”","detail":"Chambers USA (2023)"},{"title":"“Christine Savage is an expert's expert. She is thorough, business-minded and risk-focused in her advice.”","detail":" Chambers USA (2022)"},{"title":"“She is extremely effective and extraordinarily knowledgeable about export controls issues.”","detail":"Chambers Global (2022)"},{"title":"Top Ranked Lawyer, International Trade: Export Controls \u0026 Economic Sanctions ","detail":"Chambers Global, USA (2012, 2018-2025)"},{"title":"Top Ranked Lawyer, International Trade: Export Controls \u0026 Economic Sanctions","detail":"Chambers USA, Nationwide (2010-2011, 2017-2025)"},{"title":"“Exceptionally well versed in various trade regulations and has provided very insightful counsel...”","detail":"Chambers USA (2018)"},{"title":"Top Rated International Lawyer","detail":"Super Lawyers, Washington, D.C."},{"title":"Recognized Practitioner","detail":"Legal 500 US"}]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":1165},{"id":1165}]},"capability_group_id":2},"created_at":"2025-11-05T05:04:06.000Z","updated_at":"2025-11-05T05:04:06.000Z","searchable_text":"Savage{{ FIELD }}{:title=\u0026gt;\"Leading Partner, International Trade and National Security: Customs, Export Controls and Economic Sanctions\", :detail=\u0026gt;\"Legal 500 USA (2025)\"}{{ FIELD }}{:title=\u0026gt;\"\\\"Christine has a deep understanding of this area of law and gets all aspects.\\\"\", :detail=\u0026gt;\"Chambers USA, Nationwide (2025)\"}{{ FIELD }}{:title=\u0026gt;\"“She has a phenomenal grasp of the law and her guidance reliably balances the practicalities of our business with...”\", :detail=\u0026gt;\"Chambers USA (2023)\"}{{ FIELD }}{:title=\u0026gt;\"“Christine explores legal options with clients to meet business needs and legal obligations.”\", :detail=\u0026gt;\"Chambers USA (2023)\"}{{ FIELD }}{:title=\u0026gt;\"“She is able to give practical advice which is solution-orientated.”\", :detail=\u0026gt;\"Chambers USA (2023)\"}{{ FIELD }}{:title=\u0026gt;\"“Christine Savage is an expert's expert. She is thorough, business-minded and risk-focused in her advice.”\", :detail=\u0026gt;\" Chambers USA (2022)\"}{{ FIELD }}{:title=\u0026gt;\"“She is extremely effective and extraordinarily knowledgeable about export controls issues.”\", :detail=\u0026gt;\"Chambers Global (2022)\"}{{ FIELD }}{:title=\u0026gt;\"Top Ranked Lawyer, International Trade: Export Controls \u0026amp; Economic Sanctions \", :detail=\u0026gt;\"Chambers Global, USA (2012, 2018-2025)\"}{{ FIELD }}{:title=\u0026gt;\"Top Ranked Lawyer, International Trade: Export Controls \u0026amp; Economic Sanctions\", :detail=\u0026gt;\"Chambers USA, Nationwide (2010-2011, 2017-2025)\"}{{ FIELD }}{:title=\u0026gt;\"“Exceptionally well versed in various trade regulations and has provided very insightful counsel...”\", :detail=\u0026gt;\"Chambers USA (2018)\"}{{ FIELD }}{:title=\u0026gt;\"Top Rated International Lawyer\", :detail=\u0026gt;\"Super Lawyers, Washington, D.C.\"}{{ FIELD }}{:title=\u0026gt;\"Recognized Practitioner\", :detail=\u0026gt;\"Legal 500 US\"}{{ FIELD }}Assisted energy, infrastructure, defense, and biotechnology companies in evaluating their export controls and compliance procedures for purposes of positioning their investment strategies for clearance by CFIUS.{{ FIELD }}Represented several U.S. and non-U.S. aerospace and defense companies in conducting internal investigations of export control and economic sanctions laws and preparing voluntary disclosures before the Bureau of Industry and Security, Directorate of Defense Trade Controls, and the Office of Foreign Assets Control.{{ FIELD }}Representing companies in the FinTech industry with respect to economic sanctions compliance before OFAC, including responding to government subpoenas, penalty actions, conducting internal investigations, helping to design effective compliance programs, and addressing novel licensing issues.{{ FIELD }}Assisted in obtaining clearance by CFIUS for companies in sensitive sectors, including defense, critical technology, and critical infrastructure industries of foreign investment, including addressing issues related to Foreign Ownership, Control and Influence, as well as assisting the companies in negotiating mitigation agreements with the U.S. government.{{ FIELD }}Assisted numerous clients in the pharmaceutical, medical device and agricultural industries in obtaining licenses from OFAC for the sale of products in sanctioned countries, including Cuba, Iran and Syria, as well as assisting companies in designing compliance procedures to use existing U.S. government general licenses and license exceptions in a lawful manner.{{ FIELD }}Christine Savage leads our firm's practice in sanctions law, export controls, and national security investigations of inbound U.S. investment before the Committee on Foreign Investment in the U.S. (\"CFIUS\").\nChristine has over 25 years of experience helping clients handle their international trade regulatory, compliance, and investigation needs.  She advises clients in a broad range of industries, including aerospace and defense, energy, FinTech and financial services, semiconductors and information technology, and biotechnology, on issues involving sanctions and export control laws.  She also assists clients in evaluating foreign investment transactions in sensitive U.S. industries and technologies, including helping them navigate proceedings before CFIUS.  \nChristine looks for practical ways to help solve our clients' concerns, including defending clients in enforcement proceedings  and inquiries before the Office of Foreign Assets Control, Bureau of Industry and Security, and Directorate of Defense Trade Controls; assisting clients with internal investigations and compliance programs; and analyzing and structuring complex regulatory and licensing solutions.  She also represents clients' interests before the Executive Branch and Congress on the impact of trade and national security regulations on their businesses, including advocating for legislative and regulatory solutions to help advance their trade and investment goals.\nPreviously, Christine served as an advisor in the International Trade Administration at the U.S. Department of Commerce.  In that role, she acted as counsel to the government in trade remedy proceedings and litigation involving numerous countries. She also engaged with foreign government officials and industry experts as part of a U.S. government team involved in White House trade initiatives.\nChristine was recommended by Legal 500 U.S. in the International Trade category. She is recognized by Chambers Global and Chambers U.S.A. in the International Trade: Export Controls \u0026amp; Economic Sanctions category. Partner Leading Partner, International Trade and National Security: Customs, Export Controls and Economic Sanctions Legal 500 USA (2025) \"Christine has a deep understanding of this area of law and gets all aspects.\" Chambers USA, Nationwide (2025) “She has a phenomenal grasp of the law and her guidance reliably balances the practicalities of our business with...” Chambers USA (2023) “Christine explores legal options with clients to meet business needs and legal obligations.” Chambers USA (2023) “She is able to give practical advice which is solution-orientated.” Chambers USA (2023) “Christine Savage is an expert's expert. She is thorough, business-minded and risk-focused in her advice.”  Chambers USA (2022) “She is extremely effective and extraordinarily knowledgeable about export controls issues.” Chambers Global (2022) Top Ranked Lawyer, International Trade: Export Controls \u0026amp; Economic Sanctions  Chambers Global, USA (2012, 2018-2025) Top Ranked Lawyer, International Trade: Export Controls \u0026amp; Economic Sanctions Chambers USA, Nationwide (2010-2011, 2017-2025) “Exceptionally well versed in various trade regulations and has provided very insightful counsel...” Chambers USA (2018) Top Rated International Lawyer Super Lawyers, Washington, D.C. Recognized Practitioner Legal 500 US University of Michigan University of Michigan Law School Columbus School of Law, Catholic University of America Columbus School of Law, Catholic University of America U.S. Court of Appeals for the Federal Circuit U.S. Court of International Trade District of Columbia New York The District of Columbia Bar United States Court of Appeals for the Federal Circuit Court of International Trade American Bar Association, International Trade Section, Export Committee Assisted energy, infrastructure, defense, and biotechnology companies in evaluating their export controls and compliance procedures for purposes of positioning their investment strategies for clearance by CFIUS. Represented several U.S. and non-U.S. aerospace and defense companies in conducting internal investigations of export control and economic sanctions laws and preparing voluntary disclosures before the Bureau of Industry and Security, Directorate of Defense Trade Controls, and the Office of Foreign Assets Control. Representing companies in the FinTech industry with respect to economic sanctions compliance before OFAC, including responding to government subpoenas, penalty actions, conducting internal investigations, helping to design effective compliance programs, and addressing novel licensing issues. Assisted in obtaining clearance by CFIUS for companies in sensitive sectors, including defense, critical technology, and critical infrastructure industries of foreign investment, including addressing issues related to Foreign Ownership, Control and Influence, as well as assisting the companies in negotiating mitigation agreements with the U.S. government. Assisted numerous clients in the pharmaceutical, medical device and agricultural industries in obtaining licenses from OFAC for the sale of products in sanctioned countries, including Cuba, Iran and Syria, as well as assisting companies in designing compliance procedures to use existing U.S. government general licenses and license exceptions in a lawful manner.","searchable_name":"Christine E. Savage","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":202,"capability_group_featured":null,"home_page_featured":null},{"id":447453,"version":1,"owner_type":"Person","owner_id":6203,"payload":{"bio":"\u003cp\u003eJulia Schmidt specializes in owner-side real estate transactions, with substantial experience in borrower-side real estate finance. She represents property owners and developers involved in the acquisition, development, and financing of a broad range of real estate projects, including multifamily buildings, large-scale single-family developments, mixed-income and fully affordable housing, office spaces, medical office facilities, industrial properties, data centers, and other commercial assets.\u0026nbsp; Additionally, Julia advises clients on all aspects of the capital stack: taxable and tax-exempt bond financings, senior, mezzanine and subordinate debt, equity investments, and (Low-Income Housing Tax Credit) LIHTC syndications. [[--readmore--]]\u003c/p\u003e\n\u003cp\u003eJulia represents property owners and developers on the full lifecycle of real estate transactions, from acquisitions and leasing to construction and development to disposition, along with debt and equity financing for each stage.\u0026nbsp; Additionally, Julia frequently manages workouts, foreclosures and restructurings and public-private partnerships, overseeing complex, high-profile multiparty transactions from inception to closing.\u0026nbsp; Clients count on her to find practical paths through varied markets and deliver business-focused solutions that advance their objectives and get deals done.\u0026nbsp; Her extensive network -- including banks, private credit and equity providers, property owners, governmental agencies, agency lenders, and tax credit investors -- enables her to bring the right parties together and deliver effective counsel in sophisticated situations.\u003cbr\u003e\u003cbr\u003eJulia has represented numerous owners of mixed-use properties, structuring and closing intricate debt and equity financing arrangements alongside housing finance agencies and public authorities to facilitate the creation of thousands of new affordable housing units.\u0026nbsp; Among her notable achievements are closing one of the nation\u0026rsquo;s largest HUD affordable housing transactions, securing financing for the development of one of New York City\u0026rsquo;s most significant residential buildings, valued at over $1 billion, obtaining financing for billions of dollars of data center campus development throughout the eastern U.S. and coordinating financing for the acquisition a $1.6 billion multifamily portfolio.\u003cbr\u003e\u003cbr\u003eRecognized as a Fellow of the American College of Mortgage Attorneys, Julia helps her clients navigate the intersection of private development and public policy as well as the overall dynamics that shape complex real estate transactions.\u0026nbsp; She is equally effective advising entrepreneurial developers on single-asset transactions and institutional clients on portfolio-level strategies, and she brings a collaborative, deal-oriented approach that has earned the trust of repeat clients across market cycles.\u003c/p\u003e","slug":"julia-schmidt","email":"jschmidt@kslaw.com","phone":null,"matters":["\u003cp\u003eRepresented Douglaston Development, through a joint venture with Kinwood Partners, in connection with its selection by the New York City Economic Development Corporation to redevelop Gansevoort Square in Manhattan into a major mixed-income residential, cultural, and community-focused development (transaction value not publicly disclosed).\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong\u003ea confidential client\u003c/strong\u003e\u0026nbsp;in the formation of a joint venture with a syndicate of Korean institutional investors for the development and operation of large-scale data center facilities in Virginia, with total transaction value exceeding $260 million.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong\u003ea confidential institutional real estate investor\u0026nbsp;\u003c/strong\u003ein connection with a $299 million construction loan to finance the development of a 744,000-square-foot, two-building data center campus in Loudoun County, Virginia.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong\u003eDouglaston Development\u003c/strong\u003e\u0026nbsp;in a multifaceted New York City real estate transaction involving the acquisition of development sites and a tiered capital stack, representing an aggregate transaction value of approximately $392.5 million, for the development of mixed-use and luxury residential projects.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong\u003ea confidential real estate sponsor\u003c/strong\u003e\u0026nbsp;in a $450 million refinancing with Ares Management of a nearly complete 834-unit, mixed-income, waterfront multifamily development in Brooklyn, New York.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong\u003ea confidential data center owner and developer\u003c/strong\u003e\u0026nbsp;in connection with a $525 million construction loan for the expansion and improvement of data center campuses in North Carolina and Illinois.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong\u003ea confidential, publicly traded client\u003c/strong\u003e\u0026nbsp;in multiple construction financings totaling over $700 million for the development of a multi-building data center campus in Manassas, Virginia, including the VA-6 and VA-7 facilities.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong\u003eCortland Partners\u003c/strong\u003e\u0026nbsp;in its $1.6 billion acquisition of a 19-asset multifamily portfolio from Elme Communities (NYSE: ELME), including advising on acquisition structuring, co-investment capital, and acquisition and agency loan financing.\u003c/p\u003e","\u003cp\u003eRepresented developer of affordable, mixed-income and market rate projects in the ground leasing of multiple parcels in the Bronx, on which the developer will construct hundreds of affordable and moderate-income residential units, as well as a FRESH grocery store. Phase I will be comprised of 188 all-senior, all-affordable units, including a substantial set aside for formerly homeless individuals, with total development costs in excess of $112 million. The complex financing included tax-exempt bonds, four state and city loans, and LIHTC equity from a major investor.\u003c/p\u003e","\u003cp\u003eRepresented developer in the financing of a groundbreaking, multi-phase mixed-income project near the Capitol Building in Washington, DC. Phase I will be comprised of 561 residential units, with the entire project anticipated to contain over 1,100 residential units, as well as substantial retail space. Phase I financing included $160 million of debt (tax-exempt bonds and a taxable loan) and equity investment of a major affordable housing investor based on LIHTCs anticipated to be generated with respect to Phase I\u0026rsquo;s 118 low-income units.\u003c/p\u003e","\u003cp\u003eRepresented development corporation in closing a $210 million bond financing for the construction of a 40+-story building to contain more than 300 residential units, 60+ of which will be reserved for low- and moderate-income households, as well as nearly 30,000 rentable square feet of retail space. The project has anticipated total development costs of approximately $300 million and was established with a multi-unit condominium structure to facilitate the project obtaining expected LIHTCs.\u003c/p\u003e","\u003cp\u003eRepresented developer of distinctive real estate properties as financing and development counsel in closing a $175 million bond and construction loan on a project with total development costs of approximately $300 million and a major joint venture equity financing for the development of a 50+-story, 580+-unit residential building in Brooklyn. Additionally represented the owner in securing joint venture partners at various levels of the ownership structure, including major foreign investors contributing substantial equity.\u003c/p\u003e","\u003cp\u003eAssisted developer of distinctive real estate properties with refinancing a construction loan used to develop a complex in Manhattan. Comprised of three separate condominium regimes, the project contains more than 1,200 residential units (240+ reserved for low-income individuals and families), plus ancillary parking facilities and a large retail eatery. Coordinated the tender of more than $500 million in New York State Housing Finance Agency tax-exempt and taxable bonds and direct purchase of such bonds.\u003c/p\u003e","\u003cp\u003eRepresented residential and commercial real estate acquisition, development and property management firm in closing a $380 million bond and construction loan financing for the development of several structures in Manhattan. The development will contain more than 1,000 residential apartments\u0026mdash;200+ reserved for tenants whose household incomes are at or below 60 percent of the New York City Area Median Income, more than 35,000 square feet of commercial space and parking for hundreds of vehicles. The transaction is also structured to facilitate the potential syndication of tax credits. The closing required the negotiation and execution of a sublease of the affordable apartments to preserve various tax benefits.\u003c/p\u003e","\u003cp\u003eRepresented multifaceted real estate company serving the greater New York area in closing a financing transaction for the acquisition and rehabilitation of several multifamily rental properties containing 100% affordable housing in the Bronx. We negotiated a construction loan from the New York City Housing Development Corporation, permanent financing and the issuance of a letter of credit from a multinational banking and financial services holding company. Our team additionally coordinated obtaining the necessary approvals and contract extensions from HUD and the properties' current limited partners, worked with the project's nonprofit purchasing entity and negotiated amended operating documents with the client's low-income housing tax credit investor partner.\u003c/p\u003e","\u003cp\u003eRepresented real estate agent and manager in the development of a nearly 40-story tower in the Greenpoint neighborhood of Brooklyn, New York. The riverside luxury high-rise will contain more than 40,000 square feet of retail space and approximately 600 total residential apartments and condominium units.\u003c/p\u003e","\u003cp\u003eRepresented New York City luxury real estate developer in financing and developing a multifamily project in Long Island City. The project, one of the largest apartment projects in Queens, is expected to contain more than 950 residential apartment units in two towers (20% set aside for affordable housing and additional units set aside for workforce housing), more than 15,000 square feet of commercial space and parking for more than 65 vehicles. The transaction is structured to facilitate the generation and potential syndication of tax credits.\u003c/p\u003e","\u003cp\u003eRepresented developer in obtaining $539 million in construction financing from the New York State Housing Finance Agency for a residential tower project that will offer more than 900 apartments at market rates and more than 230 units of affordable housing.\u003c/p\u003e","\u003cp\u003eRepresent national residential real estate developer in closing a $95 million bond financing transaction. The client plans to build a mixed-use building containing more than 320 residential apartments and ancillary commercial space and parking, reserving 20 percent of the apartments for low- and moderate-income households in a popular area of Washington, DC. Total development costs are estimated at $140 million.\u003c/p\u003e"],"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":75,"guid":"75.capabilities","index":0,"source":"capabilities"},{"id":36,"guid":"36.capabilities","index":1,"source":"capabilities"},{"id":82,"guid":"82.capabilities","index":2,"source":"capabilities"},{"id":10,"guid":"10.capabilities","index":3,"source":"capabilities"},{"id":107,"guid":"107.capabilities","index":4,"source":"capabilities"},{"id":1434,"guid":"1434.smart_tags","index":5,"source":"smartTags"}],"is_active":true,"last_name":"Schmidt","nick_name":"Julia","clerkships":[],"first_name":"Julia","title_rank":9999,"updated_by":202,"law_schools":[{"id":755,"meta":{"degree":"J.D.","honors":"","is_law_school":"1","graduation_date":"2008-01-01 00:00:00"},"order":1,"pin_order":null,"pin_expiration":null}],"middle_name":"E.","name_suffix":"","recognitions":[{"title":"Named a Law360 Real Estate Editorial Board Member","detail":"Law360, 2025 - 2026"},{"title":"Named one of Washington, D.C.'s \"Best Lawyers in America\"","detail":"Real Estate Law, 2026"},{"title":"Fellow, American College of Mortgage Attorneys","detail":" American College of Mortgage Attorneys"}],"linked_in_url":"https://www.linkedin.com/in/juliaeschmidt/","seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eJulia Schmidt specializes in owner-side real estate transactions, with substantial experience in borrower-side real estate finance. She represents property owners and developers involved in the acquisition, development, and financing of a broad range of real estate projects, including multifamily buildings, large-scale single-family developments, mixed-income and fully affordable housing, office spaces, medical office facilities, industrial properties, data centers, and other commercial assets.\u0026nbsp; Additionally, Julia advises clients on all aspects of the capital stack: taxable and tax-exempt bond financings, senior, mezzanine and subordinate debt, equity investments, and (Low-Income Housing Tax Credit) LIHTC syndications. [[--readmore--]]\u003c/p\u003e\n\u003cp\u003eJulia represents property owners and developers on the full lifecycle of real estate transactions, from acquisitions and leasing to construction and development to disposition, along with debt and equity financing for each stage.\u0026nbsp; Additionally, Julia frequently manages workouts, foreclosures and restructurings and public-private partnerships, overseeing complex, high-profile multiparty transactions from inception to closing.\u0026nbsp; Clients count on her to find practical paths through varied markets and deliver business-focused solutions that advance their objectives and get deals done.\u0026nbsp; Her extensive network -- including banks, private credit and equity providers, property owners, governmental agencies, agency lenders, and tax credit investors -- enables her to bring the right parties together and deliver effective counsel in sophisticated situations.\u003cbr\u003e\u003cbr\u003eJulia has represented numerous owners of mixed-use properties, structuring and closing intricate debt and equity financing arrangements alongside housing finance agencies and public authorities to facilitate the creation of thousands of new affordable housing units.\u0026nbsp; Among her notable achievements are closing one of the nation\u0026rsquo;s largest HUD affordable housing transactions, securing financing for the development of one of New York City\u0026rsquo;s most significant residential buildings, valued at over $1 billion, obtaining financing for billions of dollars of data center campus development throughout the eastern U.S. and coordinating financing for the acquisition a $1.6 billion multifamily portfolio.\u003cbr\u003e\u003cbr\u003eRecognized as a Fellow of the American College of Mortgage Attorneys, Julia helps her clients navigate the intersection of private development and public policy as well as the overall dynamics that shape complex real estate transactions.\u0026nbsp; She is equally effective advising entrepreneurial developers on single-asset transactions and institutional clients on portfolio-level strategies, and she brings a collaborative, deal-oriented approach that has earned the trust of repeat clients across market cycles.\u003c/p\u003e","matters":["\u003cp\u003eRepresented Douglaston Development, through a joint venture with Kinwood Partners, in connection with its selection by the New York City Economic Development Corporation to redevelop Gansevoort Square in Manhattan into a major mixed-income residential, cultural, and community-focused development (transaction value not publicly disclosed).\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong\u003ea confidential client\u003c/strong\u003e\u0026nbsp;in the formation of a joint venture with a syndicate of Korean institutional investors for the development and operation of large-scale data center facilities in Virginia, with total transaction value exceeding $260 million.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong\u003ea confidential institutional real estate investor\u0026nbsp;\u003c/strong\u003ein connection with a $299 million construction loan to finance the development of a 744,000-square-foot, two-building data center campus in Loudoun County, Virginia.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong\u003eDouglaston Development\u003c/strong\u003e\u0026nbsp;in a multifaceted New York City real estate transaction involving the acquisition of development sites and a tiered capital stack, representing an aggregate transaction value of approximately $392.5 million, for the development of mixed-use and luxury residential projects.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong\u003ea confidential real estate sponsor\u003c/strong\u003e\u0026nbsp;in a $450 million refinancing with Ares Management of a nearly complete 834-unit, mixed-income, waterfront multifamily development in Brooklyn, New York.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong\u003ea confidential data center owner and developer\u003c/strong\u003e\u0026nbsp;in connection with a $525 million construction loan for the expansion and improvement of data center campuses in North Carolina and Illinois.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong\u003ea confidential, publicly traded client\u003c/strong\u003e\u0026nbsp;in multiple construction financings totaling over $700 million for the development of a multi-building data center campus in Manassas, Virginia, including the VA-6 and VA-7 facilities.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong\u003eCortland Partners\u003c/strong\u003e\u0026nbsp;in its $1.6 billion acquisition of a 19-asset multifamily portfolio from Elme Communities (NYSE: ELME), including advising on acquisition structuring, co-investment capital, and acquisition and agency loan financing.\u003c/p\u003e","\u003cp\u003eRepresented developer of affordable, mixed-income and market rate projects in the ground leasing of multiple parcels in the Bronx, on which the developer will construct hundreds of affordable and moderate-income residential units, as well as a FRESH grocery store. Phase I will be comprised of 188 all-senior, all-affordable units, including a substantial set aside for formerly homeless individuals, with total development costs in excess of $112 million. The complex financing included tax-exempt bonds, four state and city loans, and LIHTC equity from a major investor.\u003c/p\u003e","\u003cp\u003eRepresented developer in the financing of a groundbreaking, multi-phase mixed-income project near the Capitol Building in Washington, DC. Phase I will be comprised of 561 residential units, with the entire project anticipated to contain over 1,100 residential units, as well as substantial retail space. Phase I financing included $160 million of debt (tax-exempt bonds and a taxable loan) and equity investment of a major affordable housing investor based on LIHTCs anticipated to be generated with respect to Phase I\u0026rsquo;s 118 low-income units.\u003c/p\u003e","\u003cp\u003eRepresented development corporation in closing a $210 million bond financing for the construction of a 40+-story building to contain more than 300 residential units, 60+ of which will be reserved for low- and moderate-income households, as well as nearly 30,000 rentable square feet of retail space. The project has anticipated total development costs of approximately $300 million and was established with a multi-unit condominium structure to facilitate the project obtaining expected LIHTCs.\u003c/p\u003e","\u003cp\u003eRepresented developer of distinctive real estate properties as financing and development counsel in closing a $175 million bond and construction loan on a project with total development costs of approximately $300 million and a major joint venture equity financing for the development of a 50+-story, 580+-unit residential building in Brooklyn. Additionally represented the owner in securing joint venture partners at various levels of the ownership structure, including major foreign investors contributing substantial equity.\u003c/p\u003e","\u003cp\u003eAssisted developer of distinctive real estate properties with refinancing a construction loan used to develop a complex in Manhattan. Comprised of three separate condominium regimes, the project contains more than 1,200 residential units (240+ reserved for low-income individuals and families), plus ancillary parking facilities and a large retail eatery. Coordinated the tender of more than $500 million in New York State Housing Finance Agency tax-exempt and taxable bonds and direct purchase of such bonds.\u003c/p\u003e","\u003cp\u003eRepresented residential and commercial real estate acquisition, development and property management firm in closing a $380 million bond and construction loan financing for the development of several structures in Manhattan. The development will contain more than 1,000 residential apartments\u0026mdash;200+ reserved for tenants whose household incomes are at or below 60 percent of the New York City Area Median Income, more than 35,000 square feet of commercial space and parking for hundreds of vehicles. The transaction is also structured to facilitate the potential syndication of tax credits. The closing required the negotiation and execution of a sublease of the affordable apartments to preserve various tax benefits.\u003c/p\u003e","\u003cp\u003eRepresented multifaceted real estate company serving the greater New York area in closing a financing transaction for the acquisition and rehabilitation of several multifamily rental properties containing 100% affordable housing in the Bronx. We negotiated a construction loan from the New York City Housing Development Corporation, permanent financing and the issuance of a letter of credit from a multinational banking and financial services holding company. Our team additionally coordinated obtaining the necessary approvals and contract extensions from HUD and the properties' current limited partners, worked with the project's nonprofit purchasing entity and negotiated amended operating documents with the client's low-income housing tax credit investor partner.\u003c/p\u003e","\u003cp\u003eRepresented real estate agent and manager in the development of a nearly 40-story tower in the Greenpoint neighborhood of Brooklyn, New York. The riverside luxury high-rise will contain more than 40,000 square feet of retail space and approximately 600 total residential apartments and condominium units.\u003c/p\u003e","\u003cp\u003eRepresented New York City luxury real estate developer in financing and developing a multifamily project in Long Island City. The project, one of the largest apartment projects in Queens, is expected to contain more than 950 residential apartment units in two towers (20% set aside for affordable housing and additional units set aside for workforce housing), more than 15,000 square feet of commercial space and parking for more than 65 vehicles. The transaction is structured to facilitate the generation and potential syndication of tax credits.\u003c/p\u003e","\u003cp\u003eRepresented developer in obtaining $539 million in construction financing from the New York State Housing Finance Agency for a residential tower project that will offer more than 900 apartments at market rates and more than 230 units of affordable housing.\u003c/p\u003e","\u003cp\u003eRepresent national residential real estate developer in closing a $95 million bond financing transaction. The client plans to build a mixed-use building containing more than 320 residential apartments and ancillary commercial space and parking, reserving 20 percent of the apartments for low- and moderate-income households in a popular area of Washington, DC. Total development costs are estimated at $140 million.\u003c/p\u003e"],"recognitions":[{"title":"Named a Law360 Real Estate Editorial Board Member","detail":"Law360, 2025 - 2026"},{"title":"Named one of Washington, D.C.'s \"Best Lawyers in America\"","detail":"Real Estate Law, 2026"},{"title":"Fellow, American College of Mortgage Attorneys","detail":" American College of Mortgage Attorneys"}]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":11990}]},"capability_group_id":1},"created_at":"2026-04-10T13:40:12.000Z","updated_at":"2026-04-10T13:40:12.000Z","searchable_text":"Schmidt{{ FIELD }}{:title=\u0026gt;\"Named a Law360 Real Estate Editorial Board Member\", :detail=\u0026gt;\"Law360, 2025 - 2026\"}{{ FIELD }}{:title=\u0026gt;\"Named one of Washington, D.C.'s \\\"Best Lawyers in America\\\"\", :detail=\u0026gt;\"Real Estate Law, 2026\"}{{ FIELD }}{:title=\u0026gt;\"Fellow, American College of Mortgage Attorneys\", :detail=\u0026gt;\" American College of Mortgage Attorneys\"}{{ FIELD }}Represented Douglaston Development, through a joint venture with Kinwood Partners, in connection with its selection by the New York City Economic Development Corporation to redevelop Gansevoort Square in Manhattan into a major mixed-income residential, cultural, and community-focused development (transaction value not publicly disclosed).{{ FIELD }}Represented a confidential client in the formation of a joint venture with a syndicate of Korean institutional investors for the development and operation of large-scale data center facilities in Virginia, with total transaction value exceeding $260 million.{{ FIELD }}Represented a confidential institutional real estate investor in connection with a $299 million construction loan to finance the development of a 744,000-square-foot, two-building data center campus in Loudoun County, Virginia.{{ FIELD }}Represented Douglaston Development in a multifaceted New York City real estate transaction involving the acquisition of development sites and a tiered capital stack, representing an aggregate transaction value of approximately $392.5 million, for the development of mixed-use and luxury residential projects.{{ FIELD }}Represented a confidential real estate sponsor in a $450 million refinancing with Ares Management of a nearly complete 834-unit, mixed-income, waterfront multifamily development in Brooklyn, New York.{{ FIELD }}Represented a confidential data center owner and developer in connection with a $525 million construction loan for the expansion and improvement of data center campuses in North Carolina and Illinois.{{ FIELD }}Represented a confidential, publicly traded client in multiple construction financings totaling over $700 million for the development of a multi-building data center campus in Manassas, Virginia, including the VA-6 and VA-7 facilities.{{ FIELD }}Represented Cortland Partners in its $1.6 billion acquisition of a 19-asset multifamily portfolio from Elme Communities (NYSE: ELME), including advising on acquisition structuring, co-investment capital, and acquisition and agency loan financing.{{ FIELD }}Represented developer of affordable, mixed-income and market rate projects in the ground leasing of multiple parcels in the Bronx, on which the developer will construct hundreds of affordable and moderate-income residential units, as well as a FRESH grocery store. Phase I will be comprised of 188 all-senior, all-affordable units, including a substantial set aside for formerly homeless individuals, with total development costs in excess of $112 million. The complex financing included tax-exempt bonds, four state and city loans, and LIHTC equity from a major investor.{{ FIELD }}Represented developer in the financing of a groundbreaking, multi-phase mixed-income project near the Capitol Building in Washington, DC. Phase I will be comprised of 561 residential units, with the entire project anticipated to contain over 1,100 residential units, as well as substantial retail space. Phase I financing included $160 million of debt (tax-exempt bonds and a taxable loan) and equity investment of a major affordable housing investor based on LIHTCs anticipated to be generated with respect to Phase I’s 118 low-income units.{{ FIELD }}Represented development corporation in closing a $210 million bond financing for the construction of a 40+-story building to contain more than 300 residential units, 60+ of which will be reserved for low- and moderate-income households, as well as nearly 30,000 rentable square feet of retail space. The project has anticipated total development costs of approximately $300 million and was established with a multi-unit condominium structure to facilitate the project obtaining expected LIHTCs.{{ FIELD }}Represented developer of distinctive real estate properties as financing and development counsel in closing a $175 million bond and construction loan on a project with total development costs of approximately $300 million and a major joint venture equity financing for the development of a 50+-story, 580+-unit residential building in Brooklyn. Additionally represented the owner in securing joint venture partners at various levels of the ownership structure, including major foreign investors contributing substantial equity.{{ FIELD }}Assisted developer of distinctive real estate properties with refinancing a construction loan used to develop a complex in Manhattan. Comprised of three separate condominium regimes, the project contains more than 1,200 residential units (240+ reserved for low-income individuals and families), plus ancillary parking facilities and a large retail eatery. Coordinated the tender of more than $500 million in New York State Housing Finance Agency tax-exempt and taxable bonds and direct purchase of such bonds.{{ FIELD }}Represented residential and commercial real estate acquisition, development and property management firm in closing a $380 million bond and construction loan financing for the development of several structures in Manhattan. The development will contain more than 1,000 residential apartments—200+ reserved for tenants whose household incomes are at or below 60 percent of the New York City Area Median Income, more than 35,000 square feet of commercial space and parking for hundreds of vehicles. The transaction is also structured to facilitate the potential syndication of tax credits. The closing required the negotiation and execution of a sublease of the affordable apartments to preserve various tax benefits.{{ FIELD }}Represented multifaceted real estate company serving the greater New York area in closing a financing transaction for the acquisition and rehabilitation of several multifamily rental properties containing 100% affordable housing in the Bronx. We negotiated a construction loan from the New York City Housing Development Corporation, permanent financing and the issuance of a letter of credit from a multinational banking and financial services holding company. Our team additionally coordinated obtaining the necessary approvals and contract extensions from HUD and the properties' current limited partners, worked with the project's nonprofit purchasing entity and negotiated amended operating documents with the client's low-income housing tax credit investor partner.{{ FIELD }}Represented real estate agent and manager in the development of a nearly 40-story tower in the Greenpoint neighborhood of Brooklyn, New York. The riverside luxury high-rise will contain more than 40,000 square feet of retail space and approximately 600 total residential apartments and condominium units.{{ FIELD }}Represented New York City luxury real estate developer in financing and developing a multifamily project in Long Island City. The project, one of the largest apartment projects in Queens, is expected to contain more than 950 residential apartment units in two towers (20% set aside for affordable housing and additional units set aside for workforce housing), more than 15,000 square feet of commercial space and parking for more than 65 vehicles. The transaction is structured to facilitate the generation and potential syndication of tax credits.{{ FIELD }}Represented developer in obtaining $539 million in construction financing from the New York State Housing Finance Agency for a residential tower project that will offer more than 900 apartments at market rates and more than 230 units of affordable housing.{{ FIELD }}Represent national residential real estate developer in closing a $95 million bond financing transaction. The client plans to build a mixed-use building containing more than 320 residential apartments and ancillary commercial space and parking, reserving 20 percent of the apartments for low- and moderate-income households in a popular area of Washington, DC. Total development costs are estimated at $140 million.{{ FIELD }}Julia Schmidt specializes in owner-side real estate transactions, with substantial experience in borrower-side real estate finance. She represents property owners and developers involved in the acquisition, development, and financing of a broad range of real estate projects, including multifamily buildings, large-scale single-family developments, mixed-income and fully affordable housing, office spaces, medical office facilities, industrial properties, data centers, and other commercial assets.  Additionally, Julia advises clients on all aspects of the capital stack: taxable and tax-exempt bond financings, senior, mezzanine and subordinate debt, equity investments, and (Low-Income Housing Tax Credit) LIHTC syndications. \nJulia represents property owners and developers on the full lifecycle of real estate transactions, from acquisitions and leasing to construction and development to disposition, along with debt and equity financing for each stage.  Additionally, Julia frequently manages workouts, foreclosures and restructurings and public-private partnerships, overseeing complex, high-profile multiparty transactions from inception to closing.  Clients count on her to find practical paths through varied markets and deliver business-focused solutions that advance their objectives and get deals done.  Her extensive network -- including banks, private credit and equity providers, property owners, governmental agencies, agency lenders, and tax credit investors -- enables her to bring the right parties together and deliver effective counsel in sophisticated situations.Julia has represented numerous owners of mixed-use properties, structuring and closing intricate debt and equity financing arrangements alongside housing finance agencies and public authorities to facilitate the creation of thousands of new affordable housing units.  Among her notable achievements are closing one of the nation’s largest HUD affordable housing transactions, securing financing for the development of one of New York City’s most significant residential buildings, valued at over $1 billion, obtaining financing for billions of dollars of data center campus development throughout the eastern U.S. and coordinating financing for the acquisition a $1.6 billion multifamily portfolio.Recognized as a Fellow of the American College of Mortgage Attorneys, Julia helps her clients navigate the intersection of private development and public policy as well as the overall dynamics that shape complex real estate transactions.  She is equally effective advising entrepreneurial developers on single-asset transactions and institutional clients on portfolio-level strategies, and she brings a collaborative, deal-oriented approach that has earned the trust of repeat clients across market cycles. Partner Named a Law360 Real Estate Editorial Board Member Law360, 2025 - 2026 Named one of Washington, D.C.'s \"Best Lawyers in America\" Real Estate Law, 2026 Fellow, American College of Mortgage Attorneys  American College of Mortgage Attorneys Williams College  Georgetown University Georgetown University Law Center District of Columbia Massachusetts New York Virginia American Bar Association Commercial Real Estate Executive Women (CREW) Network National Housing \u0026amp; Rehabilitation Association (NH\u0026amp;RA) American College of Mortgage Attorneys (ACMA) Represented Douglaston Development, through a joint venture with Kinwood Partners, in connection with its selection by the New York City Economic Development Corporation to redevelop Gansevoort Square in Manhattan into a major mixed-income residential, cultural, and community-focused development (transaction value not publicly disclosed). Represented a confidential client in the formation of a joint venture with a syndicate of Korean institutional investors for the development and operation of large-scale data center facilities in Virginia, with total transaction value exceeding $260 million. Represented a confidential institutional real estate investor in connection with a $299 million construction loan to finance the development of a 744,000-square-foot, two-building data center campus in Loudoun County, Virginia. Represented Douglaston Development in a multifaceted New York City real estate transaction involving the acquisition of development sites and a tiered capital stack, representing an aggregate transaction value of approximately $392.5 million, for the development of mixed-use and luxury residential projects. Represented a confidential real estate sponsor in a $450 million refinancing with Ares Management of a nearly complete 834-unit, mixed-income, waterfront multifamily development in Brooklyn, New York. Represented a confidential data center owner and developer in connection with a $525 million construction loan for the expansion and improvement of data center campuses in North Carolina and Illinois. Represented a confidential, publicly traded client in multiple construction financings totaling over $700 million for the development of a multi-building data center campus in Manassas, Virginia, including the VA-6 and VA-7 facilities. Represented Cortland Partners in its $1.6 billion acquisition of a 19-asset multifamily portfolio from Elme Communities (NYSE: ELME), including advising on acquisition structuring, co-investment capital, and acquisition and agency loan financing. Represented developer of affordable, mixed-income and market rate projects in the ground leasing of multiple parcels in the Bronx, on which the developer will construct hundreds of affordable and moderate-income residential units, as well as a FRESH grocery store. Phase I will be comprised of 188 all-senior, all-affordable units, including a substantial set aside for formerly homeless individuals, with total development costs in excess of $112 million. The complex financing included tax-exempt bonds, four state and city loans, and LIHTC equity from a major investor. Represented developer in the financing of a groundbreaking, multi-phase mixed-income project near the Capitol Building in Washington, DC. Phase I will be comprised of 561 residential units, with the entire project anticipated to contain over 1,100 residential units, as well as substantial retail space. Phase I financing included $160 million of debt (tax-exempt bonds and a taxable loan) and equity investment of a major affordable housing investor based on LIHTCs anticipated to be generated with respect to Phase I’s 118 low-income units. Represented development corporation in closing a $210 million bond financing for the construction of a 40+-story building to contain more than 300 residential units, 60+ of which will be reserved for low- and moderate-income households, as well as nearly 30,000 rentable square feet of retail space. The project has anticipated total development costs of approximately $300 million and was established with a multi-unit condominium structure to facilitate the project obtaining expected LIHTCs. Represented developer of distinctive real estate properties as financing and development counsel in closing a $175 million bond and construction loan on a project with total development costs of approximately $300 million and a major joint venture equity financing for the development of a 50+-story, 580+-unit residential building in Brooklyn. Additionally represented the owner in securing joint venture partners at various levels of the ownership structure, including major foreign investors contributing substantial equity. Assisted developer of distinctive real estate properties with refinancing a construction loan used to develop a complex in Manhattan. Comprised of three separate condominium regimes, the project contains more than 1,200 residential units (240+ reserved for low-income individuals and families), plus ancillary parking facilities and a large retail eatery. Coordinated the tender of more than $500 million in New York State Housing Finance Agency tax-exempt and taxable bonds and direct purchase of such bonds. Represented residential and commercial real estate acquisition, development and property management firm in closing a $380 million bond and construction loan financing for the development of several structures in Manhattan. The development will contain more than 1,000 residential apartments—200+ reserved for tenants whose household incomes are at or below 60 percent of the New York City Area Median Income, more than 35,000 square feet of commercial space and parking for hundreds of vehicles. The transaction is also structured to facilitate the potential syndication of tax credits. The closing required the negotiation and execution of a sublease of the affordable apartments to preserve various tax benefits. Represented multifaceted real estate company serving the greater New York area in closing a financing transaction for the acquisition and rehabilitation of several multifamily rental properties containing 100% affordable housing in the Bronx. We negotiated a construction loan from the New York City Housing Development Corporation, permanent financing and the issuance of a letter of credit from a multinational banking and financial services holding company. Our team additionally coordinated obtaining the necessary approvals and contract extensions from HUD and the properties' current limited partners, worked with the project's nonprofit purchasing entity and negotiated amended operating documents with the client's low-income housing tax credit investor partner. Represented real estate agent and manager in the development of a nearly 40-story tower in the Greenpoint neighborhood of Brooklyn, New York. The riverside luxury high-rise will contain more than 40,000 square feet of retail space and approximately 600 total residential apartments and condominium units. Represented New York City luxury real estate developer in financing and developing a multifamily project in Long Island City. The project, one of the largest apartment projects in Queens, is expected to contain more than 950 residential apartment units in two towers (20% set aside for affordable housing and additional units set aside for workforce housing), more than 15,000 square feet of commercial space and parking for more than 65 vehicles. The transaction is structured to facilitate the generation and potential syndication of tax credits. Represented developer in obtaining $539 million in construction financing from the New York State Housing Finance Agency for a residential tower project that will offer more than 900 apartments at market rates and more than 230 units of affordable housing. Represent national residential real estate developer in closing a $95 million bond financing transaction. The client plans to build a mixed-use building containing more than 320 residential apartments and ancillary commercial space and parking, reserving 20 percent of the apartments for low- and moderate-income households in a popular area of Washington, DC. Total development costs are estimated at $140 million.","searchable_name":"Julia E. Schmidt","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":202,"capability_group_featured":null,"home_page_featured":null},{"id":442375,"version":1,"owner_type":"Person","owner_id":923,"payload":{"bio":"\u003cp\u003eJohn Shakow\u0026nbsp;focuses on complex regulatory, commercial, investigation and litigation issues related to pharmaceutical government pricing and price reporting. A Chambers-ranked partner in our FDA and Life Sciences practice and co-chair of the firm's Life Sciences \u0026amp; Healthcare Industry Group, John represents pharmaceutical and biotechnology manufacturers in every facet of government drug payor program compliance and liability mitigation.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eJohn has over 25 years'\u0026nbsp;experience in helping pharmaceutical and biotechnology clients resolve commercial and organizational challenges while maintaining the integrity of their price-reporting compliance efforts.\u003c/p\u003e\n\u003cp\u003eHe counsels clients on their rights and obligations under Medicaid, Medicare,340B, VA/FSS and related programs, and regularly assists them in interactions with the Centers for Medicare and Medicaid Services, the Health Resources and Services Administration, the Department of Health and Human Services Office of Inspector General, and the Veterans Administration.\u003c/p\u003e\n\u003cp\u003eJohn often conducts in-depth pricing assessments to develop and implement government price calculation and reporting policies, procedures, systems and methodologies. John has overseen\u0026nbsp;dozens of substantial\u0026nbsp;\u003cem\u003ebona fide\u003c/em\u003e\u0026nbsp;service fee analysis projects for large and small drug manufacturers. He is experienced in managing the coordination and integration of pricing methodologies in major pharmaceutical mergers.\u003c/p\u003e\n\u003cp\u003eJohn has significant pharmaceutical litigation and investigation experience. He regularly challenges government agencies' positions on drug pricing and reimbursement matters, and defends clients in federal and state investigations related to price reporting. John represents manufacturers in 340B, IRA, and Medicaid Drug Rebate Program litigation, and has counseled drug manufacturers before the House Energy \u0026amp; Commerce and Senate Finance committees in drug-pricing investigations and inquiries.\u003c/p\u003e","slug":"john-shakow","email":"jshakow@kslaw.com","phone":null,"matters":null,"taggings":{"tags":[],"meta_tags":[{"id":179}]},"expertise":[{"id":103,"guid":"103.capabilities","index":0,"source":"capabilities"},{"id":81,"guid":"81.capabilities","index":1,"source":"capabilities"},{"id":23,"guid":"23.capabilities","index":2,"source":"capabilities"},{"id":2,"guid":"2.capabilities","index":3,"source":"capabilities"},{"id":21,"guid":"21.capabilities","index":4,"source":"capabilities"},{"id":24,"guid":"24.capabilities","index":5,"source":"capabilities"},{"id":122,"guid":"122.capabilities","index":6,"source":"capabilities"},{"id":1193,"guid":"1193.smart_tags","index":7,"source":"smartTags"},{"id":133,"guid":"133.capabilities","index":8,"source":"capabilities"}],"is_active":true,"last_name":"Shakow","nick_name":"John","clerkships":[],"first_name":"John","title_rank":9999,"updated_by":35,"law_schools":[],"middle_name":"D.","name_suffix":"","recognitions":[{"title":"“John is extremely strong and extremely client-focused.”","detail":"CHAMBERS USA, 2022"},{"title":"“Top Ranked Lawyer,” Healthcare: Pharmaceutical/Medical Products Regulatory","detail":"CHAMBERS USA, 2021, 2022, 2023 and 2024"},{"title":"Recommended Key Lawyer: 2021, 2022, 2023","detail":"Legal 500"},{"title":"Shortlist for Regulatory Attorney of the Year: Pricing \u0026 Reimbursement, 2017-2023","detail":"LMG Life Sciences"},{"title":"2016 Lifetime Achievement Award","detail":"Institute for International Research's Medicaid Drug Rebate Program"},{"title":"Life Sciences Star: Pricing and Reimbursement, 2012 to 2018","detail":"Guide to Leading Life Sciences Firms and Attorneys in North America"}],"linked_in_url":"https://www.linkedin.com/in/JohnShakow/","seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eJohn Shakow\u0026nbsp;focuses on complex regulatory, commercial, investigation and litigation issues related to pharmaceutical government pricing and price reporting. A Chambers-ranked partner in our FDA and Life Sciences practice and co-chair of the firm's Life Sciences \u0026amp; Healthcare Industry Group, John represents pharmaceutical and biotechnology manufacturers in every facet of government drug payor program compliance and liability mitigation.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eJohn has over 25 years'\u0026nbsp;experience in helping pharmaceutical and biotechnology clients resolve commercial and organizational challenges while maintaining the integrity of their price-reporting compliance efforts.\u003c/p\u003e\n\u003cp\u003eHe counsels clients on their rights and obligations under Medicaid, Medicare,340B, VA/FSS and related programs, and regularly assists them in interactions with the Centers for Medicare and Medicaid Services, the Health Resources and Services Administration, the Department of Health and Human Services Office of Inspector General, and the Veterans Administration.\u003c/p\u003e\n\u003cp\u003eJohn often conducts in-depth pricing assessments to develop and implement government price calculation and reporting policies, procedures, systems and methodologies. John has overseen\u0026nbsp;dozens of substantial\u0026nbsp;\u003cem\u003ebona fide\u003c/em\u003e\u0026nbsp;service fee analysis projects for large and small drug manufacturers. He is experienced in managing the coordination and integration of pricing methodologies in major pharmaceutical mergers.\u003c/p\u003e\n\u003cp\u003eJohn has significant pharmaceutical litigation and investigation experience. He regularly challenges government agencies' positions on drug pricing and reimbursement matters, and defends clients in federal and state investigations related to price reporting. John represents manufacturers in 340B, IRA, and Medicaid Drug Rebate Program litigation, and has counseled drug manufacturers before the House Energy \u0026amp; Commerce and Senate Finance committees in drug-pricing investigations and inquiries.\u003c/p\u003e","recognitions":[{"title":"“John is extremely strong and extremely client-focused.”","detail":"CHAMBERS USA, 2022"},{"title":"“Top Ranked Lawyer,” Healthcare: Pharmaceutical/Medical Products Regulatory","detail":"CHAMBERS USA, 2021, 2022, 2023 and 2024"},{"title":"Recommended Key Lawyer: 2021, 2022, 2023","detail":"Legal 500"},{"title":"Shortlist for Regulatory Attorney of the Year: Pricing \u0026 Reimbursement, 2017-2023","detail":"LMG Life Sciences"},{"title":"2016 Lifetime Achievement Award","detail":"Institute for International Research's Medicaid Drug Rebate Program"},{"title":"Life Sciences Star: Pricing and Reimbursement, 2012 to 2018","detail":"Guide to Leading Life Sciences Firms and Attorneys in North America"}]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":11649}]},"capability_group_id":2},"created_at":"2025-11-05T05:03:46.000Z","updated_at":"2025-11-05T05:03:46.000Z","searchable_text":"Shakow{{ FIELD }}{:title=\u0026gt;\"“John is extremely strong and extremely client-focused.”\", :detail=\u0026gt;\"CHAMBERS USA, 2022\"}{{ FIELD }}{:title=\u0026gt;\"“Top Ranked Lawyer,” Healthcare: Pharmaceutical/Medical Products Regulatory\", :detail=\u0026gt;\"CHAMBERS USA, 2021, 2022, 2023 and 2024\"}{{ FIELD }}{:title=\u0026gt;\"Recommended Key Lawyer: 2021, 2022, 2023\", :detail=\u0026gt;\"Legal 500\"}{{ FIELD }}{:title=\u0026gt;\"Shortlist for Regulatory Attorney of the Year: Pricing \u0026amp; Reimbursement, 2017-2023\", :detail=\u0026gt;\"LMG Life Sciences\"}{{ FIELD }}{:title=\u0026gt;\"2016 Lifetime Achievement Award\", :detail=\u0026gt;\"Institute for International Research's Medicaid Drug Rebate Program\"}{{ FIELD }}{:title=\u0026gt;\"Life Sciences Star: Pricing and Reimbursement, 2012 to 2018\", :detail=\u0026gt;\"Guide to Leading Life Sciences Firms and Attorneys in North America\"}{{ FIELD }}John Shakow focuses on complex regulatory, commercial, investigation and litigation issues related to pharmaceutical government pricing and price reporting. A Chambers-ranked partner in our FDA and Life Sciences practice and co-chair of the firm's Life Sciences \u0026amp; Healthcare Industry Group, John represents pharmaceutical and biotechnology manufacturers in every facet of government drug payor program compliance and liability mitigation.\nJohn has over 25 years' experience in helping pharmaceutical and biotechnology clients resolve commercial and organizational challenges while maintaining the integrity of their price-reporting compliance efforts.\nHe counsels clients on their rights and obligations under Medicaid, Medicare,340B, VA/FSS and related programs, and regularly assists them in interactions with the Centers for Medicare and Medicaid Services, the Health Resources and Services Administration, the Department of Health and Human Services Office of Inspector General, and the Veterans Administration.\nJohn often conducts in-depth pricing assessments to develop and implement government price calculation and reporting policies, procedures, systems and methodologies. John has overseen dozens of substantial bona fide service fee analysis projects for large and small drug manufacturers. He is experienced in managing the coordination and integration of pricing methodologies in major pharmaceutical mergers.\nJohn has significant pharmaceutical litigation and investigation experience. He regularly challenges government agencies' positions on drug pricing and reimbursement matters, and defends clients in federal and state investigations related to price reporting. John represents manufacturers in 340B, IRA, and Medicaid Drug Rebate Program litigation, and has counseled drug manufacturers before the House Energy \u0026amp; Commerce and Senate Finance committees in drug-pricing investigations and inquiries. John D Shakow Partner “John is extremely strong and extremely client-focused.” CHAMBERS USA, 2022 “Top Ranked Lawyer,” Healthcare: Pharmaceutical/Medical Products Regulatory CHAMBERS USA, 2021, 2022, 2023 and 2024 Recommended Key Lawyer: 2021, 2022, 2023 Legal 500 Shortlist for Regulatory Attorney of the Year: Pricing \u0026amp; Reimbursement, 2017-2023 LMG Life Sciences 2016 Lifetime Achievement Award Institute for International Research's Medicaid Drug Rebate Program Life Sciences Star: Pricing and Reimbursement, 2012 to 2018 Guide to Leading Life Sciences Firms and Attorneys in North America Swarthmore College  University of Virginia University of Virginia School of Law U.S. Court of Appeals for the Ninth Circuit U.S. Court of Appeals for the D.C. Circuit U.S. District Court for the Eastern District of Virginia U.S. District Court for the Central District of Illinois U.S. District Court for the District of Columbia District of Columbia Virginia District of Columbia Bar State Bar of Virginia","searchable_name":"John D. Shakow","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":35,"capability_group_featured":null,"home_page_featured":null},{"id":427262,"version":1,"owner_type":"Person","owner_id":6596,"payload":{"bio":"\u003cp\u003eJeff has 30 years\u0026rsquo; experience in US medical device law and regulation. \u0026nbsp;He counsels firms in regulatory strategy and filings, including presubmissions, clearances, approvals, breakthrough designations, and internal agency appeals.\u0026nbsp; He helps firms develop a sound regulatory strategy for bringing their medical devices through US FDA review, to draft the relevant submissions, and to respond to FDA\u0026rsquo;s requests for information and data.\u0026nbsp; When advising start-ups and mid-sized manufacturers, Jeffrey recognizes the business considerations involved in creating regulatory strategies and managing compliance.\u0026nbsp; His mission is to bring companies through the FDA process as efficiently and expeditiously as possible.\u0026nbsp; Jeffrey also counsels companies on post-market compliance, such as reporting to FDA, complying with the quality system regulation, labeling and advertising compliance, recalls, inspections, and warning letters, and he is an expert in FDA\u0026rsquo;s regulation of combination products (e.g., drug-device combinations).[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eJeff is a national authority on FDA\u0026rsquo;s regulation of medical devices, combination products, and HCT/Ps.\u0026nbsp; He actively contributes to industry conversations on FDA regulation of medical devices. He has published hundreds of articles on various topics relating to FDA\u0026rsquo;s regulation of medical devices.\u003c/p\u003e\n\u003cp\u003eHe is a past member of the Editorial Advisory Board for both\u0026nbsp;\u003cem\u003eMDDI\u0026nbsp;\u003c/em\u003eand\u0026nbsp;\u003cem\u003eUpdate\u0026nbsp;\u003c/em\u003emagazines, co-editor of two textbooks,\u0026nbsp;\u003cem\u003ePromotion of Biomedical Products\u0026nbsp;\u003c/em\u003e(Food and Drug Law Institute, 2006) and\u0026nbsp;\u003cem\u003eCombination Products, How to Develop the Optimal Strategic Path for Approval\u0026nbsp;\u003c/em\u003e(FDA News 2005).\u0026nbsp; He has contributed chapters to several textbooks, including\u0026nbsp;\u003cem\u003eMedical Devices Law and Regulation Answer Book\u003c/em\u003e\u0026nbsp;(Practising Law Institute 2023 ed.).\u003c/p\u003e\n\u003cp\u003eJeff was a Lecturer and Fischell Literati teaching the University of Maryland\u0026rsquo;s Regulatory Law: Medical Devices course. He has served on the Medical Devices and Diagnostics Committee, Food and Drug Law Institute.\u003c/p\u003e","slug":"jeffrey-shapiro","email":"jshapiro@kslaw.com","phone":null,"matters":null,"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":21,"guid":"21.capabilities","index":0,"source":"capabilities"},{"id":81,"guid":"81.capabilities","index":1,"source":"capabilities"},{"id":103,"guid":"103.capabilities","index":2,"source":"capabilities"},{"id":112,"guid":"112.capabilities","index":3,"source":"capabilities"},{"id":761,"guid":"761.smart_tags","index":4,"source":"smartTags"},{"id":1202,"guid":"1202.smart_tags","index":5,"source":"smartTags"},{"id":826,"guid":"826.smart_tags","index":6,"source":"smartTags"}],"is_active":true,"last_name":"Shapiro","nick_name":"Jeffrey","clerkships":[],"first_name":"Jeffrey","title_rank":9999,"updated_by":35,"law_schools":[{"id":824,"meta":{"degree":"J.D.","honors":"cum laude","is_law_school":"1","graduation_date":"1986-01-01 00:00:00"},"order":1,"pin_order":null,"pin_expiration":null}],"middle_name":"K.","name_suffix":"","recognitions":[{"title":"Life Sciences Key Lawyer","detail":"The Legal 500 (2024)"},{"title":"Life Science Star","detail":"LMG Life Sciences, 2012 – 2023"},{"title":"DC Super Lawyer","detail":"Super Lawyers, 2014 – 2023"},{"title":"The International Who’s Who of Business Lawyers – Life Sciences","detail":"Who’s Who Legal, 2014 – 2023"},{"title":"Nominee for Regulatory Attorney of the Year","detail":"LMG Life Sciences, 2017"}],"linked_in_url":null,"seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eJeff has 30 years\u0026rsquo; experience in US medical device law and regulation. \u0026nbsp;He counsels firms in regulatory strategy and filings, including presubmissions, clearances, approvals, breakthrough designations, and internal agency appeals.\u0026nbsp; He helps firms develop a sound regulatory strategy for bringing their medical devices through US FDA review, to draft the relevant submissions, and to respond to FDA\u0026rsquo;s requests for information and data.\u0026nbsp; When advising start-ups and mid-sized manufacturers, Jeffrey recognizes the business considerations involved in creating regulatory strategies and managing compliance.\u0026nbsp; His mission is to bring companies through the FDA process as efficiently and expeditiously as possible.\u0026nbsp; Jeffrey also counsels companies on post-market compliance, such as reporting to FDA, complying with the quality system regulation, labeling and advertising compliance, recalls, inspections, and warning letters, and he is an expert in FDA\u0026rsquo;s regulation of combination products (e.g., drug-device combinations).[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eJeff is a national authority on FDA\u0026rsquo;s regulation of medical devices, combination products, and HCT/Ps.\u0026nbsp; He actively contributes to industry conversations on FDA regulation of medical devices. He has published hundreds of articles on various topics relating to FDA\u0026rsquo;s regulation of medical devices.\u003c/p\u003e\n\u003cp\u003eHe is a past member of the Editorial Advisory Board for both\u0026nbsp;\u003cem\u003eMDDI\u0026nbsp;\u003c/em\u003eand\u0026nbsp;\u003cem\u003eUpdate\u0026nbsp;\u003c/em\u003emagazines, co-editor of two textbooks,\u0026nbsp;\u003cem\u003ePromotion of Biomedical Products\u0026nbsp;\u003c/em\u003e(Food and Drug Law Institute, 2006) and\u0026nbsp;\u003cem\u003eCombination Products, How to Develop the Optimal Strategic Path for Approval\u0026nbsp;\u003c/em\u003e(FDA News 2005).\u0026nbsp; He has contributed chapters to several textbooks, including\u0026nbsp;\u003cem\u003eMedical Devices Law and Regulation Answer Book\u003c/em\u003e\u0026nbsp;(Practising Law Institute 2023 ed.).\u003c/p\u003e\n\u003cp\u003eJeff was a Lecturer and Fischell Literati teaching the University of Maryland\u0026rsquo;s Regulatory Law: Medical Devices course. He has served on the Medical Devices and Diagnostics Committee, Food and Drug Law Institute.\u003c/p\u003e","recognitions":[{"title":"Life Sciences Key Lawyer","detail":"The Legal 500 (2024)"},{"title":"Life Science Star","detail":"LMG Life Sciences, 2012 – 2023"},{"title":"DC Super Lawyer","detail":"Super Lawyers, 2014 – 2023"},{"title":"The International Who’s Who of Business Lawyers – Life Sciences","detail":"Who’s Who Legal, 2014 – 2023"},{"title":"Nominee for Regulatory Attorney of the Year","detail":"LMG Life Sciences, 2017"}]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":11031}]},"capability_group_id":2},"created_at":"2025-05-26T04:59:28.000Z","updated_at":"2025-05-26T04:59:28.000Z","searchable_text":"Shapiro{{ FIELD }}{:title=\u0026gt;\"Life Sciences Key Lawyer\", :detail=\u0026gt;\"The Legal 500 (2024)\"}{{ FIELD }}{:title=\u0026gt;\"Life Science Star\", :detail=\u0026gt;\"LMG Life Sciences, 2012 – 2023\"}{{ FIELD }}{:title=\u0026gt;\"DC Super Lawyer\", :detail=\u0026gt;\"Super Lawyers, 2014 – 2023\"}{{ FIELD }}{:title=\u0026gt;\"The International Who’s Who of Business Lawyers – Life Sciences\", :detail=\u0026gt;\"Who’s Who Legal, 2014 – 2023\"}{{ FIELD }}{:title=\u0026gt;\"Nominee for Regulatory Attorney of the Year\", :detail=\u0026gt;\"LMG Life Sciences, 2017\"}{{ FIELD }}Jeff has 30 years’ experience in US medical device law and regulation.  He counsels firms in regulatory strategy and filings, including presubmissions, clearances, approvals, breakthrough designations, and internal agency appeals.  He helps firms develop a sound regulatory strategy for bringing their medical devices through US FDA review, to draft the relevant submissions, and to respond to FDA’s requests for information and data.  When advising start-ups and mid-sized manufacturers, Jeffrey recognizes the business considerations involved in creating regulatory strategies and managing compliance.  His mission is to bring companies through the FDA process as efficiently and expeditiously as possible.  Jeffrey also counsels companies on post-market compliance, such as reporting to FDA, complying with the quality system regulation, labeling and advertising compliance, recalls, inspections, and warning letters, and he is an expert in FDA’s regulation of combination products (e.g., drug-device combinations).\nJeff is a national authority on FDA’s regulation of medical devices, combination products, and HCT/Ps.  He actively contributes to industry conversations on FDA regulation of medical devices. He has published hundreds of articles on various topics relating to FDA’s regulation of medical devices.\nHe is a past member of the Editorial Advisory Board for both MDDI and Update magazines, co-editor of two textbooks, Promotion of Biomedical Products (Food and Drug Law Institute, 2006) and Combination Products, How to Develop the Optimal Strategic Path for Approval (FDA News 2005).  He has contributed chapters to several textbooks, including Medical Devices Law and Regulation Answer Book (Practising Law Institute 2023 ed.).\nJeff was a Lecturer and Fischell Literati teaching the University of Maryland’s Regulatory Law: Medical Devices course. He has served on the Medical Devices and Diagnostics Committee, Food and Drug Law Institute. Partner Life Sciences Key Lawyer The Legal 500 (2024) Life Science Star LMG Life Sciences, 2012 – 2023 DC Super Lawyer Super Lawyers, 2014 – 2023 The International Who’s Who of Business Lawyers – Life Sciences Who’s Who Legal, 2014 – 2023 Nominee for Regulatory Attorney of the Year LMG Life Sciences, 2017 Brown University  Harvard University Harvard Law School District of Columbia","searchable_name":"Jeffrey K. Shapiro","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":35,"capability_group_featured":null,"home_page_featured":null},{"id":442317,"version":1,"owner_type":"Person","owner_id":57,"payload":{"bio":"\u003cp\u003eHap Shashy specializes in tax matters. As a partner and group leader of our Tax practice, Hap advises clients in a number of industries on a wide variety of tax planning and tax controversy issues.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eHap is a former IRS Chief Counsel. He represents domestic and foreign clients in a wide range of complex tax planning, tax regulatory and tax controversy matters. He represents clients in numerous industries, including energy, natural resources, healthcare, finance, technology, telecommunications, media, real estate, industrials and transportation.\u003c/p\u003e\n\u003cp\u003eHap's tax planning matters include domestic and cross-border mergers and acquisitions, partnerships and joint ventures, and financing transactions, as well as leasing and licensing transactions, natural resources and commodities transactions, and bankruptcy and debt restructurings. His tax regulatory matters include tax ruling requests and administrative projects before the IRS and the U.S. Treasury. Hap also represents clients in tax controversy and litigation matters, including alternative dispute resolution.\u003c/p\u003e\n\u003cp\u003eAs IRS Chief Counsel, Hap was responsible for the IRS regulation and ruling program, and for litigation before the U.S. Tax Court. Under his leadership, the IRS Office of Chief Counsel litigated a variety of tax cases and issued numerous tax regulations and rulings covering corporations, partnerships, transfer pricing, foreign tax credits, financial instruments and derivatives, and other topics.\u003c/p\u003e\n\u003cp\u003eA frequent author and speaker, Hap has also served as an adjunct professor of Tax at New York University School of Law and at Southern Methodist University School of Law. Hap serves on the advisory boards of the NYU Tax Institute, the Texas Federal Tax Institute and the Florida Tax Institute. He has been regularly recognized by \u003cem data-redactor-tag=\"em\"\u003eChambers USA,\u003c/em\u003e \u003cem data-redactor-tag=\"em\"\u003eAmerica\u0026rsquo;s Leading Lawyers for Business,\u003c/em\u003e \u003cem data-redactor-tag=\"em\"\u003eThe Best Lawyers in America,\u003c/em\u003e \u003cem data-redactor-tag=\"em\"\u003eWashingtonian's\u003c/em\u003e Best Lawyers in Washington, D.C.\u003cem data-redactor-tag=\"em\"\u003e,\u003c/em\u003e and \u003cem data-redactor-tag=\"em\"\u003eLegal 500.\u003c/em\u003e\u003c/p\u003e","slug":"abraham-shashy","email":"hshashy@kslaw.com","phone":"","matters":null,"taggings":{"tags":[],"meta_tags":[{"id":228}]},"expertise":[{"id":75,"guid":"75.capabilities","index":0,"source":"capabilities"},{"id":26,"guid":"26.capabilities","index":1,"source":"capabilities"},{"id":32,"guid":"32.capabilities","index":2,"source":"capabilities"},{"id":33,"guid":"33.capabilities","index":3,"source":"capabilities"},{"id":102,"guid":"102.capabilities","index":4,"source":"capabilities"},{"id":37,"guid":"37.capabilities","index":5,"source":"capabilities"},{"id":107,"guid":"107.capabilities","index":6,"source":"capabilities"},{"id":115,"guid":"115.capabilities","index":7,"source":"capabilities"},{"id":1140,"guid":"1140.smart_tags","index":8,"source":"smartTags"},{"id":1141,"guid":"1141.smart_tags","index":9,"source":"smartTags"},{"id":80,"guid":"80.capabilities","index":10,"source":"capabilities"},{"id":118,"guid":"118.capabilities","index":11,"source":"capabilities"},{"id":1153,"guid":"1153.smart_tags","index":12,"source":"smartTags"}],"is_active":true,"last_name":"Shashy","nick_name":"Hap","clerkships":[],"first_name":"Abraham","title_rank":9999,"updated_by":101,"law_schools":[],"middle_name":"N.M.","name_suffix":"Jr.","recognitions":[{"title":"Lawyer of the Year for Tax Law in Washington, D.C. ","detail":"Best Lawyers, 2021"},{"title":"“First-rate federal tax lawyer … encyclopedic knowledge of tax issues.\" ","detail":"Chambers USA"},{"title":"Named a “Lawyer of the Year” in his jurisdiction for receiving the “highest overall peer feedback. ","detail":"The Best Lawyers in America"},{"title":"Ranked amongst Washington, DC’s Best Lawyers: Tax","detail":"Best Lawyers in Washington, D.C. — Washingtonian"}],"linked_in_url":null,"seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eHap Shashy specializes in tax matters. As a partner and group leader of our Tax practice, Hap advises clients in a number of industries on a wide variety of tax planning and tax controversy issues.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eHap is a former IRS Chief Counsel. He represents domestic and foreign clients in a wide range of complex tax planning, tax regulatory and tax controversy matters. He represents clients in numerous industries, including energy, natural resources, healthcare, finance, technology, telecommunications, media, real estate, industrials and transportation.\u003c/p\u003e\n\u003cp\u003eHap's tax planning matters include domestic and cross-border mergers and acquisitions, partnerships and joint ventures, and financing transactions, as well as leasing and licensing transactions, natural resources and commodities transactions, and bankruptcy and debt restructurings. His tax regulatory matters include tax ruling requests and administrative projects before the IRS and the U.S. Treasury. Hap also represents clients in tax controversy and litigation matters, including alternative dispute resolution.\u003c/p\u003e\n\u003cp\u003eAs IRS Chief Counsel, Hap was responsible for the IRS regulation and ruling program, and for litigation before the U.S. Tax Court. Under his leadership, the IRS Office of Chief Counsel litigated a variety of tax cases and issued numerous tax regulations and rulings covering corporations, partnerships, transfer pricing, foreign tax credits, financial instruments and derivatives, and other topics.\u003c/p\u003e\n\u003cp\u003eA frequent author and speaker, Hap has also served as an adjunct professor of Tax at New York University School of Law and at Southern Methodist University School of Law. Hap serves on the advisory boards of the NYU Tax Institute, the Texas Federal Tax Institute and the Florida Tax Institute. He has been regularly recognized by \u003cem data-redactor-tag=\"em\"\u003eChambers USA,\u003c/em\u003e \u003cem data-redactor-tag=\"em\"\u003eAmerica\u0026rsquo;s Leading Lawyers for Business,\u003c/em\u003e \u003cem data-redactor-tag=\"em\"\u003eThe Best Lawyers in America,\u003c/em\u003e \u003cem data-redactor-tag=\"em\"\u003eWashingtonian's\u003c/em\u003e Best Lawyers in Washington, D.C.\u003cem data-redactor-tag=\"em\"\u003e,\u003c/em\u003e and \u003cem data-redactor-tag=\"em\"\u003eLegal 500.\u003c/em\u003e\u003c/p\u003e","recognitions":[{"title":"Lawyer of the Year for Tax Law in Washington, D.C. ","detail":"Best Lawyers, 2021"},{"title":"“First-rate federal tax lawyer … encyclopedic knowledge of tax issues.\" ","detail":"Chambers USA"},{"title":"Named a “Lawyer of the Year” in his jurisdiction for receiving the “highest overall peer feedback. ","detail":"The Best Lawyers in America"},{"title":"Ranked amongst Washington, DC’s Best Lawyers: Tax","detail":"Best Lawyers in Washington, D.C. — Washingtonian"}]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":5169}]},"capability_group_id":1},"created_at":"2025-11-05T05:02:13.000Z","updated_at":"2025-11-05T05:02:13.000Z","searchable_text":"Shashy{{ FIELD }}{:title=\u0026gt;\"Lawyer of the Year for Tax Law in Washington, D.C. \", :detail=\u0026gt;\"Best Lawyers, 2021\"}{{ FIELD }}{:title=\u0026gt;\"“First-rate federal tax lawyer … encyclopedic knowledge of tax issues.\\\" \", :detail=\u0026gt;\"Chambers USA\"}{{ FIELD }}{:title=\u0026gt;\"Named a “Lawyer of the Year” in his jurisdiction for receiving the “highest overall peer feedback. \", :detail=\u0026gt;\"The Best Lawyers in America\"}{{ FIELD }}{:title=\u0026gt;\"Ranked amongst Washington, DC’s Best Lawyers: Tax\", :detail=\u0026gt;\"Best Lawyers in Washington, D.C. — Washingtonian\"}{{ FIELD }}Hap Shashy specializes in tax matters. As a partner and group leader of our Tax practice, Hap advises clients in a number of industries on a wide variety of tax planning and tax controversy issues.\nHap is a former IRS Chief Counsel. He represents domestic and foreign clients in a wide range of complex tax planning, tax regulatory and tax controversy matters. He represents clients in numerous industries, including energy, natural resources, healthcare, finance, technology, telecommunications, media, real estate, industrials and transportation.\nHap's tax planning matters include domestic and cross-border mergers and acquisitions, partnerships and joint ventures, and financing transactions, as well as leasing and licensing transactions, natural resources and commodities transactions, and bankruptcy and debt restructurings. His tax regulatory matters include tax ruling requests and administrative projects before the IRS and the U.S. Treasury. Hap also represents clients in tax controversy and litigation matters, including alternative dispute resolution.\nAs IRS Chief Counsel, Hap was responsible for the IRS regulation and ruling program, and for litigation before the U.S. Tax Court. Under his leadership, the IRS Office of Chief Counsel litigated a variety of tax cases and issued numerous tax regulations and rulings covering corporations, partnerships, transfer pricing, foreign tax credits, financial instruments and derivatives, and other topics.\nA frequent author and speaker, Hap has also served as an adjunct professor of Tax at New York University School of Law and at Southern Methodist University School of Law. Hap serves on the advisory boards of the NYU Tax Institute, the Texas Federal Tax Institute and the Florida Tax Institute. He has been regularly recognized by Chambers USA, America’s Leading Lawyers for Business, The Best Lawyers in America, Washingtonian's Best Lawyers in Washington, D.C., and Legal 500. Abraham N.M. Shashy Partner Lawyer of the Year for Tax Law in Washington, D.C.  Best Lawyers, 2021 “First-rate federal tax lawyer … encyclopedic knowledge of tax issues.\"  Chambers USA Named a “Lawyer of the Year” in his jurisdiction for receiving the “highest overall peer feedback.  The Best Lawyers in America Ranked amongst Washington, DC’s Best Lawyers: Tax Best Lawyers in Washington, D.C. — Washingtonian University of Florida Levin College of Law University of Florida Levin College of Law New York University New York University School of Law Supreme Court of the United States U.S. Court of Appeals for the Sixth Circuit U.S. Tax Court District of Columbia Florida New York Texas District of Columbia Bar Texas Bar Florida Bar New York State Bar","searchable_name":"Abraham N.M. Shashy, Jr. (Hap)","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":101,"capability_group_featured":null,"home_page_featured":null},{"id":447572,"version":1,"owner_type":"Person","owner_id":5046,"payload":{"bio":"\u003cp\u003eJesse Snyder is a partner\u0026nbsp;in the Washington, D.C., office of King \u0026amp; Spalding and a member of the firm\u0026rsquo;s Technology, Appellate, and Administrative Law practice groups.\u0026nbsp;Jesse litigates prime time technology disputes,\u0026nbsp;including those involving AI, data privacy,\u0026nbsp;cybersecurity, intellectual property, appeals,\u0026nbsp;strategic counseling, and bespoke cross-disciplinary solutions for clients facing significant risk. No matter the issue, Jesse is always present\u0026nbsp;to help\u0026nbsp;his clients navigate\u0026nbsp;their\u0026nbsp;toughest challenges.\u0026nbsp;[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eJesse helps\u0026nbsp;his clients traverse\u0026nbsp;scores of pressing fronts: novel\u0026nbsp;disputes, government-facing advocacy, compliance, governance, licensing, national security, international trade, as well as practical business-minded matters to drive ROI and to galvanize KPIs. In addition to his well-established\u0026nbsp;appellate and administrative law practice, Jesse has served as lead counsel\u0026nbsp;in numerous litigations, including\u0026nbsp;high-stakes disputes touching on data privacy and cybersecurity, intellectual property, pixel technology, and generative AI.\u0026nbsp;What's more, Jesse regularly\u0026nbsp;counsels clients in highly scrutinized industries on the development and implementation of cybersecurity, privacy, and generative AI compliance programs and protocols. Moreover, Jesse has been called upon to provide forensic analysis, technical advice, and legal defense\u0026nbsp;to various clients facing exigent online attacks as well as\u0026nbsp;illicit hacking events. He also\u0026nbsp;routinely\u0026nbsp;advises clients on AI algorithm and large language model\u0026nbsp;development, data mapping,\u0026nbsp;as well as various considerations and strategies when implementing AI into existing and nascent processes. In addition, Jesse takes pride in his dedicated practice aimed at\u0026nbsp;advancing\u0026nbsp;the talents of entrepreneurs to compete and to succeed, thereby providing steady advice and pragmatic guidance\u0026nbsp;to help propel his clients forward to achieve\u0026nbsp;their business objectives.\u0026nbsp;\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eIn view\u0026nbsp;of his achievements in these areas, Jesse was nominated by his clients and received recognition by the BTI Consulting Group\u0026nbsp;as a 2025 Client Service All-Star, \"the gold standard used by corporate counsel and law firms alike to identify the attorneys delivering the absolute\u0026nbsp;best levels of client service -- better than all others.\"\u0026nbsp; During 2025 in particular, BTI noted that \"only two\u0026nbsp;attorneys earned their organic recognition from multiple clients,\" and Jesse was\u0026nbsp;one of\u0026nbsp;those two.\u0026nbsp;Building further, the University of Mississippi School of Law's Center for Air and Space Law invited Jesse to be\u0026nbsp;a 2025 and 2026 guest lecturer on cybersecurity and AI. The Sedona Conference also chose Jesse to serve on the 2026 working group on AI and trade secrets, working to build industry consensus around\u0026nbsp;these areas of growing\u0026nbsp;importance.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eDuring law school, Jesse\u0026nbsp;served as editor in chief of the flagship law review publication, graduated in\u0026nbsp;the highest percentile of his class, and was inducted into the National Order of Scribes.\u0026nbsp;He is a published author in 24\u0026nbsp;different law reviews, covering a variety of topics ranging from the Antiterrorism Act and\u0026nbsp;First Amendment to patent law\u0026nbsp;and Twenty-first Amendment.\u0026nbsp;He also serves as an\u0026nbsp;\u003cem\u003eex officio\u003c/em\u003e\u0026nbsp;member of Texas A\u0026amp;M\u0026rsquo;s faculty committee on clerkship placements.\u0026nbsp;Before joining King \u0026amp; Spalding, Jesse served as a term law clerk to three federal judges: the Honorable Eugene E. Siler, Jr. of the U.S. Court of Appeals for the Sixth Circuit, the Honorable Jimmie V. Reyna of the U.S. Court of Appeals for the Federal Circuit, and the Honorable Jorge A. Solis of the U.S. District Court for the Northern District of Texas.\u003c/p\u003e\n\u003cp\u003eBefore attending law school, Jesse amassed experience as an engineer at Stryker Corporation and as a commissioned military officer serving in the Air Force during the attacks on September 11, 2001. His medical-device experience covers a wide array of technology platforms for use in endoscopic procedures. And as a graduate of the Air Force Academy, Jesse is a proud combat veteran of Operations Iraqi Freedom, Multinational Corps-Iraq, and Combined Joint Task Force 7. During his service, he\u0026nbsp;received multiple medals and awards. In addition, as an extension of his sustained commitment to public service, Jesse\u0026nbsp;pioneered the firm's Armed Forces Attorney Coalition, a group whose purpose is to\u0026nbsp;promote\u0026nbsp;veteran interests\u0026nbsp;in the legal profession as well as\u0026nbsp;more broadly. Jesse also carries an abiding\u0026nbsp;dedication\u0026nbsp;to pro bono legal services, as demonstrated by his past multiyear recognition as a member of the North Carolina\u0026nbsp;Pro Bono Honor Society. Jesse is an avid runner, and he has been so for over 35\u0026nbsp;years.\u003c/p\u003e","slug":"jesse-snyder","email":"jsnyder@kslaw.com","phone":null,"matters":["\u003cp\u003eJesse Snyder serves as lead counsel for litigations involving an industry-leading AI company offering products and services for legal departments worldwide.\u003c/p\u003e","\u003cp\u003eJesse Snyder is lead counsel to an industry-leading jet propulsion system manufacturer for the U.S. military, advising on AI, IP, privacy, trade, antitrust, and compliance.\u003c/p\u003e","\u003cp\u003eJesse is lead counsel to a pioneering and disrupting aerospace defense contractor designing pilot training devices for flight school, including achieving an agency corrective action through a successful bid protest.\u003c/p\u003e","\u003cp\u003eJesse is lead counsel to one of the largest national defense aerospace companies on AI governance and compliance, data mapping, and cybersecurity.\u003c/p\u003e","\u003cp\u003eJesse is lead counsel to an industry-leading space company pioneering human habitation in low-Earth orbit, advising on litigation, data security, and AI matters.\u003c/p\u003e","\u003cp\u003eJesse is lead counsel to numerous large-scale AI companies on governance, compliance, and international trade with an emphasis on national security.\u003c/p\u003e","\u003cp\u003eJesse is lead counsel to a prominent AI-enabled cybersecurity company on privacy, security, international trade, and intellectual property.\u003c/p\u003e","\u003cp\u003eJesse is lead counsel to numerous startups on research, design, development, and patenting of AI technology.\u003c/p\u003e","\u003cp\u003eJesse is lead counsel to an AI-enabled pharmaceutical company on the development and patenting of cannabis-plant-material compounds.\u003c/p\u003e","\u003cp\u003eJesse represented Google in the pathmarking copyright dispute against Oracle over use of APIs when coding.\u003c/p\u003e","\u003cp\u003eJesse delivered a complete defense victory for GW Pharma in a patent dispute over one of the few FDA-approved drugs containing cannabis plant materials. S\u003cem\u003eee Canopy Growth Corp. v. GW Pharma Ltd.\u003c/em\u003e, No. 22-1603 (Fed. Cir. Apr. 24, 2023).\u003c/p\u003e","\u003cp\u003eJesse represented Equifax on various fronts during the 2017 data incident, including advising on congressional oversight, regulatory enforcement, state attorneys general litigation, and private lawsuits.\u003c/p\u003e"],"taggings":{"tags":[],"meta_tags":[{"id":3270}]},"expertise":[{"id":2,"guid":"2.capabilities","index":0,"source":"capabilities"},{"id":13,"guid":"13.capabilities","index":1,"source":"capabilities"},{"id":1202,"guid":"1202.smart_tags","index":2,"source":"smartTags"},{"id":826,"guid":"826.smart_tags","index":3,"source":"smartTags"},{"id":763,"guid":"763.smart_tags","index":4,"source":"smartTags"},{"id":761,"guid":"761.smart_tags","index":5,"source":"smartTags"},{"id":116,"guid":"116.capabilities","index":6,"source":"capabilities"},{"id":6,"guid":"6.capabilities","index":7,"source":"capabilities"},{"id":115,"guid":"115.capabilities","index":8,"source":"capabilities"},{"id":106,"guid":"106.capabilities","index":9,"source":"capabilities"},{"id":118,"guid":"118.capabilities","index":10,"source":"capabilities"},{"id":133,"guid":"133.capabilities","index":11,"source":"capabilities"},{"id":1472,"guid":"1472.smart_tags","index":12,"source":"smartTags"}],"is_active":true,"last_name":"Snyder","nick_name":"Jesse","clerkships":[{"name":"Law Clerk, the Honorable Eugene E. Siler, Jr., U.S. Court of Appeals for the Sixth Circuit","years_held":"2016–2017"},{"name":"Law Clerk, the Honorable Jimmie V. Reyna, U.S. Court of Appeals for the Federal Circuit","years_held":"2015–2016"},{"name":"Law Clerk, the Honorable Jorge A. Solis, U.S. District Court for the Northern District of Texas","years_held":"2012–2013"}],"first_name":"Jesse","title_rank":9999,"updated_by":202,"law_schools":[{"id":1980,"meta":{"degree":"J.D.","honors":"summa cum laude","is_law_school":"1","graduation_date":"2012-01-01 00:00:00"},"order":1,"pin_order":null,"pin_expiration":null}],"middle_name":" ","name_suffix":"","recognitions":[{"title":"2025, 2026 Guest Lecturer on AI, IP, and Cybersecurity","detail":"University of Mississippi School of Law"},{"title":"2026 Sedona Working Group Member on AI and Trade Secrets","detail":"The Sedona Conference"},{"title":"2025 Client Service All-Star","detail":"BTI Consulting Group"},{"title":"24 Scholarly Publications","detail":"Harvard, NYU, Virginia, British Journal of American Legal Studies, and More"},{"title":"Federal Clerkship","detail":"U.S. Court of Appeals for the Sixth Circuit"},{"title":"Federal Clerkship","detail":"U.S. Court of Appeals for the Federal Circuit"},{"title":"Federal Clerkship","detail":"U.S. District Court for the Northern District of Texas"},{"title":"Past Member of the North Carolina Pro Bono Honor Society","detail":"North Carolina State Bar"},{"title":"National Order of Scribes","detail":"The American Society of Legal Writers"}],"linked_in_url":null,"seodescription":"Jesse Snyder is a partner in the Washington, D.C., office of King \u0026 Spalding. Read more about him.","primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eJesse Snyder is a partner\u0026nbsp;in the Washington, D.C., office of King \u0026amp; Spalding and a member of the firm\u0026rsquo;s Technology, Appellate, and Administrative Law practice groups.\u0026nbsp;Jesse litigates prime time technology disputes,\u0026nbsp;including those involving AI, data privacy,\u0026nbsp;cybersecurity, intellectual property, appeals,\u0026nbsp;strategic counseling, and bespoke cross-disciplinary solutions for clients facing significant risk. No matter the issue, Jesse is always present\u0026nbsp;to help\u0026nbsp;his clients navigate\u0026nbsp;their\u0026nbsp;toughest challenges.\u0026nbsp;[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eJesse helps\u0026nbsp;his clients traverse\u0026nbsp;scores of pressing fronts: novel\u0026nbsp;disputes, government-facing advocacy, compliance, governance, licensing, national security, international trade, as well as practical business-minded matters to drive ROI and to galvanize KPIs. In addition to his well-established\u0026nbsp;appellate and administrative law practice, Jesse has served as lead counsel\u0026nbsp;in numerous litigations, including\u0026nbsp;high-stakes disputes touching on data privacy and cybersecurity, intellectual property, pixel technology, and generative AI.\u0026nbsp;What's more, Jesse regularly\u0026nbsp;counsels clients in highly scrutinized industries on the development and implementation of cybersecurity, privacy, and generative AI compliance programs and protocols. Moreover, Jesse has been called upon to provide forensic analysis, technical advice, and legal defense\u0026nbsp;to various clients facing exigent online attacks as well as\u0026nbsp;illicit hacking events. He also\u0026nbsp;routinely\u0026nbsp;advises clients on AI algorithm and large language model\u0026nbsp;development, data mapping,\u0026nbsp;as well as various considerations and strategies when implementing AI into existing and nascent processes. In addition, Jesse takes pride in his dedicated practice aimed at\u0026nbsp;advancing\u0026nbsp;the talents of entrepreneurs to compete and to succeed, thereby providing steady advice and pragmatic guidance\u0026nbsp;to help propel his clients forward to achieve\u0026nbsp;their business objectives.\u0026nbsp;\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eIn view\u0026nbsp;of his achievements in these areas, Jesse was nominated by his clients and received recognition by the BTI Consulting Group\u0026nbsp;as a 2025 Client Service All-Star, \"the gold standard used by corporate counsel and law firms alike to identify the attorneys delivering the absolute\u0026nbsp;best levels of client service -- better than all others.\"\u0026nbsp; During 2025 in particular, BTI noted that \"only two\u0026nbsp;attorneys earned their organic recognition from multiple clients,\" and Jesse was\u0026nbsp;one of\u0026nbsp;those two.\u0026nbsp;Building further, the University of Mississippi School of Law's Center for Air and Space Law invited Jesse to be\u0026nbsp;a 2025 and 2026 guest lecturer on cybersecurity and AI. The Sedona Conference also chose Jesse to serve on the 2026 working group on AI and trade secrets, working to build industry consensus around\u0026nbsp;these areas of growing\u0026nbsp;importance.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eDuring law school, Jesse\u0026nbsp;served as editor in chief of the flagship law review publication, graduated in\u0026nbsp;the highest percentile of his class, and was inducted into the National Order of Scribes.\u0026nbsp;He is a published author in 24\u0026nbsp;different law reviews, covering a variety of topics ranging from the Antiterrorism Act and\u0026nbsp;First Amendment to patent law\u0026nbsp;and Twenty-first Amendment.\u0026nbsp;He also serves as an\u0026nbsp;\u003cem\u003eex officio\u003c/em\u003e\u0026nbsp;member of Texas A\u0026amp;M\u0026rsquo;s faculty committee on clerkship placements.\u0026nbsp;Before joining King \u0026amp; Spalding, Jesse served as a term law clerk to three federal judges: the Honorable Eugene E. Siler, Jr. of the U.S. Court of Appeals for the Sixth Circuit, the Honorable Jimmie V. Reyna of the U.S. Court of Appeals for the Federal Circuit, and the Honorable Jorge A. Solis of the U.S. District Court for the Northern District of Texas.\u003c/p\u003e\n\u003cp\u003eBefore attending law school, Jesse amassed experience as an engineer at Stryker Corporation and as a commissioned military officer serving in the Air Force during the attacks on September 11, 2001. His medical-device experience covers a wide array of technology platforms for use in endoscopic procedures. And as a graduate of the Air Force Academy, Jesse is a proud combat veteran of Operations Iraqi Freedom, Multinational Corps-Iraq, and Combined Joint Task Force 7. During his service, he\u0026nbsp;received multiple medals and awards. In addition, as an extension of his sustained commitment to public service, Jesse\u0026nbsp;pioneered the firm's Armed Forces Attorney Coalition, a group whose purpose is to\u0026nbsp;promote\u0026nbsp;veteran interests\u0026nbsp;in the legal profession as well as\u0026nbsp;more broadly. Jesse also carries an abiding\u0026nbsp;dedication\u0026nbsp;to pro bono legal services, as demonstrated by his past multiyear recognition as a member of the North Carolina\u0026nbsp;Pro Bono Honor Society. Jesse is an avid runner, and he has been so for over 35\u0026nbsp;years.\u003c/p\u003e","matters":["\u003cp\u003eJesse Snyder serves as lead counsel for litigations involving an industry-leading AI company offering products and services for legal departments worldwide.\u003c/p\u003e","\u003cp\u003eJesse Snyder is lead counsel to an industry-leading jet propulsion system manufacturer for the U.S. military, advising on AI, IP, privacy, trade, antitrust, and compliance.\u003c/p\u003e","\u003cp\u003eJesse is lead counsel to a pioneering and disrupting aerospace defense contractor designing pilot training devices for flight school, including achieving an agency corrective action through a successful bid protest.\u003c/p\u003e","\u003cp\u003eJesse is lead counsel to one of the largest national defense aerospace companies on AI governance and compliance, data mapping, and cybersecurity.\u003c/p\u003e","\u003cp\u003eJesse is lead counsel to an industry-leading space company pioneering human habitation in low-Earth orbit, advising on litigation, data security, and AI matters.\u003c/p\u003e","\u003cp\u003eJesse is lead counsel to numerous large-scale AI companies on governance, compliance, and international trade with an emphasis on national security.\u003c/p\u003e","\u003cp\u003eJesse is lead counsel to a prominent AI-enabled cybersecurity company on privacy, security, international trade, and intellectual property.\u003c/p\u003e","\u003cp\u003eJesse is lead counsel to numerous startups on research, design, development, and patenting of AI technology.\u003c/p\u003e","\u003cp\u003eJesse is lead counsel to an AI-enabled pharmaceutical company on the development and patenting of cannabis-plant-material compounds.\u003c/p\u003e","\u003cp\u003eJesse represented Google in the pathmarking copyright dispute against Oracle over use of APIs when coding.\u003c/p\u003e","\u003cp\u003eJesse delivered a complete defense victory for GW Pharma in a patent dispute over one of the few FDA-approved drugs containing cannabis plant materials. S\u003cem\u003eee Canopy Growth Corp. v. GW Pharma Ltd.\u003c/em\u003e, No. 22-1603 (Fed. Cir. Apr. 24, 2023).\u003c/p\u003e","\u003cp\u003eJesse represented Equifax on various fronts during the 2017 data incident, including advising on congressional oversight, regulatory enforcement, state attorneys general litigation, and private lawsuits.\u003c/p\u003e"],"recognitions":[{"title":"2025, 2026 Guest Lecturer on AI, IP, and Cybersecurity","detail":"University of Mississippi School of Law"},{"title":"2026 Sedona Working Group Member on AI and Trade Secrets","detail":"The Sedona Conference"},{"title":"2025 Client Service All-Star","detail":"BTI Consulting Group"},{"title":"24 Scholarly Publications","detail":"Harvard, NYU, Virginia, British Journal of American Legal Studies, and More"},{"title":"Federal Clerkship","detail":"U.S. Court of Appeals for the Sixth Circuit"},{"title":"Federal Clerkship","detail":"U.S. Court of Appeals for the Federal Circuit"},{"title":"Federal Clerkship","detail":"U.S. District Court for the Northern District of Texas"},{"title":"Past Member of the North Carolina Pro Bono Honor Society","detail":"North Carolina State Bar"},{"title":"National Order of Scribes","detail":"The American Society of Legal Writers"}]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":11370}]},"capability_group_id":3},"created_at":"2026-04-15T20:49:35.000Z","updated_at":"2026-04-15T20:49:35.000Z","searchable_text":"Snyder{{ FIELD }}{:title=\u0026gt;\"2025, 2026 Guest Lecturer on AI, IP, and Cybersecurity\", :detail=\u0026gt;\"University of Mississippi School of Law\"}{{ FIELD }}{:title=\u0026gt;\"2026 Sedona Working Group Member on AI and Trade Secrets\", :detail=\u0026gt;\"The Sedona Conference\"}{{ FIELD }}{:title=\u0026gt;\"2025 Client Service All-Star\", :detail=\u0026gt;\"BTI Consulting Group\"}{{ FIELD }}{:title=\u0026gt;\"24 Scholarly Publications\", :detail=\u0026gt;\"Harvard, NYU, Virginia, British Journal of American Legal Studies, and More\"}{{ FIELD }}{:title=\u0026gt;\"Federal Clerkship\", :detail=\u0026gt;\"U.S. Court of Appeals for the Sixth Circuit\"}{{ FIELD }}{:title=\u0026gt;\"Federal Clerkship\", :detail=\u0026gt;\"U.S. Court of Appeals for the Federal Circuit\"}{{ FIELD }}{:title=\u0026gt;\"Federal Clerkship\", :detail=\u0026gt;\"U.S. District Court for the Northern District of Texas\"}{{ FIELD }}{:title=\u0026gt;\"Past Member of the North Carolina Pro Bono Honor Society\", :detail=\u0026gt;\"North Carolina State Bar\"}{{ FIELD }}{:title=\u0026gt;\"National Order of Scribes\", :detail=\u0026gt;\"The American Society of Legal Writers\"}{{ FIELD }}Jesse Snyder serves as lead counsel for litigations involving an industry-leading AI company offering products and services for legal departments worldwide.{{ FIELD }}Jesse Snyder is lead counsel to an industry-leading jet propulsion system manufacturer for the U.S. military, advising on AI, IP, privacy, trade, antitrust, and compliance.{{ FIELD }}Jesse is lead counsel to a pioneering and disrupting aerospace defense contractor designing pilot training devices for flight school, including achieving an agency corrective action through a successful bid protest.{{ FIELD }}Jesse is lead counsel to one of the largest national defense aerospace companies on AI governance and compliance, data mapping, and cybersecurity.{{ FIELD }}Jesse is lead counsel to an industry-leading space company pioneering human habitation in low-Earth orbit, advising on litigation, data security, and AI matters.{{ FIELD }}Jesse is lead counsel to numerous large-scale AI companies on governance, compliance, and international trade with an emphasis on national security.{{ FIELD }}Jesse is lead counsel to a prominent AI-enabled cybersecurity company on privacy, security, international trade, and intellectual property.{{ FIELD }}Jesse is lead counsel to numerous startups on research, design, development, and patenting of AI technology.{{ FIELD }}Jesse is lead counsel to an AI-enabled pharmaceutical company on the development and patenting of cannabis-plant-material compounds.{{ FIELD }}Jesse represented Google in the pathmarking copyright dispute against Oracle over use of APIs when coding.{{ FIELD }}Jesse delivered a complete defense victory for GW Pharma in a patent dispute over one of the few FDA-approved drugs containing cannabis plant materials. See Canopy Growth Corp. v. GW Pharma Ltd., No. 22-1603 (Fed. Cir. Apr. 24, 2023).{{ FIELD }}Jesse represented Equifax on various fronts during the 2017 data incident, including advising on congressional oversight, regulatory enforcement, state attorneys general litigation, and private lawsuits.{{ FIELD }}Jesse Snyder is a partner in the Washington, D.C., office of King \u0026amp; Spalding and a member of the firm’s Technology, Appellate, and Administrative Law practice groups. Jesse litigates prime time technology disputes, including those involving AI, data privacy, cybersecurity, intellectual property, appeals, strategic counseling, and bespoke cross-disciplinary solutions for clients facing significant risk. No matter the issue, Jesse is always present to help his clients navigate their toughest challenges. \nJesse helps his clients traverse scores of pressing fronts: novel disputes, government-facing advocacy, compliance, governance, licensing, national security, international trade, as well as practical business-minded matters to drive ROI and to galvanize KPIs. In addition to his well-established appellate and administrative law practice, Jesse has served as lead counsel in numerous litigations, including high-stakes disputes touching on data privacy and cybersecurity, intellectual property, pixel technology, and generative AI. What's more, Jesse regularly counsels clients in highly scrutinized industries on the development and implementation of cybersecurity, privacy, and generative AI compliance programs and protocols. Moreover, Jesse has been called upon to provide forensic analysis, technical advice, and legal defense to various clients facing exigent online attacks as well as illicit hacking events. He also routinely advises clients on AI algorithm and large language model development, data mapping, as well as various considerations and strategies when implementing AI into existing and nascent processes. In addition, Jesse takes pride in his dedicated practice aimed at advancing the talents of entrepreneurs to compete and to succeed, thereby providing steady advice and pragmatic guidance to help propel his clients forward to achieve their business objectives.  \nIn view of his achievements in these areas, Jesse was nominated by his clients and received recognition by the BTI Consulting Group as a 2025 Client Service All-Star, \"the gold standard used by corporate counsel and law firms alike to identify the attorneys delivering the absolute best levels of client service -- better than all others.\"  During 2025 in particular, BTI noted that \"only two attorneys earned their organic recognition from multiple clients,\" and Jesse was one of those two. Building further, the University of Mississippi School of Law's Center for Air and Space Law invited Jesse to be a 2025 and 2026 guest lecturer on cybersecurity and AI. The Sedona Conference also chose Jesse to serve on the 2026 working group on AI and trade secrets, working to build industry consensus around these areas of growing importance. \nDuring law school, Jesse served as editor in chief of the flagship law review publication, graduated in the highest percentile of his class, and was inducted into the National Order of Scribes. He is a published author in 24 different law reviews, covering a variety of topics ranging from the Antiterrorism Act and First Amendment to patent law and Twenty-first Amendment. He also serves as an ex officio member of Texas A\u0026amp;M’s faculty committee on clerkship placements. Before joining King \u0026amp; Spalding, Jesse served as a term law clerk to three federal judges: the Honorable Eugene E. Siler, Jr. of the U.S. Court of Appeals for the Sixth Circuit, the Honorable Jimmie V. Reyna of the U.S. Court of Appeals for the Federal Circuit, and the Honorable Jorge A. Solis of the U.S. District Court for the Northern District of Texas.\nBefore attending law school, Jesse amassed experience as an engineer at Stryker Corporation and as a commissioned military officer serving in the Air Force during the attacks on September 11, 2001. His medical-device experience covers a wide array of technology platforms for use in endoscopic procedures. And as a graduate of the Air Force Academy, Jesse is a proud combat veteran of Operations Iraqi Freedom, Multinational Corps-Iraq, and Combined Joint Task Force 7. During his service, he received multiple medals and awards. In addition, as an extension of his sustained commitment to public service, Jesse pioneered the firm's Armed Forces Attorney Coalition, a group whose purpose is to promote veteran interests in the legal profession as well as more broadly. Jesse also carries an abiding dedication to pro bono legal services, as demonstrated by his past multiyear recognition as a member of the North Carolina Pro Bono Honor Society. Jesse is an avid runner, and he has been so for over 35 years. Jesse Snyder lawyer Partner 2025, 2026 Guest Lecturer on AI, IP, and Cybersecurity University of Mississippi School of Law 2026 Sedona Working Group Member on AI and Trade Secrets The Sedona Conference 2025 Client Service All-Star BTI Consulting Group 24 Scholarly Publications Harvard, NYU, Virginia, British Journal of American Legal Studies, and More Federal Clerkship U.S. Court of Appeals for the Sixth Circuit Federal Clerkship U.S. Court of Appeals for the Federal Circuit Federal Clerkship U.S. District Court for the Northern District of Texas Past Member of the North Carolina Pro Bono Honor Society North Carolina State Bar National Order of Scribes The American Society of Legal Writers United States Air Force Academy  Texas A\u0026amp;M University Texas A\u0026amp;M School of Law U.S. Court of Appeals for the Federal Circuit U.S. Court of Appeals for the Sixth Circuit U.S. District Court for the Eastern District of Texas U.S. District Court for the Northern District of Texas District of Columbia North Carolina Texas North Carolina State Bar D.C. Bar Association Texas State Bar Assoication Buncombe County Bar Law Clerk, the Honorable Eugene E. Siler, Jr., U.S. Court of Appeals for the Sixth Circuit Law Clerk, the Honorable Jimmie V. Reyna, U.S. Court of Appeals for the Federal Circuit Law Clerk, the Honorable Jorge A. Solis, U.S. District Court for the Northern District of Texas Jesse Snyder serves as lead counsel for litigations involving an industry-leading AI company offering products and services for legal departments worldwide. Jesse Snyder is lead counsel to an industry-leading jet propulsion system manufacturer for the U.S. military, advising on AI, IP, privacy, trade, antitrust, and compliance. Jesse is lead counsel to a pioneering and disrupting aerospace defense contractor designing pilot training devices for flight school, including achieving an agency corrective action through a successful bid protest. Jesse is lead counsel to one of the largest national defense aerospace companies on AI governance and compliance, data mapping, and cybersecurity. Jesse is lead counsel to an industry-leading space company pioneering human habitation in low-Earth orbit, advising on litigation, data security, and AI matters. Jesse is lead counsel to numerous large-scale AI companies on governance, compliance, and international trade with an emphasis on national security. Jesse is lead counsel to a prominent AI-enabled cybersecurity company on privacy, security, international trade, and intellectual property. Jesse is lead counsel to numerous startups on research, design, development, and patenting of AI technology. Jesse is lead counsel to an AI-enabled pharmaceutical company on the development and patenting of cannabis-plant-material compounds. Jesse represented Google in the pathmarking copyright dispute against Oracle over use of APIs when coding. Jesse delivered a complete defense victory for GW Pharma in a patent dispute over one of the few FDA-approved drugs containing cannabis plant materials. See Canopy Growth Corp. v. GW Pharma Ltd., No. 22-1603 (Fed. Cir. Apr. 24, 2023). Jesse represented Equifax on various fronts during the 2017 data incident, including advising on congressional oversight, regulatory enforcement, state attorneys general litigation, and private lawsuits.","searchable_name":"Jesse Snyder","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":202,"capability_group_featured":null,"home_page_featured":null},{"id":443994,"version":1,"owner_type":"Person","owner_id":6954,"payload":{"bio":"\u003cp\u003eBen is a versatile litigator and former Silicon Valley in-house counsel focused on complex litigation, appellate and critical-issue advocacy, and regulatory investigations. Ben joins King \u0026amp; Spalding from Google, where he helped design and execute the company\u0026rsquo;s AI regulatory strategy. He has extensive experience helping clients inside and outside the technology sector navigate issues of administrative law, antitrust, consumer protection, privacy, and securities. Ben draws on his in-house experience to drive comprehensive client solutions that address legal, business, and reputational risk.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eBen was one of Google\u0026rsquo;s first AI regulatory lawyers. There, he led cross-functional teams responding to AI inquiries from regulators around the world, and, working closely with senior executives and business leaders, he helped develop and manage the company\u0026rsquo;s overarching AI regulatory strategy. Beyond AI, Ben directed defense strategy on litigation and regulatory matters arising under Section 5 of the FTC Act 5, state unfair and deceptive acts statutes, the federal securities laws, and global privacy laws. He also managed strategic regulatory compliance enhancements, working closely with business units like marketing, human resources, and finance to deliver compliance readiness on-time and on-budget.\u003c/p\u003e\n\u003cp\u003eBefore Google, Ben was a partner at a litigation boutique in Washington, D.C. There, in addition to trial court work, Ben argued numerous times in the federal courts of appeals, and was regularly tapped to draft appellate briefs, case-dispositive motions, and federal agency comments. He authored or co-authored winning briefs in the Supreme Court of the United States and in trial and appellate courts across the country.\u003c/p\u003e\n\u003cp\u003eBen served as a law clerk for the Honorable A. Raymond Randolph of the United States Court of Appeals for the D.C. Circuit. He has been named \u0026ldquo;Litigator of the Week\u0026rdquo; by \u003cem\u003eGlobal Competition Review\u003c/em\u003e and \u0026ldquo;Legal Lion\u0026rdquo; by \u003cem\u003eLaw360 \u003c/em\u003efor his work.\u003c/p\u003e","slug":"benjamin-softness","email":"bsoftness@kslaw.com","phone":null,"matters":["\u003cp\u003eRepresented a large technology client in federal and state consumer products investigations arising under Section 5 of the FTC Act and state consumer protection laws\u003c/p\u003e","\u003cp\u003eRepresented a large technology client in shareholder class action under federal securities laws\u003c/p\u003e","\u003cp\u003eRepresented AT\u0026amp;T in a Section 5 consumer-protection case through district court litigation and appeals\u003c/p\u003e","\u003cp\u003eDefended AT\u0026amp;T\u0026rsquo;s merger with Time Warner against DOJ antitrust challenge pre-trial, at trial, and on appeal, \u003cem\u003eUnited States v. AT\u0026amp;T\u003c/em\u003e, 916 F.3d 1029 (D.C. Cir. 2019), \u003cem\u003eaff\u0026rsquo;g \u003c/em\u003e310 F. Supp. 3d 161 (D.D.C. 2018).\u003c/p\u003e","\u003cp\u003eAssisted Fortune 50 client with third-party subpoena defense and anticipated appellate work in a copyright case\u003c/p\u003e","\u003cp\u003eFounding member of the litigation team representing Petersen Energia Inversora, S.A.U., Petersen Energia, S.A.U., and Eton Park Capital Management in litigation in the Southern District of New York against the Argentine Republic and YPF, S.A., alleging claims for breach of contract and promissory estoppel arising from defendants\u0026rsquo; failure to comply with their tender offer requirements in connection with Argentina's expropriation of YPF plaintiffs against Republic of Argentina in \u003cem\u003ePetersen Energ\u0026iacute;a Inversora S.A.U. v. Argentine Republic\u003c/em\u003e.\u003c/p\u003e","\u003cp\u003eCo-authored respondent\u0026rsquo;s winning merits brief in a major antitrust case, \u003cem\u003eApple v. Pepper\u003c/em\u003e, 139 S. Ct. 1514 (2019), and was named a \u003cem\u003eGlobal Competition Review\u003c/em\u003e \u0026ldquo;Litigator of the Week\u0026rdquo; for the win.\u003c/p\u003e","\u003cp\u003eCo-authored winning brief in \u003cem\u003eStuart v. Global Tel*Link Corp\u003c/em\u003e., 956 F.3d 555 (8th Cir. 2020), affirming summary judgment on consumer protection issues and class decertification (named \u003cem\u003eLaw360\u003c/em\u003e \u0026ldquo;Legal Lion\u0026rdquo; for victory).\u003c/p\u003e","\u003cp\u003eCo-authored petitioners\u0026rsquo; winning briefs challenging agency rulemaking in \u003cem\u003eGlobal Tel*Link v. FCC,\u003c/em\u003e 866 F.3d 397 (D.C. Cir. 2017).\u003c/p\u003e","\u003cp\u003eBriefed and argued \u003cem\u003eSanders v. United States\u003c/em\u003e, 937 F.3d 316 (4th Cir. 2019), representing \u003cem\u003epro bono\u003c/em\u003e client the Brady Center to Prevent Gun Violence as \u003cem\u003eamicus curiae\u003c/em\u003e. The Fourth Circuit, citing Brady\u0026rsquo;s brief, reinstated dismissed claims brought by victims of the 2015 shooting at Mother Emanuel Church in Charleston, S.C.\u003c/p\u003e"],"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":74,"guid":"74.capabilities","index":0,"source":"capabilities"},{"id":2,"guid":"2.capabilities","index":1,"source":"capabilities"},{"id":129,"guid":"129.capabilities","index":2,"source":"capabilities"},{"id":5,"guid":"5.capabilities","index":3,"source":"capabilities"},{"id":19,"guid":"19.capabilities","index":4,"source":"capabilities"},{"id":6,"guid":"6.capabilities","index":5,"source":"capabilities"},{"id":111,"guid":"111.capabilities","index":6,"source":"capabilities"},{"id":20,"guid":"20.capabilities","index":7,"source":"capabilities"},{"id":133,"guid":"133.capabilities","index":8,"source":"capabilities"},{"id":118,"guid":"118.capabilities","index":9,"source":"capabilities"},{"id":764,"guid":"764.smart_tags","index":10,"source":"smartTags"},{"id":750,"guid":"750.smart_tags","index":11,"source":"smartTags"},{"id":1,"guid":"1.capabilities","index":12,"source":"capabilities"}],"is_active":true,"last_name":"Softness","nick_name":"Benjamin","clerkships":[{"name":"Law Clerk, Hon. A Raymond Randolph, U.S. Court of Appeals for the D.C. Circuit","years_held":"2013 - 2014"},{"name":"Intern, Hon. Richard J. Leon, U.S. District Court for the District of Columbia","years_held":"2011 - 2011"}],"first_name":"Benjamin","title_rank":9999,"updated_by":202,"law_schools":[{"id":2282,"meta":{"degree":"J.D.","honors":"summa cum laude","is_law_school":"1","graduation_date":"2013-01-01 00:00:00"},"order":1,"pin_order":null,"pin_expiration":null}],"middle_name":"","name_suffix":"","recognitions":[{"title":"Litigator of the Week","detail":"Global Competition Review, 2019"},{"title":"Legal Lion","detail":"Law360, 2020"}],"linked_in_url":"https://www.linkedin.com/in/benjamin-softness-7b16322/","seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eBen is a versatile litigator and former Silicon Valley in-house counsel focused on complex litigation, appellate and critical-issue advocacy, and regulatory investigations. Ben joins King \u0026amp; Spalding from Google, where he helped design and execute the company\u0026rsquo;s AI regulatory strategy. He has extensive experience helping clients inside and outside the technology sector navigate issues of administrative law, antitrust, consumer protection, privacy, and securities. Ben draws on his in-house experience to drive comprehensive client solutions that address legal, business, and reputational risk.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eBen was one of Google\u0026rsquo;s first AI regulatory lawyers. There, he led cross-functional teams responding to AI inquiries from regulators around the world, and, working closely with senior executives and business leaders, he helped develop and manage the company\u0026rsquo;s overarching AI regulatory strategy. Beyond AI, Ben directed defense strategy on litigation and regulatory matters arising under Section 5 of the FTC Act 5, state unfair and deceptive acts statutes, the federal securities laws, and global privacy laws. He also managed strategic regulatory compliance enhancements, working closely with business units like marketing, human resources, and finance to deliver compliance readiness on-time and on-budget.\u003c/p\u003e\n\u003cp\u003eBefore Google, Ben was a partner at a litigation boutique in Washington, D.C. There, in addition to trial court work, Ben argued numerous times in the federal courts of appeals, and was regularly tapped to draft appellate briefs, case-dispositive motions, and federal agency comments. He authored or co-authored winning briefs in the Supreme Court of the United States and in trial and appellate courts across the country.\u003c/p\u003e\n\u003cp\u003eBen served as a law clerk for the Honorable A. Raymond Randolph of the United States Court of Appeals for the D.C. Circuit. He has been named \u0026ldquo;Litigator of the Week\u0026rdquo; by \u003cem\u003eGlobal Competition Review\u003c/em\u003e and \u0026ldquo;Legal Lion\u0026rdquo; by \u003cem\u003eLaw360 \u003c/em\u003efor his work.\u003c/p\u003e","matters":["\u003cp\u003eRepresented a large technology client in federal and state consumer products investigations arising under Section 5 of the FTC Act and state consumer protection laws\u003c/p\u003e","\u003cp\u003eRepresented a large technology client in shareholder class action under federal securities laws\u003c/p\u003e","\u003cp\u003eRepresented AT\u0026amp;T in a Section 5 consumer-protection case through district court litigation and appeals\u003c/p\u003e","\u003cp\u003eDefended AT\u0026amp;T\u0026rsquo;s merger with Time Warner against DOJ antitrust challenge pre-trial, at trial, and on appeal, \u003cem\u003eUnited States v. AT\u0026amp;T\u003c/em\u003e, 916 F.3d 1029 (D.C. Cir. 2019), \u003cem\u003eaff\u0026rsquo;g \u003c/em\u003e310 F. Supp. 3d 161 (D.D.C. 2018).\u003c/p\u003e","\u003cp\u003eAssisted Fortune 50 client with third-party subpoena defense and anticipated appellate work in a copyright case\u003c/p\u003e","\u003cp\u003eFounding member of the litigation team representing Petersen Energia Inversora, S.A.U., Petersen Energia, S.A.U., and Eton Park Capital Management in litigation in the Southern District of New York against the Argentine Republic and YPF, S.A., alleging claims for breach of contract and promissory estoppel arising from defendants\u0026rsquo; failure to comply with their tender offer requirements in connection with Argentina's expropriation of YPF plaintiffs against Republic of Argentina in \u003cem\u003ePetersen Energ\u0026iacute;a Inversora S.A.U. v. Argentine Republic\u003c/em\u003e.\u003c/p\u003e","\u003cp\u003eCo-authored respondent\u0026rsquo;s winning merits brief in a major antitrust case, \u003cem\u003eApple v. Pepper\u003c/em\u003e, 139 S. Ct. 1514 (2019), and was named a \u003cem\u003eGlobal Competition Review\u003c/em\u003e \u0026ldquo;Litigator of the Week\u0026rdquo; for the win.\u003c/p\u003e","\u003cp\u003eCo-authored winning brief in \u003cem\u003eStuart v. Global Tel*Link Corp\u003c/em\u003e., 956 F.3d 555 (8th Cir. 2020), affirming summary judgment on consumer protection issues and class decertification (named \u003cem\u003eLaw360\u003c/em\u003e \u0026ldquo;Legal Lion\u0026rdquo; for victory).\u003c/p\u003e","\u003cp\u003eCo-authored petitioners\u0026rsquo; winning briefs challenging agency rulemaking in \u003cem\u003eGlobal Tel*Link v. FCC,\u003c/em\u003e 866 F.3d 397 (D.C. Cir. 2017).\u003c/p\u003e","\u003cp\u003eBriefed and argued \u003cem\u003eSanders v. United States\u003c/em\u003e, 937 F.3d 316 (4th Cir. 2019), representing \u003cem\u003epro bono\u003c/em\u003e client the Brady Center to Prevent Gun Violence as \u003cem\u003eamicus curiae\u003c/em\u003e. The Fourth Circuit, citing Brady\u0026rsquo;s brief, reinstated dismissed claims brought by victims of the 2015 shooting at Mother Emanuel Church in Charleston, S.C.\u003c/p\u003e"],"recognitions":[{"title":"Litigator of the Week","detail":"Global Competition Review, 2019"},{"title":"Legal Lion","detail":"Law360, 2020"}]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":12616}]},"capability_group_id":3},"created_at":"2025-12-05T05:02:27.000Z","updated_at":"2025-12-05T05:02:27.000Z","searchable_text":"Softness{{ FIELD }}{:title=\u0026gt;\"Litigator of the Week\", :detail=\u0026gt;\"Global Competition Review, 2019\"}{{ FIELD }}{:title=\u0026gt;\"Legal Lion\", :detail=\u0026gt;\"Law360, 2020\"}{{ FIELD }}Represented a large technology client in federal and state consumer products investigations arising under Section 5 of the FTC Act and state consumer protection laws{{ FIELD }}Represented a large technology client in shareholder class action under federal securities laws{{ FIELD }}Represented AT\u0026amp;T in a Section 5 consumer-protection case through district court litigation and appeals{{ FIELD }}Defended AT\u0026amp;T’s merger with Time Warner against DOJ antitrust challenge pre-trial, at trial, and on appeal, United States v. AT\u0026amp;T, 916 F.3d 1029 (D.C. Cir. 2019), aff’g 310 F. Supp. 3d 161 (D.D.C. 2018).{{ FIELD }}Assisted Fortune 50 client with third-party subpoena defense and anticipated appellate work in a copyright case{{ FIELD }}Founding member of the litigation team representing Petersen Energia Inversora, S.A.U., Petersen Energia, S.A.U., and Eton Park Capital Management in litigation in the Southern District of New York against the Argentine Republic and YPF, S.A., alleging claims for breach of contract and promissory estoppel arising from defendants’ failure to comply with their tender offer requirements in connection with Argentina's expropriation of YPF plaintiffs against Republic of Argentina in Petersen Energía Inversora S.A.U. v. Argentine Republic.{{ FIELD }}Co-authored respondent’s winning merits brief in a major antitrust case, Apple v. Pepper, 139 S. Ct. 1514 (2019), and was named a Global Competition Review “Litigator of the Week” for the win.{{ FIELD }}Co-authored winning brief in Stuart v. Global Tel*Link Corp., 956 F.3d 555 (8th Cir. 2020), affirming summary judgment on consumer protection issues and class decertification (named Law360 “Legal Lion” for victory).{{ FIELD }}Co-authored petitioners’ winning briefs challenging agency rulemaking in Global Tel*Link v. FCC, 866 F.3d 397 (D.C. Cir. 2017).{{ FIELD }}Briefed and argued Sanders v. United States, 937 F.3d 316 (4th Cir. 2019), representing pro bono client the Brady Center to Prevent Gun Violence as amicus curiae. The Fourth Circuit, citing Brady’s brief, reinstated dismissed claims brought by victims of the 2015 shooting at Mother Emanuel Church in Charleston, S.C.{{ FIELD }}Ben is a versatile litigator and former Silicon Valley in-house counsel focused on complex litigation, appellate and critical-issue advocacy, and regulatory investigations. Ben joins King \u0026amp; Spalding from Google, where he helped design and execute the company’s AI regulatory strategy. He has extensive experience helping clients inside and outside the technology sector navigate issues of administrative law, antitrust, consumer protection, privacy, and securities. Ben draws on his in-house experience to drive comprehensive client solutions that address legal, business, and reputational risk.\nBen was one of Google’s first AI regulatory lawyers. There, he led cross-functional teams responding to AI inquiries from regulators around the world, and, working closely with senior executives and business leaders, he helped develop and manage the company’s overarching AI regulatory strategy. Beyond AI, Ben directed defense strategy on litigation and regulatory matters arising under Section 5 of the FTC Act 5, state unfair and deceptive acts statutes, the federal securities laws, and global privacy laws. He also managed strategic regulatory compliance enhancements, working closely with business units like marketing, human resources, and finance to deliver compliance readiness on-time and on-budget.\nBefore Google, Ben was a partner at a litigation boutique in Washington, D.C. There, in addition to trial court work, Ben argued numerous times in the federal courts of appeals, and was regularly tapped to draft appellate briefs, case-dispositive motions, and federal agency comments. He authored or co-authored winning briefs in the Supreme Court of the United States and in trial and appellate courts across the country.\nBen served as a law clerk for the Honorable A. Raymond Randolph of the United States Court of Appeals for the D.C. Circuit. He has been named “Litigator of the Week” by Global Competition Review and “Legal Lion” by Law360 for his work. Partner Litigator of the Week Global Competition Review, 2019 Legal Lion Law360, 2020 Amherst College  University of Pennsylvania University of Pennsylvania Law School U.S. Court of Appeals for the Federal Circuit Supreme Court of the United States U.S. Court of Appeals for the Fourth Circuit U.S. Court of Appeals for the D.C. Circuit U.S. District Court for the District of Columbia California District of Columbia New York Bar Association of San Francisco Law Clerk, Hon. A Raymond Randolph, U.S. Court of Appeals for the D.C. Circuit Intern, Hon. Richard J. Leon, U.S. District Court for the District of Columbia Represented a large technology client in federal and state consumer products investigations arising under Section 5 of the FTC Act and state consumer protection laws Represented a large technology client in shareholder class action under federal securities laws Represented AT\u0026amp;T in a Section 5 consumer-protection case through district court litigation and appeals Defended AT\u0026amp;T’s merger with Time Warner against DOJ antitrust challenge pre-trial, at trial, and on appeal, United States v. AT\u0026amp;T, 916 F.3d 1029 (D.C. Cir. 2019), aff’g 310 F. Supp. 3d 161 (D.D.C. 2018). Assisted Fortune 50 client with third-party subpoena defense and anticipated appellate work in a copyright case Founding member of the litigation team representing Petersen Energia Inversora, S.A.U., Petersen Energia, S.A.U., and Eton Park Capital Management in litigation in the Southern District of New York against the Argentine Republic and YPF, S.A., alleging claims for breach of contract and promissory estoppel arising from defendants’ failure to comply with their tender offer requirements in connection with Argentina's expropriation of YPF plaintiffs against Republic of Argentina in Petersen Energía Inversora S.A.U. v. Argentine Republic. Co-authored respondent’s winning merits brief in a major antitrust case, Apple v. Pepper, 139 S. Ct. 1514 (2019), and was named a Global Competition Review “Litigator of the Week” for the win. Co-authored winning brief in Stuart v. Global Tel*Link Corp., 956 F.3d 555 (8th Cir. 2020), affirming summary judgment on consumer protection issues and class decertification (named Law360 “Legal Lion” for victory). Co-authored petitioners’ winning briefs challenging agency rulemaking in Global Tel*Link v. FCC, 866 F.3d 397 (D.C. Cir. 2017). Briefed and argued Sanders v. United States, 937 F.3d 316 (4th Cir. 2019), representing pro bono client the Brady Center to Prevent Gun Violence as amicus curiae. The Fourth Circuit, citing Brady’s brief, reinstated dismissed claims brought by victims of the 2015 shooting at Mother Emanuel Church in Charleston, S.C.","searchable_name":"Benjamin Softness","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":202,"capability_group_featured":null,"home_page_featured":null},{"id":442766,"version":1,"owner_type":"Person","owner_id":5387,"payload":{"bio":"\u003cp\u003eAs a data, privacy and security, health care, and employee benefits partner at King \u0026amp; Spalding LLP, Adam Solander provides counsel on data breach and cybersecurity issues across various industries, particularly health care. Adam represents clients with respect to employee benefits regulatory and compliance issues including designing, implementing, and maintaining employee benefit plans. He also advises clients on issues related to managed care laws and telemedicine.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eAdam has experience helping clients preparing for, responding to, and recovering from data, privacy and security incidents. He is a Certified CSF Practitioner, a designation given by the Health Information Trust Alliance (HITRUST). This organization provides training to develop and maintain effective security programs for health care and life sciences companies that comply with security laws, regulations, and standards, including HITECH, HIPAA, PCI, JCAHO, CMS, ISO, NIST, and various other federal, state, and business requirements.\u003c/p\u003e\n\u003cp\u003ePrior to joining King \u0026amp; Spalding, Adam was a member of a nationally recognized law firm where he was a part of their health care and life sciences practice group. Much of his experience is centered around assisting health care clients with HIPAA compliance, ERISA, managed care laws, telemedicine, and privacy and data security. \u0026nbsp;He also assisted private equity companies with evaluating privacy and security and employee benefits compliance risk in connection with potential investments.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003ePreviously, he served as Health Policy Counsel at the ERISA Industry Committee. There, he counseled Fortune 500 companies on healthcare legislation, including ACA, the HITECH Act, and ERISA. He also has experience advocating on behalf of trade associations and advocacy groups to Congress and Executive branch.\u003c/p\u003e","slug":"adam-solander","email":"asolander@kslaw.com","phone":null,"matters":null,"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":6,"guid":"6.capabilities","index":0,"source":"capabilities"},{"id":81,"guid":"81.capabilities","index":1,"source":"capabilities"},{"id":28,"guid":"28.capabilities","index":2,"source":"capabilities"},{"id":24,"guid":"24.capabilities","index":3,"source":"capabilities"},{"id":103,"guid":"103.capabilities","index":4,"source":"capabilities"},{"id":80,"guid":"80.capabilities","index":5,"source":"capabilities"},{"id":761,"guid":"761.smart_tags","index":6,"source":"smartTags"}],"is_active":true,"last_name":"Solander","nick_name":"Adam","clerkships":[],"first_name":"Adam","title_rank":9999,"updated_by":101,"law_schools":[{"id":1562,"meta":{"degree":"J.D.","honors":null,"is_law_school":1,"graduation_date":"2007-01-01 00:00:00 UTC"},"order":1,"pin_order":null,"pin_expiration":null}],"middle_name":"C.","name_suffix":"","recognitions":[{"title":"Named to Washington DC Rising Stars list","detail":"Super Lawyers, 2016-2018"},{"title":"Received Readers’ Choice Award","detail":"JD Supra, 2016"},{"title":"Received Burton Award for Legal Writing","detail":"Burton Awards Program in association with the Library of Congress, 2014"}],"linked_in_url":"https://www.linkedin.com/in/adamsolander/","seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eAs a data, privacy and security, health care, and employee benefits partner at King \u0026amp; Spalding LLP, Adam Solander provides counsel on data breach and cybersecurity issues across various industries, particularly health care. Adam represents clients with respect to employee benefits regulatory and compliance issues including designing, implementing, and maintaining employee benefit plans. He also advises clients on issues related to managed care laws and telemedicine.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eAdam has experience helping clients preparing for, responding to, and recovering from data, privacy and security incidents. He is a Certified CSF Practitioner, a designation given by the Health Information Trust Alliance (HITRUST). This organization provides training to develop and maintain effective security programs for health care and life sciences companies that comply with security laws, regulations, and standards, including HITECH, HIPAA, PCI, JCAHO, CMS, ISO, NIST, and various other federal, state, and business requirements.\u003c/p\u003e\n\u003cp\u003ePrior to joining King \u0026amp; Spalding, Adam was a member of a nationally recognized law firm where he was a part of their health care and life sciences practice group. Much of his experience is centered around assisting health care clients with HIPAA compliance, ERISA, managed care laws, telemedicine, and privacy and data security. \u0026nbsp;He also assisted private equity companies with evaluating privacy and security and employee benefits compliance risk in connection with potential investments.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003ePreviously, he served as Health Policy Counsel at the ERISA Industry Committee. There, he counseled Fortune 500 companies on healthcare legislation, including ACA, the HITECH Act, and ERISA. He also has experience advocating on behalf of trade associations and advocacy groups to Congress and Executive branch.\u003c/p\u003e","recognitions":[{"title":"Named to Washington DC Rising Stars list","detail":"Super Lawyers, 2016-2018"},{"title":"Received Readers’ Choice Award","detail":"JD Supra, 2016"},{"title":"Received Burton Award for Legal Writing","detail":"Burton Awards Program in association with the Library of Congress, 2014"}]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":6393}]},"capability_group_id":2},"created_at":"2025-11-13T04:56:44.000Z","updated_at":"2025-11-13T04:56:44.000Z","searchable_text":"Solander{{ FIELD }}{:title=\u0026gt;\"Named to Washington DC Rising Stars list\", :detail=\u0026gt;\"Super Lawyers, 2016-2018\"}{{ FIELD }}{:title=\u0026gt;\"Received Readers’ Choice Award\", :detail=\u0026gt;\"JD Supra, 2016\"}{{ FIELD }}{:title=\u0026gt;\"Received Burton Award for Legal Writing\", :detail=\u0026gt;\"Burton Awards Program in association with the Library of Congress, 2014\"}{{ FIELD }}As a data, privacy and security, health care, and employee benefits partner at King \u0026amp; Spalding LLP, Adam Solander provides counsel on data breach and cybersecurity issues across various industries, particularly health care. Adam represents clients with respect to employee benefits regulatory and compliance issues including designing, implementing, and maintaining employee benefit plans. He also advises clients on issues related to managed care laws and telemedicine.\nAdam has experience helping clients preparing for, responding to, and recovering from data, privacy and security incidents. He is a Certified CSF Practitioner, a designation given by the Health Information Trust Alliance (HITRUST). This organization provides training to develop and maintain effective security programs for health care and life sciences companies that comply with security laws, regulations, and standards, including HITECH, HIPAA, PCI, JCAHO, CMS, ISO, NIST, and various other federal, state, and business requirements.\nPrior to joining King \u0026amp; Spalding, Adam was a member of a nationally recognized law firm where he was a part of their health care and life sciences practice group. Much of his experience is centered around assisting health care clients with HIPAA compliance, ERISA, managed care laws, telemedicine, and privacy and data security.  He also assisted private equity companies with evaluating privacy and security and employee benefits compliance risk in connection with potential investments. \nPreviously, he served as Health Policy Counsel at the ERISA Industry Committee. There, he counseled Fortune 500 companies on healthcare legislation, including ACA, the HITECH Act, and ERISA. He also has experience advocating on behalf of trade associations and advocacy groups to Congress and Executive branch. Partner Named to Washington DC Rising Stars list Super Lawyers, 2016-2018 Received Readers’ Choice Award JD Supra, 2016 Received Burton Award for Legal Writing Burton Awards Program in association with the Library of Congress, 2014 West Virginia University West Virginia University College of Law Pennsylvania State University Pennsylvania State University, Dickinson School of Law West Virginia University West Virginia University College of Law District of Columbia District of Columbia Bar Association Member, American Health Lawyers Association","searchable_name":"Adam C. Solander","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":101,"capability_group_featured":null,"home_page_featured":null}]}}